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The adrenal gland is a small endocrine organ with inherent regenerative capacity. Numerous 
studies proposed a stem cell niche located in the capsule of adrenal cortex. This project 
investigated mRNA and protein spatial expression of potential stem cell markers in the 
adrenal cortex. One of these markers (Thy-1) was used to isolate potential stem cells from 
dispersed primary adrenal cortex cells using magnetic-activated cell sorting (MACS). Thy-1 
positive cells were monitored while they survived in vitro for over one year. Thy-1 cells were 
demonstrated to be undifferentiated fibroblastic-like cells with characteristics similar to those 
of mesenchymal stem cells in vitro such as plastic adherent, can form colonies, the confluent 
cells have a whirlpool-like formation and the significant (P< 0.05) increase of Thy-1 
expression during cultivation in vitro. Thy-1 positive cells showed the expression of other 
stem cell markers such as Wt1, Etv5 and ID4. The monitoring of Thy-1 positive cells 
behavioural changes in vitro showed slow division rate, slow cell migration and the 
coexistence of senescent cells in their early months of cultivation. In comparison, in the late 
months of cultivation, the cells showed a significant (P< 0.05) increase in cell division rate 
and cell migration similar to cancer cell behaviour in vitro. As these cells were generally 
undifferentiated and they have characteristics of mesenchymal stem cells, differentiation 
attempts were first conducted using external differentiation factors (forskolin, ACTH and 
AT20 cell line media). However, the results showed non-significant responses to these 
treatments. The second differentiation experiments were conducted by forcing expression of 
Sf1 protein in Thy-1 positive cells using a cloning vector. Transfection with Sf1caused a 
significant (P< 0.05) reduction in ID4 mRNA expression and significantly (P< 0.05) elevated 
the expression of the progenitor marker Gli1 and the expression of steroidogenic enzyme 
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and anti-rabbit Alexa647. All samples were mounted and cell nuclei were stained with DAPI in (A, E 
and I).  Merged images of (A), (B) and (C) are shown in (D) and of (E), (F) and (G) in (H), and (I), (J) 
and (K) in (L). The arrows in (G and J) refer to the location of Etv5 and ID4 expression in the nucleus, 
respectively. Scale bars: 20µm. 
Figure 3.14 Dual-staining immunocytofluorescence on three month old cultures of Thy-1 positive cells 
isolated using MACS. Cells were fixed with 4%PFA in PBS. (B) Cells were incubated with anti-CD45 
antibody. (F and J) Cells were incubated with anti-Thy-1 antibody. (C, G or K) Cells were incubated 
with control rabbit IgG, anti-SF1 antibody or with anti-WT1 antibody (Abcam) before detection with 
anti-mouse Alexa 647 in (B, F and J) and with anti-rabbit Alexa546 in (C, G and K). All samples were 
mounted and cell nuclei were stained with DAPI in (A, E and I). Merged images of (A), (B) and (C) are 
shown in (D) and of (E), (F) and (G) in (H), and (I), (J) and (K) in (L). Arrows refer to Sf1 single cell 
expression. Scale bars: 20µm. 
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Figure 3.15 Dual-staining immunohistofluorescence on rat adrenal gland cryosections. Adrenal gland 
sections were fixed with ice-cold acetone. (B) Adrenal sections were incubated with mouse IgG. (F 
and J) Adrenal sections were incubated with anti-Thy-1 antibody. (C, G or K) Adrenal sections were 
incubated with control rabbit IgG, anti-SF1 antibody or with anti-WT1 antibody (Abcam) before 
detection with secondary anti-mouse Alexa 647 in (B, F and J) and with anti-rabbit Alexa 546 in (C, G 
and K). All sections were mounted and cell nuclei were stained with DAPI in (A, E and I). Merged 
images of (A), (B) and (C)  are shown in (D) and of (E), (F) and (G) in (H), and (I), (J) and (K) in (L). 
Scale bars: 50µm. 
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Figure 3.16 Dual-Immunocytofluorescence on 10 month old cultures of Thy-1 positive cells isolated 
using MACS. Cells were fixed with 4%PFA in PBS. Cells were incubated with mouse anti-Thy-1 
antibody (B and F), or incubated with a rabbit anti-WT1 antibody (Abcam) (C and G) before detection 
with anti-mouse Alexa 488 and anti-rabbit Alexa 647. All samples were mounted and cell nuclei were 
stained with DAPI in (A and E). Merged images of (A), (B) and (C) are shown in (D) and of (E), (F) and 
(G) in (H). The upper row of photos are low magnification (A, B, C and D). The lower row of photos 
are high magnification (E, F, G and H). Arrows refer to the WT1 expression in the nucleus and in the 
cytoplasm of the cells. Scale bars: 20µm. 
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Figure 3.17 Dual-Immunocytofluorescence on 10 month old cultures of Thy-1 positive cells isolated 
using MACS. Cells were fixed with 4%PFA in PBS. Cells were incubated with mouse anti-Thy-1 
antibody (B and F), or incubated with a rabbit anti-Etv5 antibody (Abcam) (C and G) before detection 
with anti-mouse Alexa 488 and anti-rabbit Alexa 647. All samples were mounted and cell nuclei were 
stained with DAPI in (A and E). Merged images of (A), (B) and (C) are shown in (D) and of (E), (F) and 
(G) in (H). The upper row of photos are low magnification (A, B, C and D). The lower row of photos 
are high magnification (E, F, G and H). Arrows refer to the Etv5 expression in the nucleus of the cells. 
Scale bars: 20µm. 
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Figure 3.18 Dual-Immunocytofluorescence on 10 month old cultures of Thy-1 positive cells isolated 
using MACS. Cells were fixed with 4%PFA in PBS. Cells were incubated with mouse anti-Thy-1 
antibody (B and F), or incubated with a rabbit anti-ID4 antibody (Abcam) (C and G) before detection 
with anti-mouse Alexa 488 and anti-rabbit Alexa 647. All samples were mounted and cell nuclei were 
stained with DAPI in (A and E). Merged images of (A), (B) and (C) are shown in (D) and of (E), (F) and 
(G) in (H). The upper row of photos are low magnification (A, B, C and D). The lower row of photos 
are high magnification (E, F, G and H). Arrows refer to the ID4 expression in the nucleus of the cells. 
Scale bars: 20µm. 
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Figure 3.19 Dual-Immunocytofluorescence on 10 month old cultures of Thy-1 positive cells isolated 
using MACS. Cells were fixed with 4%PFA in PBS. Cells were incubated with mouse anti-Thy-1 
antibody (B and F), or incubated with a rabbit anti-Sf1 antibody (Abcam) (C and G) before detection 
with anti-mouse Alexa 488 and anti-rabbit Alexa 647. All samples were mounted and cell nuclei were 
stained with DAPI in (A and E). Merged images of (A), (B) and (C) are shown in (D) and of (E), (F) and 




are high magnification (E, F, G and H). The Sf1 expression was not detected in the cells. Scale bars: 
20µm. 
Figure 3.20 Immunocytofluorescence on 12 months old colony cultures of Thy-1 positive cells. Cells 
were fixed with 4%PFA in PBS. Cells were incubated with anti-Thy-1 antibody (B) before detection 
with anti-mouse Alexa 546. Merged images of (A) and (B) are shown in (C) and of (D) and (E) in (F). 
The expression of the Thy-1 protein was mainly located in the cells in and around the colony centre. 
While the cells growing far from the colony centre lost Thy-1 expression. The upper row of photos are 
low magnification (A, B and C). The lower row of photos are high magnification (D, E and F). All 
samples were mounted and cell nuclei were stained with DAPI (A). Merged images of (A) and (B) are 





Figure 3.21.  Detection of  β actin and Thy-1 protein expression in Thy-1 positive cells using Western 
blotting after different periods of times in vitro. (A) Thy-1 negative cells collected directly after MACS. 
(B) Thy-1 positive cells collected after 1month in vitro. (C) Thy-1 positive cells collected after 6months 
in vitro. (D) Thy-1 positive cells collected after 11months in vitro. Cells were counted before lysis with 
RIPA buffer in the presence of Protease Inhibiter Cocktail (1:200). Proteins were resolved on a 10% 
SDS gel before Western blotting with mouse anti-Thy-1 antibody (1:1000).  The graph shows the 
Western blotting analysis of Thy-1 expression levels normalised to the expression levels of the 
housekeeping protein (Beta Actin).  
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Figure 4.1 Amplification plots of the stability test for two housekeeping genes GAPDH and β actin 
using RT-qPCR on RNA isolated from 3 month old Thy-1 positive cells in culture including (untreated 
cells, cells after 2 days of transfection with Sf1 and cells after 2 days of transfection with native-
plasmid). The red curves represent GAPDH and the green curves represent β actin. The picture was 
acquired from this test using StepOne software connected to qPCR machine (Applied Biosystems). 
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Figure 4.2 Trendline plots of β actin expression against serial dilutions of RNA in the cDNA solution 
used for RT-qPCR (1ng/µl – 0.002 ng/µl) in both treated and control Thy-1 positive cells after 2 days of 
transfection with Sf1. 
171 
Figure 4.3 RT-qPCR relative quantification represented in fold changes of the mRNA expression of  
Sf1, CYP11A1, and 3βHSD in the Thy-1 positive cells after one week of treatment with ACTH, AT20 
cell line media and forskolin. The cells were treated in their 3
rd
 month of in vitro cultivation. The mRNA 
expression of all three genes showed no significant (p ≥ 0.05) response to all of these treatments. Three 
biological replicates were used in this experiment.    
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Figure 4.4 Agarose gel electrophoresis of Sf1 RT-PCR products. A&B are the bands of RT-PCR 
products using appropriate pair of primers against whole adrenal gland cDNA to amplify the full coding 
sequence of the rat SF1. (C) is the single band represents the product of second PCR after using the first 
product as template DNA with primers designed to add EcoR1 restriction sequences to the 5' of the SF1 
sequence and to add BamH1 restriction sequences to the 3' end of the SF1 sequence.  
175 
Figure 4.5 Agarose gel electrophoresis of the Sf1 DNA coding sequence after PCR and subsequent 
restriction digest. The targeted band was amplified using specific primers in a PCR reaction with 
primers containing EcoR1 and BamH1 restriction sites to amplify the full coding sequence of the rat 
SF1. The Sf1 DNA product was then flanked with restriction sites that were then digested with EcoR1 
and BamH1 enzymes. 
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Figure 4.6 Agarose gel electrophoresis of PCR products to amplify the full coding sequence of the rat 
SF1 using the extracted plasmid as the DNA template with appropriate pair of primers. The single DNA 
band represents the full coding sequence of the rat SF1 at approximately 1500bp.  
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Figure 4.7 Agarose gel electrophoresis of the extracted plasmid after digestion with EcoR1 and BamH1, 
showing the presence of the Sf1 at approximately 1500bp and the pIRES2 EGFP vector at 
approximately 5000bp. 
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Figure 4.8 RT-qPCR relative quantification represented fold changes of mRNA expression of Sf1 and 
Thy-1in the Thy-1 positive cells after Sf1 transfection. The cells were transfected in their 3
rd
  month of 




after transfection. Three biological replicates were used in this experiment. Summarized one-way 
ANOVA results showed significant ** (P<0.01)  increase in Sf1 expression. 
Figure 4.9 RT-qPCR relative quantification represented fold changes of mRNA expression of 3βHSD 
and CYP11A1 in the Thy-1 positive cells after Sf1 transfection. The cells were transfected in their 3rd 
month of in vitro cultivation and the mRNA expression was tested at three interval periods 2, 4 and 7 
days after transfection. Three biological replicates were used in this experiment. Summarized one-way 
ANOVA results showed significant * (P<0.05)  increase in Cyp11A1 expression.    
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Figure 4.10 RT-qPCR relative quantification represented fold changes of mRNA expression of Gli1 and 
Cyp21in the Thy-1 positive cells after Sf1 transfection. The cells were transfected in their 3
rd
 month of 
in vitro cultivation and the mRNA expression was tested at three interval periods 2, 4 and 7 days after 
transfection. Three biological replicates were used in this experiment. Summarized one-way ANOVA 
results showed significant * (P<0.05)  increase in Gli1 expression.  
182 
Figure 4.11 RT-qPCR relative quantification represented fold changes of mRNA expression of ID4 and 
Tert in the Thy-1 positive cells after Sf1 transfection. The cells were transfected in their 3
rd
 month of in 
vitro cultivation and the mRNA expression was tested at three interval periods 2, 4 and 7 days after 
transfection. Three biological replicates were used in this experiment. Summarized one-way ANOVA 
results showed significant * (P<0.05)  decrease in ID4 expression.  
183 
Figure 4.12 RT-qPCR relative quantification represented fold changes of mRNA expression of Sf1 and 
Thy-1 in the Thy-1 positive cells after Sf1 transfection. The cells were transfected in their 8
th
 month of 
in vitro cultivation and the mRNA expression was tested at three interval periods 2, 4 and 7 days after 
transfection. Three biological replicates were used in this experiment. Summarized one-way ANOVA 
results showed significant ** (P<0.01)  increase in Sf1 expression.   
185 
Figure 4.13 RT-qPCR relative quantification represented fold changes of mRNA expression of 
Cyp11A1 and 3βHSD in the Thy-1 positive cells after Sf1 transfection. The cells were transfected in 
their 8
th
 month of in vitro cultivation and the mRNA expression was tested at three interval periods 2, 4 
and 7 days after transfection. Three biological replicates were used in this experiment. Summarized one-
way ANOVA results showed significant * (P<0.05)  increase in Cyp11A1 and 3βHSD expression. 
186 
Figure 4.14 RT-qPCR relative quantification represented fold changes of mRNA expression of Gli1 and 
ID4 in the Thy-1 positive cells after Sf1 transfection. The cells were transfected in their 8
th
 month of in 
vitro cultivation and the mRNA expression was tested at three interval periods 2, 4 and 7 days after 
transfection. Three biological replicates were used in this experiment.    
187 
Figure 4.15 RT-qPCR relative quantification represented fold changes of mRNA expression of Cyp21 
and Tert in the Thy-1 positive cells after Sf1 transfection. The cells were transfected in their 8
th
 month 
of in vitro cultivation and the mRNA expression was tested at three interval periods 2, 4 and 7 days after 
transfection. Three biological replicates were used in this experiment.    
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Figure 4.16 Dual-Immunocytofluorescence staining on 3 months old cultures of Thy-1 positive cells 
isolated using MACS and transfected with the rat Sf1 gene cloned into the pIRES2 EGFP vector. Cells 
were fixed 2 days after transfection and incubated with mouse anti-Thy-1 antibody (B), incubated with a 
rabbit anti-Sf1 antibody (Abcam) (C) before detection with anti-mouse Alexa 546 and anti-rabbit Alexa 
647. The GFP expression from pIRES2 EGFP vector is shown in (D). All samples were mounted and 
cell nuclei were stained with DAPI in (A). Merged images of (A), (B), (C) and (D) are shown in (E). 
Arrow in (C) refers to the Sf1 expression in the nucleus of the cells. Circles in (D) refer to the GFP 
expression from the pIRES2 EGFP vector in the cytoplasm of the cells. Scale bars: 20µm. 
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Figure 4.17 Dual-Immunocytofluorescence staining on 8 months old cultures of Thy-1 positive cells 
isolated using MACS and transfected with the rat Sf1 gene cloned into the pIRES2 EGFP vector. Cells 
were fixed 2 days after transfection and incubated with mouse anti-Thy-1 antibody (B), incubated with a 
rabbit anti-Sf1 antibody (Abcam) (C) before detection with anti-mouse Alexa 546 and anti-rabbit Alexa 
647. The GFP expression of the pIRES2 EGFP vector is shown in (D). All samples were mounted and 
cell nuclei were stained with DAPI in (A). Merged images of (A), (B), (C) and (D) are shown in (E). 




expression from the pIRES2 EGFP vector in the cytoplasm of the cells. Scale bars: 20µm. 
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1.1 Adrenal cortex structure and function 
The adrenal glands are two small endocrine organs; one located upon each kidney. They 
consist of two distinct tissues the adrenal medulla and the adrenal cortex which are different 
in function and origin. Generally, the adrenal cortex, which is the subject of this study is 
described as a small thin endocrine gland, which is composed of three different layers or 
zones (Figure 1.1) and each of these zones has specific morphological and functional aspects 
(Wang and Rainey, 2012).  
The cortex is surrounded by a capsule inside which is the zona Glomerulosa (zG), this is 
responsible for producing and releasing mineralocorticoids, the hormones that control sodium 
reabsorption in the blood. Aldosterone is the typical mineralocorticoid in mammals, and it 
regulates the amount of potassium and sodium passed into the urine through the renin 
angiotensin aldosterone system (Norris and Carr, 2013).  
The next layer is the zona Fasciculata (zF), which produces glucocorticoids. These hormones 
regulate the metabolism of carbohydrates, fats and proteins. Glucocorticoids such as cortisol 
stimulate the liver to convert glucose to glycogen and release lipids and fatty acids into the 
blood from adipose tissue. However, cortisol increases blood glocouse because it has insulin-
antagonistic effects (Lager, 1991). Furthermore, glucocorticoids can affect skeletal muscle 
and stimulate it to release proteins or amino acids into the bloodstream. In addition, 
glucocorticoids participate in the inflammatory response (Stachenko and Giroud, 1964). 
Since the main model in this study is the rat, it is important to take into consideration that the 





hydroxylase in the adrenal cortex of the rodents. In comparison, cortisol is the main 
glucocorticoid in humans (Mitani, 2014). 
 The final, inner, layer is called the zona Reticularis (zR) which is responsible for releasing 
dehydroepiandrosterone (DHEA) and the sulphated dehydroepiandrosterone (DHEAS) in 
humans and other primates, which is also known as adrenal androgen. DHEA is similar to 
other male sex hormones, which also allow the development of male characteristics during 
early embryonic growth and puberty. In steroidogenesis, DHEA is considered the precursor 
of sex hormones. It is found to be reduced with aging and is similar to cortisol in several 
functions such as having insulin-antagonistic effects and its association with obesity. 
However, the release of adrenal androgen from the zR is not exhibited in rodents such as 
mice and rats (Mitani, 2014), due to lack of cyp17α-hydroxylase (van Weerden et al., 1992).  
Furthermore, studies based on histological assays on rats revealed a cell zone located between 
the innermost portion of the zG and the outermost portion of the zF which is called the zona 
Intermedia (zI) and does not show any hormonal releasing activity when tested by 
immunohistochemical staining methods. These cells have a high proliferative activity and 















Figure 1.1 Diagrammatic representation of the adrenal cortex showing the three distinct zones of the cortex: the 
zona Glomerulosa (zG) the source of mineralocorticoids; the zona Fasciculata (zF) synthesises cortisol and the 






1.2 Steroidogenesis in adrenal cortex  
Steroidogenesis is the process by which steroid hormones are synthesised. In mammals, it 
takes place mainly in the ovary, testis and adrenal cortex. Generally, cytochrome P450 
proteins and steroid oxidoreductases are the main enzymes responsible for steroidogenesis, 
using cholesterol as the starting material. In addition to its role in the stress axis, ACTH is the 
main hormone that stimulates the biosynthesis of steroid hormones in the adrenals. ACTH 
triggers a series of molecular events that lead to the conversion of cholesterol to 
pregnenolone by cholesterol side-chain cleavage enzyme (P450 Scc) (Jefcoate et al., 1992). 
Subsequently, each of the zones of the adrenal cortex expresses enzymes that convert 
pregnenolone to different hormones via a set of oxidoreductase reactions. For example, 
androgen in the form of dehydroepiandrosterone (DHEA) is the final product of the zR, while 
the zF converts pregnenolone to glucocorticoids such as corticosterone in rodents or cortisol 
in humans (Conley and Bird, 1997). In response to angiotensin II, the zG converts 
pregnenolone to the mineralocorticoid, aldosterone (figure 1.2). Both zF and zG have same 
group of catalytic enzymes that synthesiseing steroids from cholesterol with a zG specific  
final step enzyme (Cyp11B2) that is also called aldosterone synthase and zF specific 
expression of the final step enzyme (Cyp11B1) (King et al., 2009). Since the three active 
zones of the adrenal cortex have major roles in controlling a variety of physiological 
functions, a genetic disorder or mutation of protein within this gland often results in lethal or 
incurable diseases. Histologically, zF represents the major zone of the adrenal cortex in most 
organisms like humans and rodents and it has an important role in hypothalamic–pituitary–









Figure 1.2 The steroidogenic pathway in the adrenal cortex, ACTH stimulates molecular events which result in 
the production of steroid hormones initiated by the conversion of cholesterol to pregnenolone, this process 
requires StAR, which allows cholesterol to enter mitochondria where the cholesterol side-chain cleavage 
enzyme P450 Scc (encoded by the cytochrome P450, family 11, subfamily A, polypeptide 1 (CYP11A1)), 
converts the cholesterol to pregnenolone in all three zones of the cortex. 3β-hydroxysteroid dehydrogenase (3β-
HSDs) converts the pregnenolone to progesterone, 17OH-pregnenolone to 17OH-progesterone and DHEA to 
androstenedione in the zG, zF and zR respectively. The enzyme 21-hydroxylase (CYP21) converts progesterone 
to 11-deoxycorticosterone, 17OH-progesterone to 11-deoxycortisol in the zG and the zF. While the 17a-
hydroxlyse (CYP17) is absent in the zG, both zF and zR use the hydroxylase activity of CYP17 to produce17-
OH pregnenolone from pregnenolone in the zF, and 17-OH progesterone from progesterone in zR. CYP17 also 
catalyses 17α-OH progesterone to produce (DHEA) in the zR. The enzyme (3βHSDs) in the zR, converts 
DHEA to androstenedione, which in turn is converted to adrenal testosterone by 17β-hydroxysteroid 








1.3 Adrenal cortex and the stress axis  
Stress stimuli usually cause disruption to the physiological homeostasis of the body and the 
body has a neuroendocrine system designed to respond to these stimuli and restore 
homeostasis. The stress signal is received by both the central and peripheral nervous system. 
The stress processing system includes a number of hormones such as corticotrophin releasing 
hormone, arginine vasopressin, hormones and peptides derived from proopiomelanocortin, 
glucocorticoids, adrenaline and nor-adrenaline. All these factors are included within the stress 
or HPA axis system (Charmandari et al., 2005). This HPA axis system is tightly regulated to 
adapt to environmental stresses by releasing glucocorticoids from the zF also known as stress 
hormones. This end-products (glucocorticoids) of this neuroendocrine system, play the main 
role in the physiological adaptation of the organism against the stress factors (Nicolaides et 
al., 2015). The HPA axis system activates when the stress signal reaches the nuclei of the 
corticotropin-releasing hormone (CRH)-secreting parvocellular neurons of the hypothalamus, 
which respond by stimulating release of the proopiomelanocortin (POMC) from the pituitary 
gland into blood stream (Goncharova, 2013). POMC undergoes enzymatic cleavage by the 
prohormone convertases, which result in a number of hormones and peptides in addition to 
adrenocorticotropic hormone (ACTH). ACTH induces the zF to produce and release the 
glucocorticoids. Glucocorticoids such as cortisol have multi targets as a stress hormone 
preparing the organism to react toward the stressors by stimulating the immune system 
(Castro et al., 2011) and glycogen synthesis in the liver (Mersmann and Segal, 1969). 
Glucocorticoids also elevate blood pressure, counter-act insulin effects, increase catabolism 
of protein and raise plasma glucose (Macfarlane et al., 2008). Although all these changes are 
associated with preparing the body to adapt to maintain homeostasis during stress, any 
dysregulation of this response due to increasing the level or the period of stress will result in 
deterioration of homeostasis and might end with several acute and chronic diseases 










1.4 POMC-derived peptides and receptors 
The exsistance of POMC as a precursor of multiple hormones and biologically active 
peptides was not known until the late seventies of the last century. The early studies of Ascoli 
& Legnani in 1912 revealed the basic relationship between the pituitary gland and the adrenal 
gland when scientists recorded adrenal atrophy in dogs after hypophysectomy (Lowry, 1984).  
This finding was later confirmed by studying the effect of re-implanting the pituitary in 
hypophysectomised rats, which restored the adrenal cortex from atrophy and it was 
subsequently proposed that an adrenal controlling factor was released from the pituitary 
(Smith, 1930). Over time bioassays were developed to identify ACTH as the hormone that 
influence the growth of adrenal gland (Howard et al., 1955, Bell, 1954). However, the ACTH 
precursor (POMC) was not recognised until 1977 when two different experiments were 
conducted to investigate the relationship between ACTH and β-lipotrophin (as they were 
sharing similarities that led to the hypothesis that both might derive from the same precursor). 
The first group showed that both ACTH and β-lipotrophin (β-LPH) have the same precursor 
molecule, when they immunoprecipitated the same 31 kiloDalton (kD) molecule from AtT-20 
(mouse pituitary tumour cells) media after using antisera to endorphins (END) or ACTH 
(Mains et al., 1977). The second group used a cell-free translation system under the direction 
of mRNA isolated from AtT-20 cells. They identified a 28 kD protein (represents POMC 
without glycosylation) with both antisera to β-lipotrophin and ACTH (Roberts and Herbert, 
1977). Cloning of the gene encoding the precursor was reported two years later (Nakanishi et 
al. 1979), later research followed to reveal the structure of the POMC gene (which includes 
three exons) and all the peptides (figure 1.3). The ACTH peptide sequence is located in the 





at the C-terminal of the ACTH. While γ-MSH, the 16 kD fragment and the secretory signal 
sequence were at the N-terminal of the ACTH (Pritchard et al., 2002). 
Further research followed to reveal the structure and the functions of POMC-derived peptides 
and their receptors. The application of molecular cloning technologies in the 1990s revealed a 
group of melanocortin receptors, which were cloned and subtyped into five receptors 
(Mountjoy et al., 1992). The melanocortin receptors: MC1R, MC2R, MC3R, MC4R and 
MC5R are all G protein-coupled receptors and they share 7 membrane domains. However, 
they have different sequences at the N-terminus and the C-terminus (Cone, 2006). Each of 
these receptors is mainly associated with a different function such as pigmentation, 
glucocorticoid biosynthesis, energy homeostasis, and the regulation of food intake and 
exocrine glands (Dores et al., 2014). 
Although each of these receptors has a specific ligand, ACTH can bind and activate all of 
these subtypes. However, MC2R is specific for ACTH. The other POMC-melano peptides ( 
α-MSH, β-MSH and γ-MSH) can activate MC1R, MC3R, MC4R and MC5R but they have 
different affinity to each of these receptors (Brzoska et al., 2008, Caruso et al., 2014). The 
functional capacity of each POMC-derived-peptide is primarily due to their effects on a 
specific MCR. For example, α-MSH has an immune-modulating capacity because its receptor 
(MC1R) is localised on macrophages, monocytes and dendritic cells (Luger et al., 2003).  
The system of POMC-peptides and the melanocortin receptors is one of the most important 
systems regulating mammalian energy homeostasis and food intake. The result of applying 
the advanced technologies such as Cre-LoxP transgenic animals and optogenetics facilitated 
the understanding of the nature of these receptors in the plasma membrane, which have 
various active and inactive forms (Mountjoy, 2015). The advances of these new technologies 
facilitated new findings on POMC-peptide-receptor-systems and their potential of protecting 





2017). For example, MC4R deficiency is now a well-documented cause of obesity and the 








Figure 1.3 Diagram showing the POMC three exon gene and the translated protein in humans, mice and rats, 
which represents the precursor hormone of over 30 kilodaltons. The precursor hormone (POMC) contains three 
main regions or groups of peptides that are eventually cleaved into smaller and more functional peptides. The N-
terminal of POMC (1-76) comes after the secretory signal peptide and contains γ1-MSH and γ3-MSH. The 
central region (ACTH region) comes after the joining peptide (JP) and contains α-MSH and corticotropin-like 
intermediate peptide (CLIP). The C-terminal region contains beta-lipotrophin (β-LPH), which is cleaved into β-
endorphin and γ-LPH. The γ-LPH is cleaved to generate N-LPH and β-MSH. The MSH core peptide sequences 














1.3 POMC and adrenal growth 
 
The early findings of Ascoli & Legnani in 1912 sparked the investigation to identify a factor 
that was released from the pituitary and affected the growth of adrenal gland. Even before 
identifying POMC, the 1970s scientific observations suggested ACTH was the main factor 
maintaining adrenal growth and steroid production (Mulrow, 1972). However, later research 
showed the opposite of that where ACTH treatment caused inhibition of primary adrenal cell 
proliferation in vitro  (Ohare and Neville, 1973) and the quantitative evaluation of the rat 
adrenal gland did not change after treating the rats with anti-ACTH antiserum  (Rao et al., 
1978). These findings suggested specific mitogenic peptide or peptides different from ACTH 
were stimulating adrenal cortex growth and cell proliferation. Promising findings were 
recorded after Estivariz and Coworkers isolated pro-γ-MSH from the frozen human pituitary 
(Estivariz et al., 1980). The N-terminal derivatives of pro-γ-MSH were proposed to be 
responsible for adrenal growth because the post-secretion cleavages of pro-γ-MSH at the 
lysine sites (at N-terminal see figure 1.1) suggested to induce adrenal growth and mitogenesis 
(Estivariz et al., 1982). However, the processing of N-terminal POMC was not clearly 
understood at that time and it was assumed that the cleavage occurred after the lysine site that 
forms the (1–48) of the N-POMC and (51–76) of the γ3-MSH, while the cleavage occurs 
after the arginine site that forms (1–49) of the N-POMC and (50–76) Lys-γ3-MSH as 
reviewed in (Bicknell, 2016). However, it was not recognised by Estivariz and his group in 
1982, which of these peptides or their derivatives stimulate the adrenal growth and 
mitogenesis.  Several experiments were carried out to investigate the role of pro-γ-MSH 
derivatives in compensatory adrenal growth. The most interesting findings were recorded 
from a series of experiments, one of which included administration of an antibody against N-





compensatory adrenal growth, which was recognised by the elimination of increase in the 
remaining adrenal weight and DNA content after 24 hours as it was suggested as indicator of 
an inhibition of hyperplasia (Lowry et al., 1983). Further studies were carried out 
investigating the growth factor during compensatory growth, one of which used an antibody 
against γ3-MSH that significantly inhibited the increase in DNA content (Al-Dujaili et al., 
1982). Al-Dujaili and his co-workers proposed that this antibody might inhibit the proteolytic 
cleavage that is required to produce the γ3-MSH derivative that induces adrenal growth. 
Although a few investigations supported this hypothesis, non-have provided proof until a 
study demonstrated the cloning and characterisation of a serine protease that cleaved the γ3-
MSH, which was essential during the adrenal compensatory growth response (Bicknell et al., 
2001).  
 
The regenerative capacity of the adrenal gland following enucleation (pressing out the 
adrenal medulla and most of the inner cortex after incision in the adrenal capsule) provides 
another model to test POMC derivatives and their effect on adrenal growth. For example, 
Estivariz et al (1988) tested the administration of either ACTH  or purified human 1–28 of N-
POMC on the mitotic index of the female rat adrenal after adrenal enucleation and removing 
the pituitaries, the results showed that N-POMC(1–28) compensates by preventing the 
atrophy of regenerating adrenal glands in comparison with saline controls (Estivariz et al., 
1988a). The follow-up study from the same group calculated the mitotic index on adrenal 
sections after the administration of anti-N-POMC(1–28) antiserum and anti-ACTH antiserum 
followed by injecting the rats with colchicine on the next day. The results showed that anti-N-
POMC (1–28) antibody produced a significant decrease in mitotic counts, while the ACTH 
antibody only decreased the production of corticosterone  (Estivariz et al., 1988b). Although 





the cost and difficulties that accompany the purification process of the human 1–28 of N-
POMC restrict conducting more experiments, which called for using a synthetic one.  
 However, the effect of synthetic N-terminal 1–28 POMC recorded significantly less mitotic 
activity in comparison with purified 1–28 of N-POMC (Estivariz et al., 1988a). Researchers 
imputed that the reduction in activity of the synthetic N-POMC was most likely due to the 
differences of disulfide bridge arrangements (Bennett, 1984). Even in POMC gene null mice, 
the administration with synthetic 1–28 N-POMC did not affect adrenal growth, but reduced 
food intake and weight (Coll et al., 2006). Torres and co-workers emphasise the importance 
of disulphide bridges on proliferation when the modified synthetic 1-28 of N-POMC 
(disulphide bridges were changed and cysteines were replaced with methionines) increased 
the DNA synthesis in the zG and zF of the rat adrenal (Torres et al., 2010). These findings 
provoked more investigations concerning the effect of ACTH and N-POMC (1-28) on the 
proteins associated with the cell cycle of the adrenal cortex such as cyclin D and one of the 
cyclin-dependent kinase (Cdk) inhibitor proteins (P27) in the zG. Both ACTH and N-
POMC inhibited the expression of P27 and upregulated the D2 and D3 cyclins (de Mendonca 
et al., 2013). Others studied the effects of the treatments with POMC-derived peptides on the 
expression of other cell cycle key genes such as Ccnb2, Camk2a and Nek2 in the rat zG and 
zF after the inhibition of the HPA axis. The treatments with N-POMC peptides compensated 
the decreased expression of Nek2 and Notch2 that result from the inhibition of the HPA axis 
(de Mendonca et al., 2014).  
1.4 Centripetal migration of adrenocortical cells 
The centripetal migration of cells from the sub-capsular area toward the adrenal cortex 
/medulla boundary can be proposed on the basis of cell proliferation level in the region of the 
adrenal sub-capsule and the predominant level of apoptosis in the border between the zR and 





regenerative capacity and it was shown that the capsule is necessary for the regeneration of 
the adrenal cortex in earlier studies (Ingle and Higgins, 1938). Later, several attempts were 
conducted to trace these proliferating and migrating cells. The earliest cell tracing studies 
showed that the proliferative cells reach the region between the zona Fasciculata and the zona 
Reticularis one month after tritiated thymidine injection, and the zona reticularis was 
enriched with these cells two months after injection in rats (Diderholm and Hellman, 1960). 
Other researchers (Zajicek et al., 1986) estimated most of the labelled cells were localised in 
the capsule one day after injection of the rats with thymidine, these cells then crossed the 
cortex zones, reaching the medulla surface after 104 days. During the journey, 50% of the 
proliferative cells die, while the rest are eliminated at the boundary of the zR with the 
medulla. Proliferating cells were detected by other methods such as the analysis of the 
expression of proliferating cell nuclear antigen (PCNA) (Mitani et al., 1994). In rats, most of 
the labelled cells were localised in the zI and the capsule, suggesting these areas to be the 
regions where proliferative activity is highest Mitani et al.,(2003). Adrenal enucleation 
experiments revealed the role of the remaining capsular and sub-capsular cells, after 
enucleation and these cells were found to be responsible for regenerating the adrenal cortex 
(Bland et al., 2003). The regenerative capacity of the adrenal cortex has also been observed in 








1.5 Embryonic development of the adrenal cortex  
The embryonic origin of the adrenal gland has been intensively studied in mammals such as 
humans and rodents and has revealed similar characteristics in such mammals. The adrenal 
cortex shares a common developmental origin with the gonads and kidneys originating from 
the urogenital ridge and/or intermediate mesoderm of the mesothelium. The development 
begins with a single layer of the mesothelium (coelomic epithelium) enlarging in thickness at 
the urogenital ridge at around E9.5 in mice (Bandiera et al., 2013, Hatano et al., 1996) and 
around the fourth week of gestation in humans (Norris and Carr, 2013). The thick cellular 
area of the coelomic epithelium forms the adreno-gonadal primordium (AGP), which is the 
precursor of the adrenal cortex and gonads. The cells that are meant to become the adrenal 
cortex )adrenal primordium( of the AGP start to appear distinct from surrounding structures 
by differentiating into acidophilic and slightly larger cells (Hanley et al., 1999). 
 These cells partially penetrate or attach to the basic mesenchyme, which forms the primitive 
or foetal adrenal cortex. These foetal cortex cells are infiltrated by the medullary primordium 
cells that migrate from the embryonic neural crest to the innermost part of the foetal cortex, 
which will form the adrenal medulla. Around the sixth week of gestation, the mesothelium 
provides more cells to surround the original foetal acidophilic cortex cells, but these 
incoming cells are basophilic smaller cells, which densely pack at the exterior of the foetal 
zone. At the 8
th
 week of gestation, the developing foetal cortex acquires two simple zones: 
the inner foetal zone, which comprises large eosinophilic cells, and the outer definitive zone 
that contains small packed basophilic cells (Goto et al., 2006, Hanley et al., 2001). The 
mesenchymal capsule starts to surround the developing foetal cortex and around the 9
th
 week 







The morphology of the prenatal cortex preserves a relatively constant structure: the narrow 
outer layer of small cells underneath the capsule, which represent the definitive zone that 
exhibit characteristics of proliferative cells and the inner foetal zone that is composed of 
columns-like cells that reach the outer border of the medulla. During the meddle of gestation 
the cells of the definitive zone contain a low level of lipids. However, after that, as the 
embryo developing these cells gradually accumulate lipid and become steroidogenically 
active. While, the large columns-like cells (foetal zone) have typical characteristics of 
steroidogenic cells (Sucheston and Cannon, 1968, Mesiano et al., 1993). 
The foetal cortex undergoes rapid regression after birth and the definitive cortex expands on 
top of the degraded foetal cortex. However, not all the foetal cells undergo degradation, a Cre 
recombinase experiment examining the lineage of foetal adrenal cells, suggested that there 
are a population of cells belonging to the foetal adrenal buried among adult cortical cells, 
which form a third zone between the definitive zone and foetal zone called the transitional 
zone (Ishimoto and Jaffe, 2011). Cells in the transitional zone show characteristics of both 
zones (definitive and foetal zone) and they are capable of synthesising cortisol (McNutt and 
Jones, 1970). These infringing foetal cortical cells are potentially involved in the pathway of 
the adult cortex cell development till mouse embryonic day 14.5 (Zubair et al., 2008). As 
gestation advances to around the 30
th
 week, the human foetal adrenal cortex starts to exhibit 
the fundamental form of the adult zG and zF of definitive zone and transitional zone 
respectively (Sucheston and Cannon, 1968). Furthermore, in primate mammals such as 
humans, the outer layer of the foetal zone differentiates to form the zR (Brugger and Prayer, 







1.5.1 Factors associated with adrenal cortex development  
 
Several essential influences have been described as crucial for the development of the adrenal 
cortex such as blood supply, hormonal factors and paracrine adrenocortical factors 
(Willenberg and Bornstein, 2000).  Several pathways and factors have been revealed to be 
important for adrenal development. 
1.5.1.1 Wingless-type MMtv (Wnt) signalling pathway 
 
The Wnt signalling pathway has been recorded as an evolutionarily conserved pathway, 
which regulates several characteristics of the mammalian cell such as cell migration, cell 
polarity and organogenesis during development. The large family of Wnt glycoproteins 
involved in signalling pathways are activated after the Wnt ligand binds to its respective 
Frizzled receptor. This pathway has been categorized into canonical (Wnt/β-catenin 
dependent) pathway and the non-canonical (β-catenin-independent) pathway, which can 
include planar cell polarity or the Wnt/Ca
2+
 pathways (Komiya and Habas, 2008). Several of 
the Wnt pathways have been recorded to play an important role in the homeostasis and the 
development of adrenal cortex. For instance, Wnt4 is been involved in the growth and 
development of several organs such as the gonads, kidney, adrenal, mammary gland and 
pituitary (Bernard and Harley, 2007). A defect of Wnt4 (noncanonical Wnt) caused a 
disturbance in the cell migration during the development of the mammalian gonad and 
adrenal cortex (Jeays-Ward et al., 2003). In the adult tissue, the inhibition of Wnt signalling 
by protein kinase cAMP-dependent (PKA) in adrenal cortex suppresses malignancy (Drelon 








1.5.1.2 Hedgehog signalling pathway  
 
Hedgehog (Hh) was first identified during genetic screening aimed to understand the body 
segmentation of the Drosophila melanogaster embryo (Nusslein-Volhard and Wieschaus, 
1980). The hedgehog (Hh) pathways are important for embryonic development and 
mammalian cell proliferation and differentiation (Ingham and McMahon, 2001). The Hh 
signalling pathways have been associated with the regulation of vertebrate stem cell fate 
(Blank et al., 2008). These developmental and well-conserved signalling pathway molecules 
have been recorded in the development of limbs, lungs, skin and the neural tube (Xie and 
Abbruzzese, 2003, Blank et al., 2008). The Hh pathways are activated by molecules called 
ligands/morphogens such as Indian hedgehog, Desert hedgehog and Sonic hedgehog (Shh). 
These ligands are formed, modified and then secreted from the cells (Burke et al., 1999). 
Each of these ligands interacts and moves through the extracellular matrix to locate their 
receiving cells where they bind to a Patched-1 receptor, which cause the endocytosis and 
degradation of Hh. The endocytosis of Shh promotes the translocation of Smoothened (Class 
Frizzled G protein-coupled receptor) from plasma to the cell membrane. The promotion of 
Smoothened is critical to activate a family of transcription factors called the glioma-
associated oncogenes (Glis) (Ching and Vilain, 2009). The pathway activated by the sonic 
hedgehog (Shh) ligand has been suggested as important for adrenal cortex development in 
mice (Bitgood and McMahon, 1995, Guasti et al., 2011). As Shh is essential for adrenal 
cortex organogenesis, its transcriptional factor (Gli1) is found to be expressed in the mouse 
adrenal capsule (Ching and Vilain, 2009). The expression of Shh is also detected in the sub-
capsular area in mice (Guasti et al., 2011, King et al., 2009). The important role of Wilms 





maintanance (Walczak and Hammer, 2015). Recent findings showed that the activation of 
Wnt signalling (that support the regeneration of the adrenal cortex after long-term treatment 
with glucocorticoid) was related to shh signalling (Finco et al., 2018).   
1.5.1.3 Steroidogenic factor 1 (SF1) and Wilms tumour 1 (WT1) 
 
The key fate inducer of adrenocortical cells is the steroidogenic factor 1 (Sf1) or also called 
Adrenal 4 binding protein (Ad4bp), which is a transcription factor that initiates a 
differentiation programme, transforming the embryonic mesenchymal cells into differentiated 
steroidogenic cells (Luo et al., 1994). The role of Sf1 is to continue to regulate the 
transcription of steroidogenic genes for both the adrenal cortex and the gonads because it has 
binding sites up-stream of the promoter or the enhancer regions of several steroidogenic 
genes (Schimmer and White, 2010). 
 In addition to Sf1, there are other transcription factors associated with adrenal cortex 
development such as Wilms tumour 1 (WT1), which is a protein that comprises four zinc-
finger motifs at the C-terminus and a DNA-binding domain enriched with glutamine and 
proline at the N-terminus. WT1 plays an essential role in the normal development of the 
urogenital system (Berry et al., 2015) and regulates the development of interstitial progenitor 
cells during the embryonic development of the mouse testis (Wen et al., 2016). Additionally, 
it is thought to be involved in the stem/progenitor adrenocortical cell state (Bandiera et al., 
2013). Furthermore, WT1 assists with the regulation of SF1 transcription during gonadal and 
adrenal development (Wilhelm and Englert, 2002, Val et al., 2007). The important role of 
WT1 and Shh in adrenal cortex development has been proposed to be involved in the 






More factors were found to be involved in adrenal cortex development such as transcription 
factor called co-factor Cited2, which has been described to be associated with the adrenal 
cortex development because of its expression in the urogenital ridge and it was found to be 
required to specify a group of AGP cells into adrenal cortex cells when it interacts with WT1. 
This interaction promotes the expression of Sf1 in the AGP prior the splitting of gonad and 
adrenal cortex (Val et al., 2007). Factors such as homeodomain protein Pbx1 (homebox 
protein family of transcriptional factors) are suggested to induce adrenal cortex 
differentiation because the deficiency of Pbx1 reduces the outgrowth of urogenital ridge and 
in Pbx1 mutants showed minimum Sf1 expression levels in adrenal (Schnabel et al., 2003).  
Other factors like the nuclear receptor transcription factor called  Dosage-sensitive sex 
reversal, Adrenal hypoplasia congenita, on the X chromosome, number 1 (DAX1), a protein 
encoded by NR0B1 was found to be important for the adrenal cortex development because of 
the consequences associated with its mutation that cause developmentally relevant adrenal 
dis-function conditions such as congenital adrenal hypoplasia or adrenal regression (El-Khairi 
et al., 2011, Xing et al., 2017).  
Additional factors and pathways have been studied in vitro or in lineage tracing genetic 
studies have been found to be associated with the regulation of adrenal cortex development.  
Armadillo repeat-containing 5 (ARMC5) is one such factor identified in these studies and 
found to be associated with the Wnt/β-catenin signalling pathway in a subset of zona 
Fasciculata cells. Inactivating mutations of this gene have been found to be associated with a 
adrenal cortex disorder called primary macronodular adrenal hyperplasia (this disorder can be 
diagnosed by several small hormone-producing nodules in the adrenal glands)  (Berthon et 






1.6 Diseases and disorders of the adrenal cortex 
The hormones derived from the adrenal cortex are involved in different metabolic activities. 
When the adrenal cortex is unable to produce its steroids, described as adrenal insufficiency, 
death results in most cases if not treated. Adrenal insufficiency might result indirectly from 
various causes such as autoimmune diseases and genetic disorders. Epidemiological studies 
relate adrenal insufficiency to adrenal crisis. However, recent studies showed that factors 
related to the adrenal crisis were more complicated than primary and central adrenal 
insufficiency (Iwasaku et al., 2017). Such adrenal crisis usually requires lifelong treatment 
via hormone replacement which is not adequate or always available for most cases. 
Furthermore, the physiological need for adrenal cortex hormones is notably variable and 
related to patient stress levels and the time of the day, which reduce the efficiency of the 
common treatments (Dunn et al., 2004).  
1.7 Stem cells  
Every cell in an organ or tissue has specific functions that make it capable of a special role 
within these tissues until it dies, whereas stem cells are more concerned with regeneration. 
These cells such as embryonic stem cells have the ability of self-renewal and differentiation 
making them able to regenerate different types of body cells (Lu and Zhang, 2015). This 
remarkable potential of stem cells allows them to develop into almost all cell types providing 
the tissue that they reside in with a repair system that can be used in case of injury or normal 
regeneration. These cells specialise in repletion cells of a tissue by asymmetric divisions as 
well as replenishing themselves by symmetric divisions. These two functions are balanced in 
the tissue of organs (Morrison and Kimble, 2006). These two special features of stem cells 
are the main targets for researchers because they play a crucial role in regenerative medicine, 





then use them as spare parts for humans or animals. Over the last few years, stem cell therapy 
has received much attention, because of the potential medical revolution being made possible 
by tissue reprogramming and regenerative medicine (Liu et al., 2017, Lim et al., 2017, 
Henderson et al., 2017). Stem cells are classified into three types based on their ability to 
differentiate to other cell types, the first type of stem cells are called totipotent; these are cells 
that can differentiate into all cell types which represent the blastomeres of the embryonic 
cells of early stages, which quickly transit from totipotent to pluripotent (Morgani et al., 
2013). The second type is called pluripotent; these cells are capable of forming all somatic 
cells with the exception of forming the embryonic trophoblast (Mitalipov and Wolf, 2009). 
The final type is called multipotent; these cells can differentiate into a few cell types. 
Although it is difficult to identify stem cell type due to differences in isolation methods and 
approaches to characterising these cells, the International Society for Cellular Therapy has 
taken the responsibility to address human stem cells by proposing criteria to describe these 
cells (Dominici et al., 2006). However, these standards have proven to be changeable and 
depend on the new findings regarding stem cell markers (Samsonraj et al., 2015).  
1.7.1 Stem cells types 
Stem cells can be characterised by several criteria such as their differentiation potentials as 
described before in section (1.7); these include the number of cell divisions that a stem cell 
can undergo and remain undifferentiated (self-renewal capacity) or can be characterised by 
their tissue source. There are different sources of stem cells, which can generally be divided 





1.7.1.1 Embryonic stem cells (ESCs) 
Embryonic stem cells are the most potent normal stem cells that derive from the embryo and 
have a natural capacity to generate all cell classes in the normal body. Manipulating these 
cells to become a specific cell type for use in a tissue transplant is practically difficult 
(Turinetto and Giachino, 2015). These stem cells need to be directed into an adult cell type 
rather than being transformed into cancer cells, which is a possible dangerous unwanted 
effect after transplantation. Although ESCs are the most potent stem cells, isolation and 
cultivation of these cells is quite challenging. ESCs are usually generated from an in vitro 
fertilised ovum and the embryo must be maintained in vitro until the formation of the 
blastocyst, or isolation of the blastocyst from the pregnant female before it reaches the 
implantation stage into the uterus. Then the ESCs can be isolated from the inner cell mass of 
the cavity of the blastocyst (Fischbach and Fischbach, 2004). Further to the technical 
challenges, the medical community raises ethical problems related to the origin of this type of 
stem cell, since it might be involved in eliminating embryos, especially if ESCs are isolated 
from humans. These ethical issues have led the medical community to establish policies to 
limit these treatments (de Wert and Mummery, 2003). Even with approved isolation, the 
cultivation of ESCs is quite demanding. The normal (non- embryonic) or cancer cell culture 
requires transferring cells from their natural environment into a plastic culture dish in the 
laboratory, where the cells are growing over the surface of the dish in the culture medium. In 
addition to that usual requirement for in vitro cultivation, ESCs require special culture 
medium to maintain their undifferentiated state otherwise they will normally differentiate 
(Tsuji et al., 2008). Furthermore, the surface of the plastic culture dish, which faces the cells 
should be coated with a feeder layer. This feeder layer of human or mouse embryonic 
fibroblast cells is adopted to improve the attachment of ESCs to the culture dish and provide 





differentiation capacity that ESCs have allow scientists to analyse different features of several 
diseases and study the opportunities of using them in medical treatment for incurable diseases 
such as cardiac disorders (Hausburg et al., 2017).  
1.7.1.2 Adult stem cells or somatic stem cells  
Adult stem cells are a kind of undifferentiated cell within adult tissues or organs that have 
self-renewing and multi-differentiation abilities. However, they have less differentiation 
potential than embryonic stem cells. Since embryonic stem cells are derived from embryos, 
they have a potential capacity to differentiate into almost all cell classes in the body 
(Turinetto and Giachino, 2015). Adult stem cells however work as providers of new cells 
within a tissue or the organ by replacing the dead or damaged cells in order to maintain the 
viability of the tissue. Their existence in different types of organs has been well established, 
for instance in the skin, intestine, muscle and other organs (Pittenger et al., 1999). The most 
widely studied adult stem cell type is bone marrow stem cells which are the progenitors to the 
various different types of blood cell (Lebouvier et al., 2015). The heart was thought not to 
have self-renewal capacity, but there have been studies which suggest the presence of stem 
cells that have a role in the healing process after heart injury (Finan and Richard, 2015). It 
has also been suggested that the neural stem cells in the central nervous system have the 
ability to differentiate into astrocytes and neurones (Chu et al., 2015).  Generally, most of the 
clinical research in this area focuses on methods to control the differentiation ability of adult 
stem cells in order to use them in transplantation therapies. Furthermore, recent studies 
emphasise that adult stem cells can be used to manage rheumatic diseases such as rheumatoid 
arthritis and osteoarthritis (Franceschetti and De Bari, 2017).  
The limited differentiation ability of adult stem cells (multipotent) is not the only challenge 
that faces the researchers but also that adult stem cells usually remain quiescent unless they 





precursor cells) are quiescent in aged mice. However, after induction by a surgical or 
chemical lesion, these cells shifted functionally and morphologically from quiescent, 
flattened, horizontal basal cells to proliferative and pyramidal cells (Brann et al., 2015). The 
importance and the usage of adult stem cells have been well established in different types of 
adult organs. For instance, the epidermal stem cells of the skin are responsible for skin 
epithelium homeostasis, wound healing and hair renew cycle processes (Lacina et al., 2015). 
Another example is the stem cells in the dental pulp that have the ability to generate 
expanded colonies that can be used to form fibroblast colony units on plastic (Yasui et al., 
2015).  
The variety of stem cells has been detected in several adult tissues or organs derived from the 
main three embryonic primary germ layers. For example, endodermic stem cells which are 
detected in the thyroid gland (Thomas et al., 2006). Ectodermic stem cells such as 
dopaminergic neurones can give rise to neurones and support (glial) cells (Vermilyea et al., 
2017). Mesenchymal stem cells that are derived from the mesoderm, which are well studied 
as they are present in almost all vascularised organs of the body (Crisan et al., 2008), the 
adrenal cortex is also derived from the mesoderm, which might possess mesenchymal stem 
cells.  
 1.7.1.3 Mesenchymal stem cells (MSCs)  
 
 MSCs have been considered as the most potent adult stem cells with the most potential for 
clinical therapy because of their high capacity for regeneration and differentiation into 
various cell types. Furthermore, simple isolation and conventional in vitro cultivation 
methods can be used with MSCs, this facilitates the study of these cells and their use in 
research and in the clinic, especially in regenerative medicine. Unlike human embryonic stem 





the other hand, MSCs are usually isolated from adult tissues and the isolated stem cells will 
experience a new in vitro environment after a long term period in their in vivo 
microenvironment, which might alter the cell function and structure. This environmental 
alteration after transfer of the cells from in vivo to in vitro might result in losing the required 
information for development of these cells in particular (Higuita-Castro et al., 2017). These 
limitations necessitate quality controlled isolation methods for MSCs, which are based on the 
capacity of these cells to adhere to plastic and express appropriate surface stem cells markers 
(Harichandan et al., 2013).  
One of the natural therapeutic potentials of MSCs is their capacity to migrate toward special 
targets within the tissue they are raised in. The migration properties of MSCs make these 
cells capable of transporting to the damaged sites in animal tissue, but the molecular 
mechanism of MSCs migration within damaged tissue remains unclear (Tang et al., 2017, Xu 
et al., 2017). However, a few studies have suggested that chemokine receptors, ligands and 
adhesion molecules are involved in facilitating the migration for tissue repair in vivo 
(Chamberlain et al., 2007). Examples of these facilitating mediators include: platelet-derived 
growth factor receptor (Nakamizo et al., 2005, Fiedler et al., 2002), integrin 
α4β1)/vascular cell adhesion molecule-1 (Cui et al., 2017), stem cell factors such as cytokines 
that bind to receptors like c-kit, HGF/c-Met (Forte et al., 2006), stromal cell-derived factor 1 
(SDF-1)/C-X-C chemokine receptor type 4 (CXCR4) (Son et al., 2006, Nakamizo et al., 
2005), high mobility group box 1/receptor for advanced glycation end-products (Palumbo and 
Bianchi, 2004, Palumbo et al., 2007), vascular endothelial growth factor receptor (Ball et al., 
2007), monocyte chemoattractant protein-1 (MCP-1)/C-C chemokine receptor type 2 (Dwyer 
et al., 2007) and other cell adhesion molecules (Ip et al., 2007, Son et al., 2006).  
These chemokine receptors and cytokines also regulate the response of white blood cells 





thought to respond in a similar manner to leukocytes (Balkwill, 2004). The inflammatory and 
tumour signalling might induce MSC migration. For example, the chemokine receptor pairs, 
SDF-1 and CXCR4 are important mediators for the recruitment of the MSCs to tumours 
(Nakamizo et al., 2005). The cellular hypoxia that results from the expression of 
proangiogenic molecules which are expressed in several tumour microenvironments induces 
transcription factors such as hypoxia-induced transcription factor (HIF-1α) that up regulates 
genes like vascular endothelial growth factor, tumour necrosis factors, macrophage migration 
inhibitor factor, and other cytokines (Winner et al., 2007). The cellular hypoxia also 
generates chemokines such as monocyte chemoattractant protein-1, which has a role in the 
migration of MSCs to tumours (Dwyer et al., 2007). However, other chemokine-receptor 
interactions are required to induce MSC migration toward inflammatory and tumour sites for 
therapeutic purposes.  
Additional therapeutic action of MSCs includes their ability to secrete soluble factors that can 
induce an immunomodulatory environment in vitro (Ye et al., 2008) and in vivo (Joo et al., 
2010).  
MSCs have been isolated from a number of human and animal tissues such as dental pulp, 
heart, spleen, liver, adipose tissue, testes, hair follicles, dermis and bone marrow (Augello 
and De Bari, 2010). Additionally, their clinical regenerative potentials have shown applicable 
results. For example, in spite of several MSC cultures being shown to have heterogeneous 
populations of cells, MSCs have been used for various pre-clinical and clinical experiments 
to treat several conditions like cartilage injury (Borakati et al., 2017), infarction of 
myocardium, liver diseases, graft-versus-host disease (transplant rejection) and defective 
osteogenesis (Kim and Cho, 2013, Joo et al., 2010, Killington et al., 2017). Furthermore, 
managing the use of MSCs from amniotic in trans-amniotic stem cell therapy to treat new-





gastroschisis (Fauza, 2017). The sources of MSC cultures isolated from different tissues and 
cultured in vitro with different conditions raises complications in MSC identity. Even though 
there are intensive studies regarding the identification MSCs markers, there is no definite 
consensus as to what markers specific for identifying MSCs.  
1.7.1.5 Induced pluripotent stem cells (iPSCs)  
 
In 2006, scientists developed a genetic reprogramming method that induces changes in 
typical cells in the laboratory to become potentially like embryonic stem cells. Skin cells 
have been transformed into pluripotent cells through this technique. Controlling cell 
behaviour by specific genetic modification in this way therefore results in the generation of 
embryonic like stem cells (Turinetto and Giachino, 2015). The process of generating iPSCs 
involves transfecting the target cells in a two stage process with Yamanaka factors; the first 
transfection is with c-Myc and Klf4 and the second transfection with Oct4, Sox2 and Klf4. 
This process mainly aims to establish bivalent chromatin domains (an area where the DNA 
has epigenetic modifications to increase or decrease its accessibility to RNA polymerase) by 
the first wave, and DNA methylation by the second wave for obtaining pluripotency (Polo et 
al., 2012). More recent cell reprogramming methods involve using viral vectors such as 
Sendai viruses to transduce the Yamanaka factors to the target cells (Fusaki et al., 2009). The 
recombinant single-stranded RNA (ssRNA) viruses undergo cytoplasmic replication in the 
host cell and do not enter the nucleus or need to form a DNA intermediate to integrate with 
the host cell DNA. In addition, they are neither pathogenic nor tumorigenic to humans 
(Nakanishi and Otsu, 2012, Chichagova et al., 2015). Such promising techniques might 
replace older methods of harvesting stem cells from human embryos and thus release stem 
cell therapy from ethical issues to some degree. However, several mutations in signalling 





the notable resemblances of cellular reprogramming with tumorigenesis (Stadtfeld and 
Hochedlinger, 2010).  
1.7.1.4 Foetal trophoblast derived stem cells. 
ESCs are usually isolated from the inner cell mass of the cavity of the blastocyst (Fischbach 
and Fischbach, 2004). The remaining trophoblastic portion gives rise to organs and tissues 
such as placenta, amniotic fluid and umbilical cord, which also possess stem cells. The 
trophoblastic foetal tissues have stem cells that enhance and activate the growth and 
development of all foetal organs from their location inside their tissues. In comparison to 
adult tissues, foetal tissues contain relatively large numbers of stem cells, which are also 
accessible to appropriate isolation methods making them an important source of stem cells 
(Pop et al., 2015). One of the advantages of these stem cells, in addition to their young age, is 
their relative lack of ethical conflicts because all of the trophoblast system (placenta, amniotic 
fluid and umbilical cord) is normally discarded post-partum. The use of these stem cells in 
regenerative medicine is suggested to be more amenable than stem cells derived from the 
bone marrow for myocardial regenerative therapy (Makhoul et al., 2013). Furthermore, 
regarding the fact that different stem cells have different potentials and differentiation 
tendencies based on their different sources, the two sides of the human placenta (foetal and 
maternal origins) have two different therapeutic potentials (Zhu et al., 2014). Recent studies 
identify a subset of placental stem cells, which have a higher migration rate to wound injury 
and a highly effective wound healing capacity (Wang et al., 2017). 
Additionally, stem/progenitor cells also exist in the amniotic fluid, which is described as 
multipotent. Several recent studies suggest their ability to be differentiated into 
myocardial cells (Jiang and Zhang, 2017) and distal lung phenotype cells (Jensen et al., 2017, 






 Furthermore, the umbilical cord stem cells and the blood stem cells within the umbilical cord 
are tissue-specific. Similar to the stem cells in the adult bone marrow, these are thought to be 
multipotent and may differentiate into all the cells in the normal bone marrow. Various 
studies have used blood stem cells isolated from umbilical cords therapeutically to treat 
diseases. For example, umbilical cord stem cells were used to treat blood diseases and repair 
serious cardiac injuries that frequently cause heart failure (Hollweck et al., 2012). These stem 
cells have also been used for the treatment of children with perinatal brain injury (McDonald 
et al., 2017) and the treatment of acute ocular burns in children (Sharma et al., 2017). 
Scientists are also working to manipulate these stem cells by preserving the discarded 
placenta and umbilical cord blood from newborn babies for potential future use because these 
tissues showed potential pluripotency (Beeravolu et al., 2017). 
1.7.2 Stem cells markers 
 Specific proteins or genes that can be used for identifying and isolating stem cells are known 
as stem cells markers. Using these markers can allow efficient stem cell isolation using a 
method such as flow cytometry or magnetic cell sorting. Considering the functions of stem 
cells markers is important for characterising and understanding the mechanisms by which 
stem cells maintain their pluripotency/multipotency and self-renewal (Zhao et al., 2012). For 
instance, markers such as Sox2, Klf4 contribute to maintaining stem cell stability and inhibit 
the transcriptional activity that might result in differentiation (Liebau et al., 2014). Nanog and 
Oct4 were the first proteins identified as being required for maintaining the pluripotent state 
in ES cells (Loh et al., 2006, Hayashi et al., 2015). Since then, several other stem cell markers 
for pluripotency have been discovered. Furthermore, Liebau et al. (2014) address the intrinsic 





stem cells but also can be used for reprogramming adult cells to act as pluripotent stem cells 
such as Oct4, Sox2, Klf4 and c-Myc.  
 There is no agreement on a unique surface molecule to identify MSCs from various sources 
because identifying a specific set of unique characteristics facilitating reliable identification 
of these multipotent stem cells has been challenging (Lee et al., 2014). 
 However, a few criteria were suggested to be the minimum for the identification of human 
MSCs, such as their capacity to remain adherent to plastic under the standard in vitro culture 
conditions. Along with their capacity to express CD105, CD73 and CD90 and lack of 
expression of CD45, CD34, CD14 or CD11b, CD79a or CD19 and human leukocyte antigen 
– antigen D related (HLA-DR) and that they are potentially capable of differentiating into 
chondrocytes, osteoblasts and adipocytes (Dominici et al., 2006). As the bone marrow (BM) 
is the most studied source of MSCs, other surface antigens were recognised to expressed by 
this type of MSCs including CD29, CD13, CD10 and CD44 (Buhring et al., 2007). There are 
two types of markers proposed for identifying MSCs: first is the sole marker, which 
represents a core characteristic of MSCs such as the plastic adherence capacity of MSC that 
is appropriate for identification or isolation of MSCs from their natural tissues or a sole 
marker that can substitute the presence or absence of the other defined markers for MSCs 
such as CD271 (Flores-Torales et al., 2010). Second markers are called the stemness markers, 
which can identify the population of MSCs with multipotency and high colony forming units 
or markers that can specify an ESC-like population within the isolated MSCs. Therefore, the 
sole marker is required to be highly expressed while the stemness markers can be less 
expressed but at a detectable level. 
The most recognised finding regarding identifying and isolating MSCs using stem cell 





populations is now widely accepted and criteria that characterise MSCs represent a 
proportion of the isolated cells, and such heterogeneity may be reflected by some markers 
like CD200 (Pontikoglou et al., 2016). The tissue source that MSCs are originated from, 
might influence the potential capacity of the cells. For example, in addition to BM, several 
alternative tissues were recognised to be sources for MSCs and they are expected to have the 
capacity for clonogenicity and multipotency. However, only a fraction of the isolated plastic 
adherent MSCs and colony-forming units showed multipotency, which indicates a 
heterogeneous cell population with differential protein expression and cytokine profiles. This 
heterogenicity may relate back to their different niches in vivo, which result in a different 
commitment from their lineage in vitro (Russell et al., 2010). The multipotency and the 
tendency for differentiation of the isolated MSCs from different sources are also different.  
For instance, the potency of MSCs of BM to differentiate into osteocytes was higher than 
their potency to differentiate into adipocytes (Muraglia et al., 2000). While the dental follicle 
stem cells have a spontaneous tendency to differentiate into osteocytes (Lucaciu et al., 2015). 
In a differentiation comparison study, the ectopic transplantation of MSCs originating from 
BM resulted in differentiation into heterotopic bone tissue, while dental pulp-derived MSCs 
differentiated into reparative dentin-like tissue (Batouli et al., 2003). Furthermore, MSCs 
might possess an immature cell population, which present embryonic stem cell criteria by 
expressing markers like Oct-4 and Sox2 (Kuroda et al., 2010).  
1.7.3. Stem cells niches 
The stem cell microenvironment or so-called “niche” has been reported to have a crucial role 
in the regulation and maintenance of stem cells. Different niches promote different activities. 
For example, osteoblastic niches support a quiescent state where the hematopoietic stem cells 
maintain slow cycling or stay in the G0 state due to the hypoxic environment, the oxygenic 





Although several tissue stem cells types have been proven to be quiescent in their niches, 
they have the potential to be able to differentiate, proliferate and self-renew (Li and Clevers, 
2010, Wilkinson and Gottgens, 2013). The interaction between the stem cells and their niches 
provides a state that allows lifelong maintenance of the tissue and safeguards the stem cells 
from various stressful conditions, as well as stimulating these cells to proliferate and support 
the tissues with progenitor and differentiated cells (Arai and Suda, 2008). 
1.7.4. Stem cells in the adrenal cortex 
 The adrenal cortex is an active endocrine organ that contains a number of different cell types 
that are replenished continuously. The existence of stem cells is required for cortical 
homeostasis where centripetal migration of the adrenocortical cells from the capsular and 
sub-capsular areas move cells towards the border between cortex and medulla where the 
differentiated cells undergo apoptosis (Pihlajoki et al., 2015). Several studies on adrenal 
cortical stem cells have investigated the capsule, not only as a simple layer that supports the 
cortex to integrate the gland structure as most histological studies describe but also as a niche 
for adrenocortical stem cells that serve as originator cells for other cells in the cortex 
(Walczak and Hammer, 2015).  The proposed existence of stem and progenitor cells within 
the adrenal cortex date back to early studies of the 1930s. These studies revealed the capacity 
of the capsule and sub-capsular layers to restore the adrenal cortex 6 weeks after adrenal 
enucleation (Ingle and Higgins, 1938). A few years later, lineage tracing experiments were 
conducted to reveal a genetic clonal relationship between the adrenocortical capsule cells and 
the differentiated cells beneath it, which showed that inner differentiated cortex cells are 
derived from the mesenchymal Sf1-negative capsule (Salmon and Zwemer, 1941). 
The adrenal cortex of several mammalian species have been suggested to have a mix of 
clusters of undifferentiated cells in the sub-capsular layer along with cells expressing 





capacity in mice (Heikkila et al., 2002) and humans (Nishimoto et al., 2010). These findings 
suggest the presence of a stem/progenitors cells population in the adrenal cortex.  
Microarray data (donated by Dominic Cavlan, William Harvey Research Institute, Barts and 
The London School of Medicine) from a whole rat genome array was used to compare the 
expression in the zF, capsule and zI. This data highlighted a range of potential stem or 
progenitor cell markers that have been over-expressed in one or both the capsule and the zI in 
comparison to their expression level in the zF. 
 
1.3 Aims of study  
1- Firstly, this project aims to confirm these microarray data by nominating and examining a 
number of these markers and detecting their locations of expression and segregation in the 
adrenal cortex. 
2- Identify the best potential marker to be used for isolating potential stem cells and isolate 
the target cells. 
3- Study the isolated cells in vitro to investigate their gene expression including other stem 
cells markers.  
3- Study the capacity of these cells for self-renewal, viability and stability after long-term in 
vitro cultivation. 









Detection of potential stem cell marker mRNAs and protein in the adrenal 
cortex 
2.1 Introduction 
The aim of this chapter is to characterise a number of potential adrenocortical stem cell markers. 
Although, several studies have proposed the existence of adrenocortical stem cells (Heikkila et 
al., 2002, Nishimoto et al., 2010, Mitani, 1994, Walczak and Hammer, 2015), to our knowledge 
specific adult stem cell markers for adrenal cortex have not been established. Most of the 
research refers to the capsule of the adrenal gland as the niche for these stem cells. However, 
Mitani, 1994 refers to the potential of the zI in rat adrenal cortex to possess stem/progenitor cells 
as it did not show corticosteroid enzymatic activity.  
Finding stem cell markers in the adrenal cortex during this project started with bioinformatic 
analysis of microarray data (donated by Dominic Cavlan, William Harvey Research Institute, 
Barts and The London School of Medicine) from a rat whole genome array, which was used to 
compare the expression of all genes in the zF, capsule and zI. This data highlighted a range of 
potential stem or progenitor cell markers that were over-expressed in one or both the capsule and 
the zI in comparison to their expression level in the zF. This array analysis resulted in the 
identification of a wide range of potential markers. These nominated markers underwent further 
investigation in the previous studies regarding their role in stem cells characteristics. This 
combined information resulted in few nominated markers. The gene expression of these potential 
stem cell markers was examined to confirm the array data. So Reverse transcription polymerase 
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chain reaction (RT-PCRs) were conducted using specific primers (table 2.1) to confirm the gene 
expression of these potential stem cell markers. Further investigations were then conducted to 
reveal details of where the mRNA and protein of these potential markers were along with the 
spatial expression in the adrenal cortex. These investigations included molecular cloning, 
labeled-RNA probe generation, in situ hybridisation, immunohistofluorescent, microscopy and 
imaging analysis. Three proteins were identified as potential adrenocortical stem cell markers. 
Transmembrane protein121 (Tmem121), Thy-1 cell surface antigen (Thy-1) and Krüppel-like 
factor 5 (KLF5). They were selected from the microarray data (table 2.2) based on their 
expression patterns in the adrenal cortex. All of these investigations obtained primary 
information on these markers in the adrenal cortex and aided specification of the best marker for 




2.2 Material and methods 
The work within this project started with the analysis of microarray data donated by Dominic 
Cavlan, (William Harvey Research Institute, Barts and The London School of Medicine) to 
identify stem cell markers. Laser capture microdissection (Figure 2.1) of a rat adrenal gland 
section was conducted and whole genome array analysis was used to compare expression in the 
zF, capsule and zI. The analysis of these data included sort the data in Microsoft Excel to show 
the fold ratios of gene expression of over 30,000 genes based on their expression in the adrenal 
capsule divided by their expression in zF and zI. Then the fold ratios of gene expression in the 
adrenal zI were sorted in the same way, by dividing their expression in the zI by their expression 
in capsule and zF. The resulting ratios were then sorted from high-low to present clear data of 
sorted genes that were highly expressed in the capsule and zI, but have low expression in zF. A 
number of these genes were then disregarded as they represented an unknown expressed 
sequence tag (EST). The rest of the analysis was conducted by reviewing the related articles 
regarding over 60 nominated genes that show the highest expression in the capsule in 
comparison with zF and/or zI in comparison with zF. These genes or markers might identify 
important MSCs characteristics, such as the ones that have a role in self-renewal of stem cells. 





















Figure 2.1 Laser capture microdissection (LCM) of the rat adrenal cortex, targeting the nominated stem cell zones 
(capsule and zI). A: Intact rat adrenal cortex slide. B: Adrenal cortex slide after removing zI. C: Adrenal cortex slide 
with the laser system targeting the capsule before capture (Dominic Cavlan, William Harvey Research Institute 
Barts and The London School of Medicine).   
 
 All materials for experiments were sourced from Thermo-Fisher Scientific unless stated 
otherwise. 
2.2.1. Adrenal tissue  
 To test the array data regarding the gene expression of the potential stem cell markers their 
expression was examined in rat adrenal tissues. All the adrenal tissues used in this study were 
freshly isolated from adult Wistar-rats (weight 250-350g) from Harlan Envigo UK were housed 
in rooms where the ambient temperature and light were under automatic control. The rats were 
39 
 
treated under the United Kingdom Home Office Animals Act 1986. Rats were euthanised by 
CO2 asphyxiation. 
2.2.1.1 RNA isolation from rat adrenal tissue (TRIzol Reagent method)  
TRIzol reagent (Ambion) was used for the isolation of RNA from rat adrenals. TRIzol Reagent is 
a mixture of phenol, guanidine isothiocyanate, red dye and other proprietary components which 
is ready to use reagent for the isolation of total RNA. One ml of TRIzol reagent was added to a 
single adrenal gland in a 1.5ml microcentrifuge tube for homogenization. After homogenization, 
samples could be stored at -70°C for up to 1 year. To remove insoluble particles after 
homogenization the mixture was centrifuged at 12,000 g for 10 min at 4°C before the addition of 
0.1 ml (10% v/v of TRIzol reagent used) of bromochloropropane (BCP), and the supernatant was 
then transferred to a clean tube. The sample was then mixed by inversion for 15 seconds and 
incubated at room temperature for 15 min. Three phases were then observed upon addition of 
BCP: a colourless upper phase which contained RNA, a white cloudy interface which contained 
DNA and a red organic phase which contained proteins. Samples were then centrifuged for 15 
min at 12,000 g at 4°C. The microcentrifuge tubes were removed from the centrifuge and placed 
directly into a cooled rack. The colourless top layer that contained the RNA was carefully 
transferred into a clean 1.5ml microcentrifuge tubes before the addition of 0.5 ml of isopropanol 
(50% v/v of TRIzol reagent used). Tubes were mixed by inversion and left to stand at room 
temperature for 15 min before centrifugation at 12,000 g for 25 min at 4°C (the precipitated 
RNA formed a pellet on the bottom of the tube), the supernatant was discarded and 0.5 ml of 
75% (v/v) ethanol was added and mixed to wash the RNA. Next samples were centrifuged at 
7,500 x g for 5 min at 4°C. The ethanol was discarded and the pellet was suspended in 50µl of 
double distilled water (DDW). 
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To eliminate genomic DNA contamination, DNase treatment was conducted, 6µl of 10x DNase I 
reaction buffer (Appendix A.1) and 5µl DNase I RNase-free enzyme (1unit/µl) was added to 
49µl RNA and mixed which was then followed by incubation at 37°C (water bath) for 15 min. 
The RNA was then purified by the addition of 300µl of TRIzol reagent per microcentrifuge tube 
and the RNA was re-purified using the above procedure using proportionally less of each reagent 
based on the addition of 300µl of TRIzol reagent instead of 1ml. The final RNA pellet was 
dissolved in 50µl of DDW. Analysis by spectrophotometry using a Nanodrop (2000) was carried 
out to measure the concentration and the purity of isolated RNA using 1µl of the isolated RNA. 
The 260/230 and 260/280 ratio were used to estimate the RNA purity. The 260 nm wavelength 
represents the peak absorbance of the nucleic acid bases in DNA and RNA, this varies due to 
different ratios and types of bases that construct the nucleic acids. These differences alter 
depending on the concentration. RNA absorbance is doubled at 260nm to 280nm, whereas DNA 
absorbance at 260nm is 1.8 of its absorbance at 280nm. Therefore a 260/280 ratio of ~1.8 is 
generally accepted as “pure” for DNA and a ratio of ~2.0 is generally accepted as “pure” for 
RNA. If this ratio was lower than expected it might indicate the presence of contaminants such 
as protein or phenol that absorb at or near 280nm, any other contaminants that absorb at or near 
280nm may cause the same low ratio. 
2.2.1.2 RNA electrophoresis  
The isolated RNA was analysed by agarose gel electrophoresis to test its integrity. The RNA was 
mixed with loading buffer (6X DNA loading dye). The gel was prepared by melting agarose at a 
concentration of 1.2% w/v in 1X Tris Acetate EDTA (TAE) buffer (Severn Biotech) in a 
microwave for 1 min, the solution was cooled to ~65°C. Ethidium bromide was then added to a 
final concentration of 0.1μg/ml, the solution was then mixed thoroughly and poured into gel tray. 
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The agarose gel underwent electrophoresis for 1 hour, at 7 volts/centimetre (v/cm). Lastly, the 
gel was visualised by a transilluminator to identify the ribosomal RNA 28 subunit (28s) and 18 
subunits (18s) RNA bands, to confirm RNA integrity. 
2.2.2 cDNA synthesis (RT-PCR) 
For synthesis of total cDNA, a RevertAid First Strand cDNA synthesis kit was used. After 
thawing the components of the kit, they were mixed, briefly centrifuged and stored on ice. An 
aliquot of 1-5μg of isolated RNA was mixed with 1μl (100μM) oligo (dT)18 primer, or a mix of 
0.5μl (100μM) oligo (dT)18 primer and 0.5μl (100μM) random primers depending on the 
targeted gene. The volume was made up to 12 μl by the addition of nuclease-free water. 
Subsequently, the reaction volume was made up to 20μl by adding 4μl of 5X reaction buffer 
(Appendix A.2), 1μl of (20u/μl) of RiboLock RNase Inhibitor, 2μl (10 mM) deoxydNTP Mix 
and finally 1μl of (200u/μl) RevertAid reverse transcriptase. The reaction was incubated at 42°C 
for 1 hour, before termination at 70°C for 5 minutes. 
Table 2.1 List of primers (Invitrogen) used in the RT-PCR, their reference number, position in the mRNA sequence 
and their product size. 
Gene 
symbol  
Forward primer 5`-3` ( position in the sequence) Reverse primer5`-3` ( position in the sequence) Segment 
Size(bp)  
Gene code 
GAPDH  CAAGGTCATCCATGACAACTTTG (540-562) GTCCACCACCCTGTTGCTGTAG (1035-1014) 496  XM_017593963.1 
Klf5  CACAGCGCCAGAGGTGAACAATATC (507-531) ATGGATGCGTCGCTTCTCCAGATC (1020-997) 514  XM_006252403.3 
Thy-1  CCTCCAAGCCACGGACTTCATTTC (865-888)  AAGGCTCAGCAGCGCTCTCCTATC (1377-1354) 513  XM_017595476.1 
Tmem121  TTGGTAGGCGATGTGTGCTTCCTG (393-416) ATCATCTTCTGCGGTGCGATGTGC (901-878) 509 XM_006240674.3 
M13  CGCCAGGGTTTTCCCAGTCAGC  TCACACAGGAAACAGCTATGAC   





2.2.3 Generating amplicons of target genes by PCR 
 PCR was used to detect the expression of the genes of interest, as well as amplifying the desired 
amplicons that can be used later for generating RNA probes. A 25μl PCR reaction was prepared 
in 0.2 ml microcentrifuge tube by mixing 12.5μl pre-aliquoted Extensor Hi-Fidelity PCR master 
mix, 1μl of each primer (10μM), 1μl cDNA (20ng/µl) and 9.5μl of nuclease-free water to make 
the total volume 25μl. The components of the reaction were then mixed. The PCR conditions 
used were as follows: 94°C for 1 min for initial denaturation and activation of Taq polymerase, 
followed by 29 cycles of 94°C for 20 sec for denaturation, 58°C for 20 sec for primer annealing, 
finally the extension was performed at 72°C for 1 min which was carried out to ensure the 
completion of full length DNA product. The same preparations were conducted for each PCR 
with slight changes depending on the annealing temperature. After the reaction was complete the 
PCR products were then profiled by electrophoresis on a 1.2% (w/v) agarose gel with a 1Kb plus 
ladder (Generuler).  
 
2.2.4 Purification of DNA from agarose gel slices  
The QIAquick Gel Extraction Kit (Qiagen) was used to purify DNA from agarose gel slices. The 
band of interest was excised from the gel using a clean scalpel blade, placed in a 1.5ml 
microcentrifuge tube and weighed to estimate the needed volumes (assuming a density of 1g/ml). 
Three volumes of Buffer QG (Appendix A.3) were added to each 1 volume of the gel. The gel 
slices were incubated at 50°C, mixing every 2-3 minutes until the gel slice had completely 
dissolved. After the gel slice had dissolved, 1 gel volume of isopropanol was added to the sample 
and mixed. Then the mixture was transferred to a QIAquick spin column in the provided 2 ml 
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collection tube. The sample was centrifuged at 17,900 x g for 1 min to bind DNA, and the flow-
through was discarded. If the DNA was to be used for in vitro transcription, 0.5 ml Buffer QG 
was added to the QIA quick column and it was centrifuged for 1 min. The flow-through was then 
discarded and the QIAquick column placed back into the same tube. 
In order to wash the DNA, 0.75 ml of Buffer PE (Appendix A.4) was added to the QIAquick 
column, which was centrifuged for 1 min, the flow-through was discarded and the QIAquick 
column placed back into the same tube. The QIAquick column was then centrifuged for 1 min at 
17,900 x g to remove residual wash buffer. Finally, to elute the DNA, the QIAquick column was 
placed into a clean 1.5 ml microcentrifuge tube, and 50 μl of nuclease-free water was added to 
the centre of the QIAquick membrane. In order to increase the yield of purified DNA the column 
was left to stand for 1-5 min before centrifugation for 1 min. The purified DNA was analysed by 
agarose gel electrophoresis (section 2.2.1.2).   
2.2.5. Ligation  
The cloning of inserts into the pGEM-T Easy vector (Promega) was conducted by TA ligation. 
Ligation reactions were carried out using T4 ligase (Promega) to ligate the genes of interest into 
the pGEM-T Easy plasmid vector. The reaction mixture was 10μl in total, and contained 1μl of 
10x ligation buffer (Appendix A.5). Then the vector and the insert were added. The addition of 
the DNA insert and the vector was conducted using a 3:1 (insert: vector DNA) molar ratio. 
Lastly, T4 ligase (1-3 Weiss units) was added. The reactions were mixed by pipetting and 
incubated overnight at 4°C.  
2.2.6 Competent E. coli preparation and transformation 
The Inoue method for "Ultra Competent" cell preparation and transformation (Inoue et al., 1990) 
was used to prepare Mach1™ Escherichia coli (E. coli). 
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2.2.6.1 Preparation of competent cells 
A frozen E coli culture at -80ºC was thawed and used to seed 25ml of Luria-Bertani broth (LB) 
(Appendix A.6) in a 50ml falcon tube. The tubes were incubated for 6-8 hours at 37ºC with 
vigorous shaking (250-300 rpm). After incubation, the starter culture was used to inoculate three 
1litre flasks, each containing 250 ml of LB. The first flask received 2ml of starter culture, the 
second received 1 ml and the third received 0.5 ml. All three flasks were incubated overnight at 
18-22ºC with moderate shaking (190 rpm). 
The following morning, the optical density at 600 nm (OD600) of all three cultures was 
monitored every 45 minutes. When the OD600 of one of the cultures reached 0.55, the culture 
vessel was transferred to an ice-water bath for 10 minutes and the two other cultures were 
discarded. The cells were harvested by centrifugation at 2,500g for 10 minutes at 4ºC. The 
medium was removed by vacuum aspiration ensuring that any drops of remaining media adhered 
to walls of the centrifuge bottle or trapped in its neck were removed. Next, the cells were 
suspended by swirling in 80 ml of ice-cold Inoue transformation buffer (Appendix A.7), before 
centrifugation at 2,500g for 10 minutes at 4ºC to remove the buffer. 
The cells were re-suspended in 20 ml of ice-cold Inoue transformation buffer, before the addition 
of 1.5 ml of dimethyl sulfoxide (DMSO) which was followed by mixing. Working quickly, 
0.25ml aliquots of the suspension were dispensed into chilled, sterile microcentrifuge tubes. The 
competent cells were snap-frozen immediately by immersion in a bath of liquid nitrogen. The 
microcentrifuge tubes were then transferred to a dry ice before finally being stored at -80 ºC until 
needed. Before each use, a tube of competent cells was removed from the -80ºC freezer and 
thawed slowly in an ice bath.  
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 2.2.6.2 Transformation 
Aliquots of 50μl of competent cells were thawed on ice before the addition of the ligation 
reaction mix (10µl). The tubes were mixed gently and two control tubes for each transformation 
experiment were prepared. This included a tube of competent bacteria that received the same 
quantity of a standard ligation preparation but with empty plasmid DNA and a tube of cells that 
received just water. The tubes were incubated on ice for 30 minutes before a heat shocking step 
at 42ºC in a water bath for 50 seconds without shaking. This heat shock step was a critical step 
because this step efficiently closes pores in the bacterial cell membrane. The tubes were quickly 
transferred to an ice bath allowing them to cool for 1-2 minutes. Subsequently, 400 μl of LB 
medium was added to each tube. To maximise the efficiency of transformation the cultures were 
incubated at 37ºC for 1 hour at 200 rpm before 200 μl of cells were transferred onto LB agar 
plates containing the appropriate antibiotic (Appendix A.6). The plates were then inverted and 
incubated overnight at 37ºC. 
2.2.7 Purification of plasmid 
The blue-white screening was conducted for identifying recombinant bacteria that contained the 
plasmid of interest. Plasmid DNA was isolated using either the Qiagen Miniprep or the Midiprep 
purification kit. The buffers of each kit were prepared and stored according to the provider’s 
recommendations before their use. The RNase A solution was centrifuged briefly before being 
added to the Buffer P1 bottle. The Buffers P2 and N3 were checked for SDS precipitation due to 
the low storage temperatures. LyseBlue was added to Buffer P1 in a ratio of (1:1000 v/v) and 





 This kit is designed to purify up to 20μg of plasmid from 1-5ml of E. coli cultures. The white 
colonies from the agar plate were picked using a sterilised tip (one colony for each insert) and 
used to inoculate 10 ml of (LB broth) containing ampicillin (50μg/ml) to maintain the 
propagation of the targeted bacteria. The culture was incubated overnight at 37ºC and shaken at 
200 rpm. Cells (3ml) were pelleted by centrifugation before being suspended in 250μl Buffer P1 
(Appendix A.8). After the suspension, 250μl of Buffer P2 (Appendix A.9) was added and mixed 
thoroughly by inverting the tube 4–6 times until the solution became viscous. Buffer N3 (350 μl) 
(Appendix A.10) was added and immediately mixed thoroughly by inverting the tube. The 
solution became cloudy and was centrifuged for 10 minutes at 13,000 rpm. The supernatant was 
then transferred to a QIAprep spin column, centrifuged for 1 minute and the flow-through 
discarded. The QIAprep spin column was subsequently washed by adding 0.75 ml Buffer PE 
(Appendix A.11) and centrifuged for 1 minute. The flow-through was discarded and an 
additional centrifugation step was conducted for 1 minute to remove residual wash buffer. The 
QIAprep columns were then placed in a clean 1.5ml microcentrifuge tube and the plasmid DNA 
was eluted by adding 50 μl of nuclease-free water to the centre of the QIAprep spin column,  
which was left to stand for 5 minutes to increase the DNA yield before being centrifuged for 
another 1 minute. The concentrations of the purified plasmids were analysed 
spectrophotometrically with a Nanodrop spectrophotometer.  
2.2.8 Plasmid sequencing  
The plasmids in this project were sequenced in order to verify the targeted nucleotide sequences 
and to determine the orientation of the inserts in the p-GEM®-T easy vector (Promega) 
(Appendix B.1). Ten microliter of each plasmid (100ng/µl) were submitted to Source BioScience 
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for sequencing in both directions using the appropriate primer sites located in each vector.  
2.2.9 Digestion of plasmids with restriction enzymes 
Digestion of the plasmid DNA was carried out using type II endonucleases such as EcoRI and 
their specific buffers from Promega in a total volume of 20µl. The components were assembled 
in a sterile tube. The deionized water was added first, then 2µl of 10x the appropriate digestion 
buffer, which was mostly the 10X MULTI-CORE™ Buffer (Appendix A.17). After this, 0.2µl of 
acetylated BSA (10µg/µl) and then 200ng of the DNA was added and then mixed by gentle 
pipetting. Restriction enzymes were finally added (5 units). The reactions were mixed by gentle 
pipetting, spinning and then incubated for 2-4 hours at 37ºC in a water bath. The digested DNA 
was mixed with 6x the loading buffer then profiled by agarose gel electrophoresis.  
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2.2.10 In vitro transcription 
2.2.10.1 Generating the RNA-probes 
 The synthesis of the RNA probes was conducted after the isolation of RNA from rat adrenals 
using a TRIzol reagent.  This was followed by cDNA synthesis and then the presence of genes of 
interest was confirmed by PCR using forward and reverse primers (Table 1). The amplified band 
was then cloned into the pGEM®-T Easy vector. Subsequently, competent E. Coli cells were 
transformed (Inoue et al., 1990) using the recombinant vector and the insertion and orientation of 
genes of interest were detected by sequencing.  
The orientation of the clone in the pGEM®-T Easy vector was important to generate the right 
probe. Consequently, PCR experiments were set using M13 primers together with primers 
specific for the inserts for two purposes: firstly, to detect in which direction each insert was 
ligated to the vector. Secondly, to add the transcription sequence for T7 or SP6 promoters to the 
inserts, in order to use them later for in vitro transcription reaction (figure 3a). 
M13 primers (F or R) were used with both forward and reverse primers for each gene to add the 
promoter sequence to the inserts using PCR. Mixing the primers in all four possibilities for each 
insert (M13 R primer with other genes F primers / M13 F primer with other genes R primers and 
M13 F primer with other genes F primers / M13 R primer with other genes R primers) would 
reveal in what direction the inserts were ligated with the vector. If the PCR of different primers 
(F primers with R primers) result in distinct DNA bands, that means the insert is bound to the 
vector where the M13 forward primer and the T7 promoter sequences are in the vector upstream 
the forward primer of the insert. This alignment will be referred to as (correct orientation), but if 
the PCR of similar primers (F primers with F primers or R primers with R primers) resulted in 
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distinct DNA bands, that means the insert bound to the vector where the M13 reverse primer and 
the SP6 promoter sequences in the vector is upstream the forward primer sequence of the insert 
and we will refer to that alignment as (opposite orientation)  
 (figure 2.1). The PCR products were analysed by agarose gel electrophoresis and the resulted 
bands were extracted and used for in vitro transcription.  
The +1G of the start codon (ATG) of the RNA polymerase promoter sequence in the DNA 
template is the first base incorporated into the transcription product (figure 2.2). To make sense 
RNA, the 5' end of the coding strand (the target strand) must be +1 G of the promoter. For 
antisense RNA to be transcribed the 5' end of the noncoding strand must be downstream of the 


























Figure 2.3 The location of the RNA polymerase promoters (T7 and Sp6) and the transcription initiation site 
(+1G) in the pGEM®-T Easy Vector. 
 
 
Figure 2.2 The possible orientations of the inserts in the pGEM®-T Easy Vector. This was revealed 
by one of the M13 primers with one of the insert primers showing which of the RNA Polymerase 
promoters (T7 or Sp6) can be used for in vitro transcription to produce antisense ribprobes (on the 





2.2.10.2 In vitro transcription reaction 
Labelled-RNA probes were synthesised to produce two types of Digoxigenin labelled-RNA. The 
first synthesis, of coding RNA strands (sense probes) were used as a control. The second, of non-
coding RNA strands (antisense probe), were used to detect their mRNA targets in the tissues. 
These RNA strands were generated using Digoxigenin RNA labelling NTPs mix, which made 
them detectable probes through an in vitro transcription reaction 
In order to prepare the antisense probe for the inserts, an in vitro transcription reaction was setup 
in a 1.5ml microcentrifuge tube with a total reaction volume of 20μl. The mix contained DNA 
template (200ng), 2μl of 10x Digoxigenin RNA labelling NTPs mix (Roche) and 4μl of the 5x 
Transcription buffer (Appendix A.18). Finally, 1μl of (20u/μl) RNase inhibitor and 2μl of 
(20u/μl T7 or SP6) RNA polymerase was added according to the insert orientation in the vector. 
The total volume of the reaction was made up to 20μl with RNase-free water.  
Each reaction was mixed and briefly spun before incubating at 37°C for 2 hours. Finally, 2μl of 
DNase I RNase-free (1unit/µl) was added and the reaction was incubated for a further 15 
minutes. Following transcription, 2μl of the reaction was run on an agarose gel to detect the 
formation of RNA. The probe concentration was measured by spectrophotometry. Three positive 
control probes of Sf1 were also prepared to be used for the in situ hybridisation experiments.   
 
2.2.10.3 Ribo-probe cleaning 
The Qiagen’s RNeasy Mini Kit was used to clean up the RNA by removing all the enzymes and 
similar entities’. All steps of this procedure were carried out quickly at room temperature. To 
achieve this, the necessary solutions were prepared before starting the procedure. The volume of 
the reaction was adjusted to 100μl with RNase-free water, to which 350 μl of buffer RLT was 
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added, and mixed. Then 250μl of ethanol (96–100%) was also added, and mixed well by 
pipetting. The sample (700μl) was then transferred to an RNeasy Mini spin column and placed in 
a 2 ml tube. The tubes were centrifuged for 15 seconds at 9,000 x g and then the flow-through 
was discarded. The collection tubes in the previous step were reused, 500 μl of Buffer RPE was 
added to the RNeasy spin column, and centrifuged for 15 seconds at 9,000 x g to wash the spin 
column membrane, as before, the flow-through was then discarded.  
The second wash for the spin column membrane was conducted using 500μl of buffer RPE, 
centrifuged for 2 minutes and the flow-through discarded. After each centrifugation step, the 
RNeasy spin columns were carefully removed from the collection tubes to prevent any contact 
with the flow-through in order to avoid carryover of ethanol.  
Finally, the RNeasy spin column was placed in a new 1.5 ml collection tube, then 35μl of 
RNase-free water was added directly to the centre of the column membrane, followed by 
centrifugation at 9,000 x g for 1 minute to elute the RNA, after which the RNA concentration 
was measured using the Nanodrop device.  
2.2.11 Fluorescent In situ hybridisation (FISH) 
2.2.11.1 Preparing of adrenal cryosections 
 Adrenal glands from adult Wistar-rat described in (2.1) were used. Adrenal glands were 
collected as fast as possible, cleaned and placed on a tissue base mould with shallow embedding 
media to position the samples. They were covered with cryosection mounting media OCT (Cell 
path), with special attention paid to prevent air bubbles formation. The moulds were then placed 
into dry ice before being stored at -80°C overnight.  
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The tissue sections were prepared using a cryostat (Bright 5040) to a thickness of 25µm and 
were placed onto new Superfrost plus or Polysine slides which are suitable for in situ 
hybridisation and immunohistochemistry. Each of these steps was carried out in RNAse-free 
conditions. 
2.2.11.2 FISH 
The sections were thawed and dried for 20 minutes at 55°C, then fixed with 4% (w/v) 
paraformaldehyde (PFA) in phosphate buffer saline (PBS) (Appendix A.19) for 20-25 minutes, 
after which the slides were moved to a sterile and RNase-Zap treated humid chamber. The 
sections were then washed with PBS, dehydrated using a series of ethanol solutions (70%- 80%-
95%-100% v/v) for 3 minutes each and rehydrated using the opposite ethanol concentrations; 
between the dehydration and rehydration process, the samples were di-lipidated in chloroform 
for 5 minutes. The slides were washed three times with PBS for 3 minutes before being treated 
with proteinase K (Roche) 100µg/ml in RNase free water for 30 minutes at 37°C in order to 
increase the permeability.  
The pre-hybridisation step was conducted with a hybridisation buffer (Appendix A.20) for 4 
hours at 60°C to block non-specific binding. The sections were surrounded with rubber cement 
glue (Elmers) with an open side; this formed a U shape border around all sections. Then a 
coverslip was placed on each slide to form a cavity space between it and the slide sufficient for 
around 500µl, which was subsequently filled with the hybridisation buffer containing the labeled 
probe (500ng/ml) of interest. The edges of the slides were dried with microscope tissue 
(Kimberly-Clark Medical Wipes) before applying the glue, but the sections were kept untouched 
and moisturised with the hybridisation buffer during the glue bordering process. Then the open 
side was sealed with the glue to eliminate the evaporation of the hybridisation buffer during 
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hybridisation and to protect it from any possible effects of RNase. The probes were diluted with 
RNase free water to concentrations of 100ng/µl and 5µl of each diluted probe was added to 1ml 
of the hybridisation buffer (500ng/ml) before being hybridised with the probe-hybridisation 
buffer for around 30 hours at 60°C in a sterilised and RNase-Zap treated humidified chamber.  
After hybridisation, the glue and coverslips were carefully removed using a new and sterilised 
scalpel blade. The slides were washed twice in 5xSSC (Appendix A.21) and treated with a RNA 
wash buffer (Appendix A.22) for 30 minutes. Then the sections were washed twice with 5XSSC, 
the first wash at room temperature and the second wash at 55 ºC for 30 minutes each. 
Subsequently, slides were washed with 0.1X SSC at 55 ºC. The hybridisation signals were 
detected using the ELF 97 mRNA in situ hybridisation signal detection kit (Molecular Probes). 
After performing the post-hybridisation, the slides were transferred to a jar containing 1X wash 
buffer for 5 minutes at room temperature. Slides were kept undried (wet) during the ELF signal 
detection protocol. When the slides were removed from the wash buffer jar and placed in a 
humid chamber, the blocking buffer was applied to the tissue sections (250μL for each slide) and 
they were incubated for one hour at room temperature. A polyclonal sheep anti-digoxigenin 
(Fab-segments), conjugated to alkaline phosphatase (750 U/ml) (Roche,) was diluted 1:5000 
(150 mU/ml) in a blocking buffer. 250μL of the solution was added to each slide and they were 
again incubated for 30 minutes at room temperature.  
The amount of ELF 97 phosphatase substrate needed was prepared for the day’s experiments by 
a 10-fold dilution into the developing buffer (Component C) according to the manufacturer’s 
instructions. This was filtered into a sterile vial using a 0.2μm pore-size filter (Minisart), and 
centrifuged for 10 seconds in a 1.5 microcentrifuge tube. These filters allow a very small volume 
to be filtered without significant loss of sample. The substrate additive 1 (Component E) and the 
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substrate additive 2 (Component F) were both diluted each 1:500 into the substrate working 
solution. The resulting solution was vortexed and used immediately.  
After the incubation with the anti-digoxigenin-AP, the slides were washed three times, for 5 
minutes each time, with 1x wash buffer. A substrate working solution was applied to the slides 
(400μL per slide) and the samples were incubated for 15 minutes up to a maximum of 1 hour, 
depending on the abundance of the signal. To monitor this, the fluorescence microscope was 
prepared before adding the substrate working solution to be ready to check the signal every 10 
minutes. Once the signal developed sufficiently, the excess solution was removed and the slides 
washed immediately with 1x wash buffer. In order to maintain long-term signal preservation, the 
sections were treated with a post-fixation solution (Appendix A.23) for 15–30 minutes at room 
temperature. The sections were mounted by applying 3–5 drops of mounting medium (ELF 97) 
to each slide and placing a coverslip on top and these slides were examined using a fluorescent 
microscope with the 546nm filter on 5x and 20x objective. 
2.2.12 Immunohistofluorescence  
 Adrenal cryosections were prepared as described in section (2.2.11.1) with the exception of the 
thickness of the sections, which was 10µm rather than 25µm. The slides were dried for 20-30 
minutes at room temperature and then were fixed by immersion in a jar full of pre-cooled 
acetone for 20 minutes. After which they were removed and allowed to dry for 20-30 minutes at 
room temperature.  
Slides were washed twice with phosphate-buffered saline containing Triton (PBT) (Appendix 
A.24) for 5 minutes each and blocked with blocking buffer (10% v/v goat serum in PBS for 1 
hour; the serum being derived from the species in which the secondary antibody was raised, 
usually goat serum).  
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The blocking buffer was then drained off from the section and the primary antibody working 
solution was prepared by mixing the suitable amount of primary antibody with an antibody 
dilution buffer (0.5% v/v of the same serum in PBS). A drop (100-200µl) of the primary 
antibody working solution was applied to each section and they were incubated in a humidified 
chamber overnight at 4°C.  
The sections were each washed twice with PBT for 5 minutes before the addition of a drop (100-
200µl) of diluted (1:200) secondary antibody in the antibody dilution buffer. Then they were 
incubated in the dark, in a humidified chamber, at room temperature for 30 minutes before being 
washed twice in PBS for 5 minutes each. The sections were then mounted in mounting medium 
for fluorescence with DAPI (Vectashield) to stain the nucleus and covered with coverslips. The 
control sections were treated with the appropriate IgG protein instead of the primary antibody. In 
the dual immunohistofluorescence both primary and secondary antibodies (mouse and rabbit) 
were mixed together in the primary and secondary incubation steps, respectively.  
2.2.13 Microscopy  
The immunofluorescent imaging for in situ hybridisation and immunohistofluorescence 
experiments was carried out using a Zeiss-Axio Imager A1 fluorescent microscope with four 
filters: Blue/cyan filter for (4',6-diamidino-2-phenylindole (DAPI)), Alexa Fluor (AF) 488 green, 
AF 546 yellow and AF 660 red. The magnification powers of the objective lenses used in these 
experiments were 5x, 10x, 20x and 40x. The fluorescent microscope was fitted with a camera 
(Axio cam MRm) linked to a computer and controlled by AxioVison software (Rel.4.8). This 
software was used to adjust the colours, measures, and quality of the images. The quality of the 




Several potential stem cell markers were selected after a bioinformatics analysis of a whole rat 
adrenal transcriptome microarray data set. This data showed the expression of potential stem or 
progenitor cell markers based on their high expression in the capsule, or capsule and zI, in 
comparison with zF. The expression values in the microarray data were manipulated to be 
displayed in fold differences between the capsule, or capsule and zI, in comparison with zF. 
Further analysis was required for the potential stem cell markers that displayed a 50-800 fold 
increase in their expression in the capsule or capsule and zI in comparison with zF. Over 60 
potential stem/progenitor cells markers of the rat whole transcriptome were observed and 
research was conducted to collect further information about their roles in the literature. The 
selection of the potential markers was mainly based on a combination of the array data and the 
information in the literature that implied potential roles in stem/progenitor cells characteristics, 
cell proliferation and migration. In addition to the proteins that were rarely studied but they have 
a potential role in the stem cell characteristics. However, not all of the nominated stem cell 
markers met all the criteria of selection. Three potential markers were selected because they 
showed high expression in the capsule and zI in comparison with zF (table 2.2): Transmembrane 
protein121 (Tmem121), Thy-1 cell surface antigen (Thy-1) and Krüppel-like factor 5 (KLF5). 
 The next steps were conducted to confirm the microarray data and to reveal the expression 
pattern of these potential markers in the adrenal cortex. Several molecular experiments were 
conducted in order to examine the expression of these markers followed by cloning a fragment of 
these genes into the p-GEM®-T easy vector. This was followed by in vitro transcription to 
produce probes to detect the mRNA expression patterns of these markers in the rat adrenal cortex 
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by FISH. Immunohistofluorescence experiments also followed to detect the localisation of the 
proteins of interest in adrenal sections.  
 
 
Table 2.2 Microarray data of the genes of interest showing the levels of gene expression in the 
capsule, zF and zI. The genes have higher expression in the capsule and zI (the potential 
stem/progenitor cell layers) in comparison with zF. 
Gene title Gene symbol Capsule zF zI 
Kruppel-like factor 5 Klf5 149.9184 2.547829 78.12353 
Thy-1 cell Surface antigen Thy-1 334.6493 5.828303 51.53768 
Transmembrane protein121 Tmem121 138.4809 2.175656 68.63601 
 
 
2.3.1 Extraction of RNA from adrenal tissue 
RNA was extracted from adrenal glands using TRI reagent. The RNA was analysed using 
agarose gel electrophoresis (figure 2.4) and spectrophotometry. The first extracted RNA from 
one frozen adrenal was 125.3ng/µl and the A260/230 ratio was 2.19, which indicated low 
contamination with either polyphenol or polysaccharide. The A260/280 ratio was 1.8 which 
indicated very low protein or phenol contamination. As opposed to frozen adrenal glands that 
stored in -80 ºC for over six months, RNA extraction from freshly isolated adrenal gland showed 
high quality RNA (as it measured using a spectrophotometric method) and the concentration of 












2.3.2 First strand cDNA synthesis  
cDNA synthesis resulted in the generation of single stranded cDNA from the isolated RNA. 
Analysis by spectrophotometry showed that it had a concentration of 77ng/µl. 
2.3.3 Gene detection by PCR and agarose gel electrophoresis 
Polymerase chain reaction (PCR) was carried out to detect the expression of the three potential 
stem cell marker genes (figure 2.5) (Klf5, Thy-1, and Tmem121) in the adrenals and to provide 
template fragmetns suitable for riboprobe generation. The bands were excised from the gel and 
purified using the Qiagen QIAquick Gel Extraction Kit. The concentrations of these segments after 
purification were measured by spectrophotometry and showed to be 32ng/µl, 30ng/µl and 
28ng/µl, respectively.  
Figure 2.4 Agarose gel electrophoresis of 10µl of 125.3 ng/µl RNA after isolation from 
whole rat adrenal using Trizol method. The appearance of 28S and 18S ribosomal RNA 
subunits bands indicate the RNA was obtained with minimum degradation. 
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2.3.4 Transformation of E.coli with the cloned segments  
The DNA segments were ligated into the p-GEM®-T Easy plasmid and subsequently 
transformed into competent E. Coli cells. The transformed colonies were grown on LB agar 
plates; the numbers of transformed colonies were different among the three types of inserts, 












2.3.5 Plasmid isolation and restriction enzyme digestion 
 In order to confirm the ligation of an insert into the vector, one colony was picked from each 
plate and grown in 10ml of LB broth. Plasmids were then isolated using a Qiagen miniprep kit 
and then subsequently digested with EcoR1 in a total volume of 10μl. Since the restriction sites 
1 Kb ladder 
500 bp 
Klf5      Thy-1    Tmem121     
Figure 2.5 Agarose gel electrophoresis of 10µl of the PCR products that represent an approximatly 500bp 
segment of each of the three genes Klf5, Thy-1 and Tmem121. The PCR was conducted using specific 
primers to detect these genes from rat whole adrenal cDNA. This picture reveals the presence of the three 
bands of all three gene segments. 
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of EcoR1 in the p-GEM®-T easy plasmid were adjacent to the two ends of the insert (Appendix 
B.1), the isolated plasmids from the colonies were digested with EcoR1 to confirm that the 
segments were successfully cloned. After digestion, the products were separated by agarose gel 
electrophoresis (Figure 2.6). The bands of each digested plasmid were observed, where the upper 
band represented the plasmid backbone (approximately 3000bp), and the lower bands were the 





















2.3.6 Generation of templates suitable for in vitro transcription 
 The RNA-probes were not generated from the insert in the p-GEM®-T Easy vector by digestion 
with an appropriate restriction enzyme and then using either the T7 or SP6 RNA promoters to 
initiate transcription. However, amplification of the desired segment by PCR was preferable as 
3Kb p-GEM®-T 
easy vector  
500bp 
Figure 2.6 Agarose gel electrophoresis of the three cloned inserts of the genes of interest Klf5, Thy-1 and Tmem121 
with Sf1 insert as control and the mere-vector (p-GEM®-T easy), after digestion with EcoR1. The digestion releases 
the inserts from the vector, which were then separated by their size allowing profiling on an agarose gel. This analysis 
showed the appearance of digested DNA of the inserts at around 500bp, where the larger bands (3,000bp) represent 




this added either T7 or SP6 promoter to the insert and the DNA product of the PCR were much 
more than the DNA product from the digestion. To achieve this, PCR was used with one primer 
specific for the insert together with either an M13 forward or reverse primer. This revealed the 
orientation of the insert in the vector at the same time as adding either T7 or SP6 RNA 
polymerase promoter sequences to the insert. If the PCR of different primers (F primers with R 
primers) resulted in distinct DNA bands, that meant the insert bound to the vector where the M13 
forward primer and the T7 promotor sequences in the vector were upstream of the forward 
primer of the insert (correct orientation), However,  if the PCR of similar primers (F primers with 
F primers or R primers with R primers) resulted in distinct DNA bands, that meant the insert 
bound to the vector where the M13 reverse primer and the SP6 promotor sequences in the vector 
were upstream of the forward primer sequence of the insert (opposite orientation). The results 
revealed that both Thy-1 and Tmem121 inserts were ligated into the vector in the correct 
orientation such that the T7 promoter sequence of the plasmid could be used to generate the 
sense RNA of the insert. In contrast, the Klf5 insert as well as the control insert (Sf1) were in the 
opposite orientation such the SP6 promoter sequence could be used to generate sense RNA of the 


















2.3.7 In vitro transcription and RNA purification 
DIG labelled RNA probes were synthesised by in vitro transcription using the DNA segments 
described in section 3.7 along with the appropriate RNA polymerase. The RNA probes were 
purified using the RNeasy Mini Kit (Qiagen) and analysed using agarose electrophoresis (figure 
2.8) to check that the synthesis was successful. The concentration of the Klf5, Thy-1, Tmem121 
Figure 2.7 Agarose gel electrophoresis of the PCR products of the three genes Klf5, Thy-1, Tmem 121 and the 
control (Sf1) with a segment of the T7 or SP6 promoters that were added by using M13 primers in all possible 
combinations. This in turn referred to the direction in which the inserts had ligated to the vector.  A and D showed 
the products of all similar primer combinations (insert F primers with M13F primers and insert R primers with M13 
R primers). This showed the Klf5 and Sf1 bands, revealing their opposite orientation in the vector. B and C showed 
the products of all different primer combinations (insert F primers with M13R primers and insert R primers with 




and SF1 probes was determined by spectrophotometry to be 1780ng/µl, 1903ng/µl, 1650ng/µl 












2.3.8 Fluorescent in situ hybridisation (FISH) 
Spatial expression of the three genes in the rat adrenal was determined using fluorescent in situ 
hybridisation. The mRNA of Klf5, Thy-1 and Tmem121 was detected in normal adult rat adrenal 
glands. Expression of all three genes was detected within the adrenal cortical zones with 
expression being found mainly in the capsule and sub-capsular areas (Figure 2.9). Amongst the 
tested genes, Klf5 mRNA expression was mainly localised to the capsule (Figure 2.9), but Klf5 
was also expressed in the zG and zF (definitive zones). The expression of Klf5 was intense in the 
capsule, but its expression expanded into both definitive zones of the adrenal cortex (zG and zF) 
and reached the adrenal medulla. Tmem121 expression was low in the definitive zones and was 
         Sf1 Klf5                     Thy-1            Tmem121 
Figure 2.8 Agarose gel electrophoresis of the RNA probe bands of Klf5, Thy-1, Tmem121 and Sf1 after in vitro 
transcription. (A) The antisense RNA probe bands of Sf1. (B) The three antisense RNA probes bands of Klf5, Thy-1, 
Tmem121 and Sf1. The right-hand bands shown in A and B are the probes before purification, while the left-hand bands 




mainly restricted to the capsule and sub-capsular areas with slight expansion toward the zG zone 
(Figure 2.9).  
Thy-1 mRNA expression was mostly confined to the capsule and sub-capsular area (Figure 2.9) 
with high expression intensity in the capsular area. Thy-1 had the lowest expansion toward the 
definitive zones after the negative control (no probe). 
In the adrenal cortex definitive zones, the Sf1 antisense probe showed high expression in 
comparison with its expression in the capsule (Figure 2.9), and also in comparison with all of the 
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Figure 2.9 In situ hybridisation of the genes of interest on rat adrenal cryosections. A-F are the control group. A and D 
show the adrenal section where no probe was applied (negative control), B and E show the binding of the Sf1 sense RNA 
probe (sense probe control). C and F show the expression of the Sf1 antisense RNA probe (positive control). The upper row 
(A, B and C) is at low magnification and the second row (D, E and F) is at high magnification. G-L are the genes of interest 
group. G and J show the expression of the Tmem121 antisense RNA probe. H and K show the expression of the Thy-1 
antisense RNA probe. I and L show the expression of the Klf5 antisense RNA probe. The third row (G, H and I) is at low 





The detection of the mRNA of the genes of interest using FISH, was followed by detection of the 
protein expression of the same targets using immunohistofluorescence because it was necessary 
to confirm that these transcripts were being translated.  
The Klf5, Thy-1 and Tmem121 proteins were detected in normal adult rat adrenal glands. Using 
primary antibodies for the three proteins and IgG protein as a control. In agreement with the in 
situ hybridisation results, the Klf5, Thy-1 and Tmem121 protein expression results were mainly 
observed in the capsular and the subcapsular area (Figure 2.10-2.12). Tmem121 proteins 
expression was highly observed in the sub-capsular area. The pattern of Tmem121 protein 
expression was ranging from a few cells in the sub-capsular area to a long line of cells along the 
capsule with slight expansion toward the zG (Figure 2.10).  As with the Tmem121 protein 
expression the Klf5 protein expression was highly prominent in the capsule and sub-capsular 
area. However, the pattern of Klf5 protein expression was high in the capsule and reduced 
gradually in the zG and zF (Figure 2.11). Thy-1 protein expression was mostly confined to the 








Figure 2.10 Immunohistofluorescence of Tmem121 protein on rat adrenal cryosections. (A and D) 
Immunofluorescence of nuclei stained with DAPI. (B and E) Immunofluorescence of Tmem121 positive cells 
incubated with primary rabbit anti-Tmem121 antibody (ab151077) before detection with secondary anti-rabbit 




































Figure 2.11 Immunohistofluorescence of Klf5 protein on the rat adrenal cryosections. (A and D) Immunofluorescence of 
nuclei stained with DAPI. (B and E) Immunofluorescence of Klf5 positive cells incubated with primary rabbit anti-Klf5 
antibody (ab137676) before detection with secondary anti-rabbit Alexa 546 in B and E. Merged images of (A) and (B) are 




























Figure 2.12 Immunohistofluorescence of Thy-1 protein on rat adrenal cryosections. (A and D) Immunofluorescence of nuclei 
stained with DAPI. (B and E) Immunofluorescence of Thy-1 positive  cells incubated with primary mouse anti-Thy-1 antibody 
(BD Pharmingen 554895) before detection with secondary anti-mouse Alexa 546 in B and  Alexa 647 in E. Merged images of 
(A) and (B) are shown in (C) and of (D) and (E) in (F). The upper row (A-C) low magnification, the lower row (D-F) high 




Due to the lack of information regarding Tmem121 and the pattern of its area of expression in 
the adrenal cortex, dual antibody detection experiments were conducted to assay the co-
expression of Tmem121 with the proliferation marker Ki67 (Figure 2.13). The result of co-
expression between the two proteins was 0.74 (according to Spearman's rank correlation value, 
which was calculated using Image J 1.49 software). This represents high (74%) but not complete 



























































































































































































































































































































































































The major results of this chapter can be summarized in (table 2.3). 
 
 
Table 2.3 The major results of mRNA and protein expression of the stem cell nominated markers in the adrenal 
cortex after in situ hybridisation and immunohistofluorescence assays. The results showed the detection of the Klf5 
mRNA and protein expression in the capsule, zG and zF. Tmem121 mRNA and protein expression were detected in 
the capsule and zG. Thy-1  mRNA expression was detected in the capsule and zG. While Thy-1 protein expression 
was confined to the capsule. 
 
  






Capsule zG zF capsule zG zF 
Klf5 yes yes yes yes yes yes 
Tmem121 yes yes no yes yes no 






 The rat adrenal microarray data showed expression of more than 60 potential stem/progenitor 
cell markers in the rat whole genome. However, not all of them met the selection criteria. The 
selection of the potential markers considered the capsule (Walczak and Hammer, 2015) and zI 
(Mitani, 2014) as potential niches for adrenocortical stem/progenitor cells but the expression 
pattern of the nominated markers was mainly either out or beyond the capsule and/or zI. The 
combination of the array data analysis and the information in the literature regarding these 
markers implied potential roles in stem/progenitor cell characteristics and facilitated the 
nomination of three markers: Tmem121, Klf5 and Thy-1. 
Tmem121 
Although the array data showed an interesting expression pattern in the capsule with low 
expression in the zF, Tmem121 is a poorly studied protein. However, Tmem family members are 
highly conserved between species and are highly expressed in most embryonic tissues (Zhou et 
al., 2005), which might involve in the characteristic of stem cells. A human wound healing study 
showed that Tmem121 is one of the genes that contribute to cell proliferation and migration in 
human endothelial cells and its expression was co-expressed with the endothelial marker, CD31. 
Therefore, these results suggested that it might have a potential role in skin wound healing 
(Bronneke et al., 2015). 
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 Krüppel-like factor 5 (KLF5) 
 KLF5 is a member of the zinc finger protein family called Krüppel-like factors. They have a 
crucial role for the initiation and preservation of stem cell pluripotency in the embryo and 
regulate several biological processes. KLF5 participates in the formation of the trophectoderm 
and inner cell mass, and also has a role in suppressing the development of the primitive 
endoderm (Lin et al., 2010). All these interesting data therefore referred to it having a proposed 
role in the characteristics of stem cells. 
 KLF5 has a role in maintaining proliferation of several tissues. For instance, in intestinal 
epithelium tissue where cells undergo constant self-renewal activities (Kuruvilla et al., 2015), 
and has indirect effects on vascular smooth muscle proliferation (Gao et al., 2015). Klf5 also has 
an essential role in regulating the differentiation of the skeletal muscle (Hayashi et al., 2016). 
However, KLF5 expression in embryonic stem cells might imply its role in tumorigenesis and 
cancer cells but its exact role is unclear since it shows both tumour promoting and suppressing 
activities. Although several studies favour the role of KLF5 as a tumour suppressor (Xing et al., 
2014). Recent studies suggest KLF5 targeting in the PKA_Glycogen synthase kinase 3 
(GSK3β)_KLF5  pathway induces degradation in breast cancer stem cells (Shi, Liu et al. 2017). 
However the proliferation of carcinoma cells was not influenced by KLF5. Over expression of 
KLF5 also inhibits differentiation of oral carcinoma (Shibata et al., 2015).  
Thy-1(CD 90) 
Thy-1 is a highly conserved cell surface protein of 25–37kDa. It is expressed in various cell 
types of several mammalian species including humans and rodents (Petersen et al., 1998). The 
expression of Thy-1 is one of the minimal criteria for human MSC (Dominici et al., 2006a). The 
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use of Thy-1 as a marker to isolate stem cells has been recorded in several foetal and adult 
tissues cells types such as bone marrow (Dennis et al., 2007) and human liver (Herrera et al., 
2006). It has a role in regulating the cell matrix and cell to cell interaction, in addition to its role 
in cellular migration and adhesion (Rege and Hagood, 2006). 
The first laboratory experiment conducted to confirm the microarray data regarding the three 
genes of interest was RT-PCR to detect and amplify a segment of approximately 500bp of each 
of the genes of interest in the adrenal gland cDNA. These experiments were successful and the 
expression of these genes was detected in the adrenal gland (Figure 2.5). After ascertaining that 
these potential markers were being expressed in the rat adrenal, it was important to investigate 
the localisation of this expression. Therefore, the PCR product of each was inserted into a vector 
with SP6/T7 promoters to allow in situ hybridisation probe generation.  
The next steps aimed to produce RNA probes by in vitro transcription using the cloned segments 
as templates. The RNA probes were generated and several in situ methods were attempted to 
achieve in situ hybridisation, these included the whole mount in situ hybridisation procedure 
described by Nieto et al. (1996), wax and cryosection in situ hybridisation protocols. Although 
the valid working protocol with the adrenal sections that showed gene most consistent replicates 
was found to be the one described by Lomthaisong (2001), several modifications were required 
to reduce RNA degradation and increase the stringency.  
The in situ hybridisation results confirmed the microarray data showing expression in the 
capsular and the subcapsular areas of the adrenal cortex (Figure 2.9).  
Klf5 mRNA had a high narrow and intense expression in the capsule with weak and expanded 
expression in the zG and zF (Figure 2.9). The Klf5 protein expression pattern was in agreement 
with in situ hybridisation with a lower expansion in the zG and Zf, meaning that not all the 
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mRNA were translated into protein. Although the Klf5 protein is considered to be one of the 
pluripotency markers in certain embryonic stages (Hou et al., 2016), the expansion of expression 
in the two main differentiated zones (zG and zF) might not be related to the pluripotent stem 
cells within the adult adrenal cortex. This result suggested that Klf5 is not a stem cell marker in 
the adrenal cortex.  
 
Tmem121 mRNA expression was the highest in the capsule with a slight expansion in zG, this 
pattern of expression represents most of the capsular area and a small fraction of the zG. The 
Tmem121 protein expression agreed with the in situ hybridisation result. The long expanded line 
of Tmem121 protein expression mainly slight the Tmem121 from being a stem cell marker 
because the presence of stem cell populations within the adult tissue have a limited existence, as 
seen in adipose tissue  (Zaman et al., 2014), heart (Navarro-Betancourt and Hernandez, 2015) 
and bone-marrow (Guerin et al., 2015), which represent less than 0.1% of the main cell 
populations.  However, this interesting expression pattern of Tmem121 might suggest a role for 
Tmem121 in the adrenal cortex cell proliferation and migration, because the adrenal cortex 
undergoes centripetal migration that starts from the subcapsular area towards the adrenal cortex 
medulla border. The detection of Tmem121 protein expression co-expressing with the Ki67 
proliferation marker (Figure 2.13), primarily revealed a high co-expression between the two 
proteins (0.74 according to Spearman's rank correlation value). This value may refer to the 
existence of Tmem121 protein during cell proliferation (based on the Ki67) and that it might 
participate or have a role in cell proliferation, but it is not essential to this process since not all 




This result marks the beginning of further investigation regarding the role of Tmem121 protein 
in adrenal cortex cell proliferation and migration.  The high expression of Thy-1 mRNA in the 
capsule, in comparison with other marker mRNAs, combined with a restricted expression pattern 
and the molecular structure of the Thy-1 protein in the cells as a cell surface antigen, nominated 
Thy-1 as a marker for isolating the potential stem cells and to conduct further investigations.  
 Furthermore, Thy-1 has the lowest expression level in the zG and zF, these zones represent the 
most differentiated part of the adrenal cortex. The low and intense expression in just a few parts 
of the capsule with a slight expansion to the sub-capsular area suggested Thy-1 to be the most 
potential target for the isolation of stem cells because of the presence of stem cell populations 
within the adult tissue having a limited existence and mainly representing less than 0.1% of the 
main cells populations. 
 The results of in situ hybridisation and immunohistofluorescence experiments aimed to establish 
the capsule and sub-capsular area as the stem cells niche. However, Mitani et al.,(2003) 
suggested that the zI might be a stem cell niche. This result might be down to strain differences 
in the rats used in the experiments but it has also been suggested that the adrenal cortical stem 
cells are Sf1 negative but the progenitor cells are Sf1 positive as they start to express Sf1 before 
differentiation and commencing steroidogenesis (Kim et al., 2009). The expression of Sf1 was 
detected in the adrenal cortex including the zI (Figure 2.9).  
 Mitani et al.,(2003) suggested the zI as a stem/progenitor cell zone, because cell proliferation 
activity was observed in the zI after BrdU rat injection, but  Mitani et al.,(2003) also observed 
that these cells migrated into the zI from the outer portion of the zG reaching the inner potion of 
the zF and the number of these migrating labelled cells increased 3-fold. However, several 
studies have come to conclusions regarding adrenal cortical stem cells, describing them as 
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quiescent and self-renewing cells (Kim et al., 2009). A decade after the Mitani et al.,(2003) 
study, a simlar study was conducted and showed that the cells were retained within the capsular 
and sub-capsular cortex 23 weeks after administrating BrdU (Chang et al., 2013). Furthermore, 
MSCs might transport only toward the damaged sites in animals tissue, but the molecular 
mechanisms of MSCs migration within damaged tissue remain unclear (Tang et al., 2017, Xu et 
al., 2017). So, the description of the cells in the zI as migrating and proliferating cells by Mitani 
et al.,(2003) might reduce the possibility of the zI being a stem cell niche in the rat.  
These findings suggest that the stem cells of the adrenal cortex are quiescent or have a slow 
cycling feature within the capsule. Furthermore, the rat whole genome microarray data showed 
over-expression of the Sf1 gene in zI, which means the zI might possess progenitor or 
steroidogenic cells but not stem cells. These results generally showed that a few cells within the 
capsule express a high level of the Thy-1 protein, which represents a specific cell type within the 
capsule, that might be stem cells according to the most recent adrenal cortex stem cells 
hypothesis (Walczak and Hammer, 2015).  Furthermore, Thy-1 as a cell surface antigen is 
considered one of the mesenchymal multi-potent stem cell markers according to a statement 











Isolation and characterisation of the Thy-1 positive cells 
 
4.1. Introduction 
This chapter is dedicated to the isolation of potential stem cells, their culture in vitro, the study of 
the expression of other stem cell markers in the isolated cells and the monitoring of their cellular 
and molecular changes for over one year of in vitro cultivation. 
 Stem cells represent the regenerative capacity of a tissue or organ from which the next 
generation of progenitors will arise. Hence, the symmetric divisions of stem cells sustain self-
renewal in balance with asymmetric division to produce progenitor cells and this is essential for 
determining the age and continuity of the tissue of interest. Stem cell activity is associated with 
the presence of certain factors known as markers, which can be found as genes or proteins and 
have been widely used to identify several stem cell populations. Since the final recommendation 
of the previous chapter was to use the cell surface antigen (Thy-1) as a marker for the isolation of 
the potential stem cells it will be the main factor of this study and further information regarding 
the characteristics and the roles of this marker is presented. 
Thy-1 is a small (25–37kD) heavily N-glycosylated, glycophosphatidylinositol protein. The 
DNA of the Thy-1 maps to chromosome 11 in humans, 8 in rats and 9 in mice. It is considered 
one of the first glycophosphatidylinositol anchored proteins to be purified and sequenced. Early 
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investigations recognised the 110 amino acids that represent the core of the human Thy-1 
protein. While in rodent, the core protein of Thy-1 contains 111 or 112 amino acids (Pont, 1987). 
The post translational modifications of protein such as glycosylation (Reinders and Sickmann, 
2007) and the addition of carbohydrate molecules contributes to 30% of Thy-1’s total mass 
(Barclay et al., 1976).  
Thy-1 glycophosphatidylinositol group is anchored to the outer layer of the plasma membrane 
bilayer by the di-acyl group, while the glycoprotein faces the extracellular matrix (Low and 
Kincade, 1985). The glycoprotein that faces the matrix might be responsible for regulating its 
role in cell to cell communication and cell to matrix interaction (Rege and Hagood, 2006). Thy-1 
protein efficiency as a cell surface antigen with its anchored glycophosphatidylinositol facilitates 
its use as a marker for identifying and isolating specific cells types, such as human foetal hepatic 
progenitor cells (Masson et al., 2006), epithelial like cells from eutopic endometrium with a stem 
cell differentiation capacity (Henriquez et al., 2011) and thyro-trophic cells from the pituitary 
(Horiguchi et al., 2016). In general, it is considered to be one of the embryonic and MSCs 
markers (Oltulu et al., 2015). 
Thy-1 contributes to the interpretation of several cellular mechanisms, such as understanding 
retinal neuron recruitment of ion channel protein in complexes with Thy-1, and the role of 
anchored glycophosphatidylinositol in connection with the Potassium-sodium 
hyperpolarization/activated cyclic nucleotide-gated channel 4 (HCN4) subunits (Partida et al., 
2012). Others suggest this cell surface molecule enhances the adhesive capacity of cells (He et 




 Although Thy-1 has been used for a number of applications, Thy-1 protein expression is quite 
sensitive to the changes of its microenvironment.  Early studies showed that cytotoxic materials 
were found to reduce Thy-1 expression in vitro (Herberman et al., 1978). Others showed a 
significant decrease during thyrotoxicosis in vivo (Oltulu et al., 2015). Thy-1 distribution in 
adipose-derived stem cells decreased when the foetal bovine serum (FBS) in the culture media 
was replaced with alternatives such as Bovine Serum Lipids.   
So to use Thy-1 as marker for the isolation process, a production process of anti-Thy-1 antibody 
started in large scale, because a large amount was required for isolating the targeted cells and 
several later experiments. Primary cell cultures from whole rat adrenal gland were prepared and 
assessed for their normal response to ACTH, which induced the production of corticosterone. 
This experiment was required to show the capacity of the primary cells to show normal response 
in vitro as in vivo. The next primary cultures were carried out after enucleation of the adrenal 
gland to exclude the medulla and most of the zF because the target cells were located in the 
capsule and sub capsular areas.  
Magnetic activated cell sorting (MACS) was carried out using the anti-Thy-1 antibody to enrich 
the Thy-1 positive cells of the adrenocortical primary cultures. MACS is a well-documented 
method used for isolating target cells such as stem cells (Amiri et al., 2015, Zhong et al., 2015).  
The novelty of this chapter is not only the isolation of the Thy-1 positive cells from the adrenal 
cortex but also the interesting findings after culturing these cells and the changes that these cells 
underwent after cultivation for a long-term period.     
More information regarding stem cell relating markers, molecular and morphological changes 
are presented in the next sections. 
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4.1.2. Wilms Tumour 1(WT1) 
This WT1 protein is a transcription factor that encloses four zinc-finger motifs at the C-terminus 
and DNA-binding domain enriched with glutamine and proline at the N-terminus. It plays an 
essential role in the normal development of the urogenital system; the loss of the WT1 gene 
expression causes disruption to the kidney’s normal development resulting in Wilms' tumours 
(Berry et al., 2015). The WT1 mRNA in humans and rats undergoes RNA editing in specific 
tissues such as testis and kidney and is associated with proliferation and differentiation  (Sharma 
et al., 1994).  
Stress factors for the urogenital system, such as hypertension, are associated with the down-
regulation of WT1 expression (Mazzei et al., 2016). It is thought to be a coordinator of the 
embryonic developmental reversible processes, known as mesenchymal-epithelial transition 
(MET) and epithelial-mesenchymal transition (EMT) these processes are available in the 
development of the organs such as the kidney and the heart (Sampson et al., 2014). Although it 
was identified as a tumour suppressor, it has an important role in mesenchymal to epithelial 
transition in several malignancies, such as mesothelioma, which led to the suggestion that it 
could be used as a target in mesothelioma therapy (Plones et al., 2017). It also induces the hybrid 
transition of epithelial-mesenchymal and mesenchymal-epithelial in which malignant cells 
maintain both EMT and MET characteristics that might induce cell plasticity and progression of 
a tumour (Sampson et al., 2014).  
As a stem cell marker, the expression of WT1 contributes to the mesenchymal progenitors of 
pulmonary smooth muscle cells during the early stages of lung development (Moiseenko et al., 
2017). It regulates the development of interstitial progenitor cells during the embryonic 
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development of the mouse testis (Wen et al., 2016) and it is thought to be involved in the 
stem/progenitor adrenocortical cell state (Bandiera et al., 2013).  
4.1.3. E-twenty-six (Ets) variant gene 5 (Etv5) 
Etv5 belongs to a group of 26 transcription factors, that contribute to several cellular processes 
such as embryonic development, growth and apoptosis (Sharrocks, 2001). It has been found to be 
a transcriptional regulator in several cell types, such as controlling the self-renewal process of 
the spermatogonial stem cell population (Wu et al., 2011). The up-regulation of the Etv5 gene in 
vitro indirectly maintain the spermatogonial stem cell self-renewal process (Ishii et al., 2012) 
and it plays an important role in spermatogonial stem cell activity by regulating male fertility 
(Alankarage et al., 2016). A high expression of the Etv5 protein has been recorded in the primary 
salivary stem cells of humans (Srinivasan et al., 2017) and was not only involved in the 
proliferation of somatic stem cells but also in embryonic stem cells (Akagi et al., 2015). 
4.1.4. Inhibitor of DNA Binding 4 (ID4) 
ID4 is one of several highly conserved genes (ID1-4) encoding transcription factor proteins. 
These genes are expressed during several cellular activities, such as the proliferation and 
embryonic development. Although ID4 is a member of this family, it has different molecular 
pathways, expressions and functions. Several studies identify the roles of ID4 in different types 
of stem cells, for example, the regulation of stem cell proliferation and differentiation of 
neurones (Yun et al., 2004) and a regulatory role in the mammary stem cell (Junankar et al., 
2015).  The expression of ID4 maintains the stemness state of spermatogonial stem cells  (Oatley 
et al., 2011) and is essential for spermatogenesis in mice (Sun et al., 2015). Recent findings show 
86 
 
the expression levels of ID4 are indicators of the regenerative capacity of spermatogonial stem 
cells (Helsel et al., 2017).  
4.1.5. Senescence of the primary cells in vitro 
Cell senescence is identified when the doubling time of cell division in culture increased and 
then proceeds to cell death. This cellular phenomenon usually associated with morphological 
changes. The phenomenon was first described in human fibroblasts in culture, which undergo 
senescence after approximately 50 cell divisions, so-called the Hayflick limit (Hayflick and 
Moorhead, 1961). Although this phenomenon was observed in the primary cells in vitro, it might 
be related to the age of the organism (Yegorov and Zelenin, 2003). The senescence of MSCs was 
recorded in several publications which manifested in three main characteristics:  
morphological changes, reduction in proliferation and differentiation potential (Zhu et al., 2015). 
The senescence of cells has been recorded even with the most pluripotent stem cells such as 
human embryonic cells (Munoz-Espin et al., 2013) and mouse embryonic cells, which is not only 
consider as a defect but also as mechanism that contributes to embryonic development, growth 
and cell patterning (Storer et al., 2013). Certain studies refer to the interior molecular factors that 
are involved in the induction of the cell senescence. These factors include specific mRNAs 
and micro RNAs, which are considered as the main factors contributing to the senescence of the 
MSCs such as miR-199b-5p which was suggested as an indirect regulator of bone marrow MSC 
senescence (Yoo et al., 2014). While the micro RNAs 543 and 590-3p directly regulate MSCs 
senescence (Lee et al., 2014). Others found the expression level of the miR-29c-3p was increased 
significantly when the MSC undergo senescence (Shang et al., 2016). On the other side, exterior 
factors are involved in MSCs senescence such as high glucose in the culture media (Xu et al., 
2015). Later studies ceased the MSCs senescence and rejuvenated the old cells by down 
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regulation of the MicroRNA-195 and reactivating Telomerase reverse transcriptase (TERT). 
These findings referred to the senescence of MSCs as it might result from internal and external 
factors. So the senescence of MSCs can be stopped or reversed.   
4.1.6 Immortalisation of primary cells in vitro 
Transformation of normal primary cells to immortal cells in vitro with characteristics similar to 
that of tumour cells has been recorded (Gordon et al., 2014) and also the transformation of MSCs  
to immortal cells in vitro has been recorded (Urraca et al., 2015). The differences between 
normal cells and tumour cell lines from the same tissue have been widely studied and revealed 
epigenetic changes in the gene expression and DNA methylation (Baylin and Jones, 2011, 
Ehrlich, 2009). The loss of DNA methylation in the tumour cells was the main sign that this 
epigenomic alteration from normal cells to cancer cells resulted in down regulation of tumour 
suppressor genes (Jones and Baylin, 2002, Lubecka-Pietruszewska et al., 2015). The abnormal 
methylation of the tumour cells can be caused by several factors such as mutations, removing or 
altering certain genomic DNA sequences (Parsons et al., 2012).  In spite of the variety of 
literature suggesting these changes are associated with this abnormal transformation of cells from 
normal to tumour cells, how and when the cells initiate this transformation is unclear. Although 
the mutations take place and change few primary cells in the beginning, it was hard to detect or 
separate the tumour cells from the normal ones in that time and it can impute the presence of the 
cancer stem cells (Visvader and Lindeman, 2008).  However, later publications recorded the 
isolation of several cancer stem cells (Lucarelli et al., 2015, Xie et al., 2014, Yang and Lai, 
2013). Although the transforming of primary cells to immortal cells is not in favour, certain 
studies suggest the capacity of immortalised MSCs such as dental pulp stem cells to differentiate 
into functional neurons (Urraca et al., 2015). Therefore, certain studies attempted to immortalise 
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MSCs for gaining more of these pluripotent cells because the immortalisation of MSCs will 
provides more cells than the mortal cells. Immortalisation attempts were applied to the amniotic 
mesenchymal cells (Teng et al., 2013) and dental pulp stem cells (Gao et al., 2015). However, 
this immortalisation should be under control to avoid oncogenic transformation, which required 
knockdown of p53 and up-regulation of TERT (Liu et al., 2013). In short the immortalisation of 
the MSCs is more promising than the immortalisation of the primary cells in vivo or in vitro 
which more likely to consider as tumour or cancer cells.   
The aim of this chapter is to isolate Thy-1 positive cells and culture them in vitro. The cells in 
culture were then used for monitoring and observing their morphological aspects, and also for 
studying their molecular and cellular characteristics. Their stability in culture and their capacity 
to survive in vitro for the long-term period was also investigated, as it is one of the 
characteristics of MSCs. The cell behaviour and the ongoing molecular and cellular changes 
were also noted. Finally, this investigation also included the detection of expression of other 




3.2 Material and methods 
3.2.1 Primary culture of adrenal cells 
Primary cultures of adrenal cells were prepared from freshly isolated adrenal glands using 
mechanical and enzymatic digestion. Adrenal cells were isolated using a modified version of the 
procedures described by (Poolman and Brooks, 1998), (Bestervelt et al., 1993) and (Caroccia et 
al., 2010). Although the following description is the isolation of the cells of interest from the 
adrenal cortex, which includes the capsule, zG, zI and zF, the isolation of the cells from the 
whole adrenal gland was conducted for general examination and ACTH treatment.  
Adrenal glands were cleaned of fat tissue and blood and a small incision was made on the side of 
the adrenal gland. A micro- scissor was inserted into the opening and pointed forceps were used 
to conduct adrenal enucleation (a process of removing most of the inner core of adrenal gland 
medulla and most of the zF, leaving the adrenal capsule intact). The outermost part of each 
adrenal gland (containing the capsule and zG) was divided into several slices and the cells were 
dispersed by serial mechanical and enzymatic digestions (3 digests of 15 minutes each) in 
Minimum Essential Media (MEM) (Gibco) containing 1mg/ml Collagenase type I (Worthington) 
and Pancreatin (Sigma) 0.5 mg/ml using a shaking water bath at 37°C.  
After each digestion, the isolated adrenal cells were harvested and enzymatic activity was 
inhibited by the addition of 10% v/v Foetal Calf Serum (FCS) (Invitrogen) in MEM. The digests 
were pooled, the cells pelleted by centrifugation (800g for 5 minutes) and suspended in 
Dulbeccos Modified Eagle’s Medium (DMEM) (Gibco) containing penicillin (100 U/ml), 
streptomycin (100 µg/ml) (Invitrogen), L-glutamine (2µM) (Invitrogen) and 10 %v/v foetal calf 
serum. Cell viability was assessed using trypan blue exclusion staining and the number of cells 
was determined using a haemocytometer. The isolated cells were maintained for 24 hours in 
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DMEM at 37°C in a humidified atmosphere of 5% CO2 in an air incubator. They were incubated 
for 1-2 days before any further investigation or treatment.  
3.2.2 Trypan blue dye-exclusion  
The viability of the cells was assessed using trypan blue dye-exclusion; an equal quantity (50μl) 
of cell suspension and 0.4% (w/v) trypan blue in PBS was mixed thoroughly. The mixture was 
left to stand at room temperature for 2-3 minutes. The viable cells were round in shape and clear, 
while the dead cells were blue. The cells were counted using a haemocytometer under the 
microscope. The number of viable cells was calculated as follows: 
[1.00 – (Number of blue cells ÷ Number of total cells)] × 100. 
3.2.3 Treatment of primary cells with adrenocorticotropic hormone (ACTH) 
This treatment was conducted for the general assessment of the viability and hormonal response 
activity of the isolated cells. The cells were divided into five groups with each group having 
three wells of a 96 well cell culture plate (Cellstar) containing 1x105 cells in a volume of 200µl 
of DMEM media. They were incubated at 37°C in a humidified atmosphere of 5% CO2 in an air 
incubator before being treated with various doses of ACTH (Bachem), between 1nM and 1pM. 
The media of the treated cells was collected after four hours of treatment and the corticosterone 
concentrations were determined by an Enzyme Linked Immune Sorbent Assay (ELISA).  
3.2.4 Corticosterone detection using ELISA 
A competitive ELISA was applied to detect and quantify corticosterone. Maxisorp microtitre 96 
well plates (Nunc) were coated with 50μl (5ng) corticosterone-BSA (Sigma) diluted in 0.1 M 
sodium bicarbonate and incubated overnight at room temperature. The coated plates were 
washed four times with 0.1% Tween v/v in PBS before the addition of a 250μl gelatine 
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phosphate buffer (0.25% w/v gelatin in PBS (GPB)). They were stored for a minimum of 4 hours 
before use and for a maximum of three weeks in a moist box at 4°C.  
The coated plates were washed four times with 0.1% Tween v/v in PBS before use. Standards 
and samples were pipetted into appropriate wells (100μl/well). For this assay a series of 10 
doubling dilutions of corticosterone standard were prepared in GPB (standard range 0.5 – 
250ng/ml). A corticosterone antibody diluted 1:20000 in GPB (Biogenesis) was added to each 
well (100μl) with the exception of the blank zero tracer wells. The plates were incubated 
overnight at room temperature in a moist box before washing four times with 0.1% Tween v/v in 
PBS. 
 The secondary antibody, 200µl of goat anti-rabbit IgG-horseradish peroxidase (Cell signalling) 
diluted 1:2000 in GPB was added to each well and incubated for at least 1 hour in a humidified 
box. The plates were washed four times with 0.1% Tween v/v in PBS before the addition of tetra 
methyl benzidine (TMB) substrate (Appendix A.25) The reaction was allowed to proceed until a 
blue colour developed and the reaction was stopped by adding 100μl of 0.5 M HCl. The 
absorbance of each well was measured at 450nm (600nm ref) using an ELISA plate reader 
(Molecular Devices). 
3.2.5 Trypsinisation 
The cultured cells were trypsinised using TrypLE (Gibco) when they reached confluence. The 
cells were washed with PBS and then TrypLE was applied to detach them. Media was then 
added to deactivate the TrypLE and the cells were pelleted by centrifugation at 800g at 4oC for 5 
minutes. After this, the supernatant was discarded and the cells were re-suspended in the desired 
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media. Then the cells were either split into more flasks or frozen in the complete medium 
containing 10% dimethyl sulfoxide (DMSO). 
3.2.6 Thy-1 monoclonal antibody production from hybridoma 
Thy-1 antibody was produced in-house from the OX-7 hybridoma cell line. Thy-1 monoclonal 
antibody production was necessary in this project because a large amount was required for the 
experiments carried out. The OX-7 Hybridoma cells Catalogue No.: 84112008 (Sigma) produce 
mouse anti-Thy-1.1 IgG (Biochem J 1980;187:1). Hybridoma cells were received in a box of 
dry-ice containing the frozen vial. The vial was transferred to liquid nitrogen until all 
requirements for culturing the suspension cell line had been prepared.  
The culture medium was prepared for the suspension cell line using [Roswell Park Memorial 
Institute (RPMI) 1640 Medium containing penicillin (100 U/ml), streptomycin (100µg/ml), L-
glutamine (2µM) and 10% v/v foetal calf serum]. Before thawing the cells, 20ml of the medium 
was pipetted in a 25cm2 flask and kept at 37°C in a humidified atmosphere of 5% CO2 in the air. 
In a laminar flow cabinet, a piece of tissue paper sprayed with 70% alcohol was wiped around 
the cap of the frozen vial and the cap was turned a quarter turn to release any residual liquid 
nitrogen that may be trapped. The cap was then retightened and warmed by hand for a few 
seconds. Finally, the ampoule was transferred to a 37oC water bath for 1-2 minutes until only 
small ice crystals remained. This process was key, because any delay in the thawing process may 
have caused damage to the cells membranes. 
3.2.6.1 Growing hybridoma cells 
The cells were seeded at 50,000 viable cells/ml into T75cm2 flask (20ml) and incubated for two 
days where they reached 90% confluency. They were sub-cultured into three T175 cm2 flasks, 
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with each flask receiving 5ml of the culture with 60ml of the media, 65 ml in total in each flask. 
The cells were cultivated and split into four T175 cm2 flasks.  
3.2.6.2 Monoclonal antibody production 
The cell culture content of four T175 cm2 flasks was split into five 50ml tubes, spun at 800g at 
40°C for 5 minutes and re-suspended gently in 7ml sterile PBS for each tube in order to wash the 
serum from the cells. The tubes were spun again and this time the pellets were re-suspended with 
the Hybridoma-serum-free media (SFM), before being transferred to 175cm flasks and incubated 
at 37°C in a humidified atmosphere of 5% CO2 in the air. Hybridoma-SFM is a serum-free 
product optimised for the growth of hybridomas and monoclonal antibody production. It contains 
a low protein concentration (<20 μg/mL) and has no polypeptide growth or attachment factors. 
These characteristics reduce the number of factors that might interfere with Thy-1 monoclonal 
antibody purification. 
3.2.6.3 Binding Thy-1 monoclonal antibody to the protein G bind column  
Hodgkinson and Lowry’s (1982) protein affinity binding and recovery method was used to 
purify Thy-1 monoclonal antibody because the Hybridoma cells were releasing the antibody into 
the media. The media were centrifuged at 1000g at 4°C for 5 minutes to remove the cells. The 
supernatant was then filtered with a 0.22μm filter. Since this Thy-1 monoclonal antibody is a 
mouse lgG1, it has a higher affinity to bind to Protein G in comparison with protein A of the 
immunoglobulin-binding proteins.  
The protein G bind column (HiTrap Protein G HP column) was prepared for binding the Thy-1 
monoclonal antibody. The column was washed with 10ml saline (0.15M NaCL) and the filtered 
media were passed through the column for around 15 hours using a slow MINIPULS machine 
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(Gilson). The time required to pass all the media was pre–adjusted by adjusting the speed of the 
flow, which was necessary to avoid drying the column during the process. The saline was re-
attached just before the end of media to avoid drying the column. 
 3.2.6.4 Elution of the Thy-1 monoclonal antibody from the protein G column  
The binding capacity of the column is affected by the pH, so it forms the basis of the releasing 
process. First, 5ml of saturated sodium bicarbonate was prepared; 150µl of sodium bicarbonate 
solution was aliquoted into the 1.5 ml collection tubes. 
 The first column wash was with saline followed by 0.5M sodium acetate, it was then washed 
with 50mM sodium acetate with 20% acetonitrile pH 6 (pH adjusted with acetic acid) and 
approximately 1 ml of buffer was collected into each of the first 4 tubes. 
 Then the elution was started with 50mM sodium acetate with 20% acetonitrile pH 4 (formic acid 
was used to adjust the pH), around 1 ml of buffer was collected into each one of the second 
group of 4 tubes and they were mixed. Then further elution was conducted with a lower pH 
solution of 50mM sodium acetate with 20% acetonitrile pH 3.5 (formic acid was used to adjust 
the pH again). Around 1 ml of buffer was collected into each of the third group of 4 tubes and 
the protein presence was examined by Coomassie Blue. A NUNC 96 well plate was used for this 
test with 50µl of each tube being pipetted into one well of the plate. Then 100µl of Coomassie 
Blue was added. The wells in which a blue colour developed, meaning they contain the targeted 
protein and tubes are the targeted tubes, which were mixed together with the ones before and 
after the tubes that contain the protein. The acetonitrile was evaporated from the purified 
antibody using a centrifuge evaporator (1ss110bbSpeedVac system), on medium speed for 80 
minutes to reduce the total volume. The protein concentration was measured using a 
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spectrophotometer in which the UV wavelength was set to 280nm. The appropriate volume of 
PBS (300µl) was used as a blank solution, then 300µl of the antibody solution was measured to 
determine the antibody concentration. This was adjusted to less than 500 µg/µl, then the solution 
was divided into 300µl aliquots, snap-frozen in liquid nitrogen, and moved to a -80°C freezer. 
3.2.7 Western blotting  
Western blotting was conducted to separate and visualise proteins, these images were employed 
to confirm the size and the presence of the proteins of interest. Proteins released in the culture 
media were detected directly by profiling a sample of the media, while the proteins inside the 
cell were detected after preparation of cell lysate.  
3.2.7.1 Preparation of cell lysates 
The cells were processed after removing the media by centrifuging at 1500 g for 15 minutes at 4o 
C. The cells were then washed with ice-cold PBS using the same previous centrifugation step. 
Then the chilled lysis buffer (a protein inhibitor cocktail and RIPA buffer mixture (1:100)) was 
added to the pellets. The cells were added in a concentration of 1x107/ml of lysis buffer and 
mixed well.  
The lysates were passed through 21 gauge blunt needles a minimum of ten times and then 
incubated at 4oC for 30 minutes. Finally, the lysates were transferred to 1.5 ml microcentrifuge 
tubes and centrifuged at 13,000 g for 15 minutes in 4oC and the supernatant was collected and 
stored at -20oC.  
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3.2.7.2 Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis (SDS-PAGE)  
Glass plates were assembled according to the vertical electrophoresis tank instructions (BioRad), 
the concentration and volume of the separating gel (resolving gel) was determined and prepared 
first according to the appropriate instructions.  
The separating gels were pipetted into the gap between the two glass sheets quickly after 
preparation, making sure that adequate space was left for the stacking gel. In order to prevent the 
diffusion of oxygen into the gel, which could inhibit the polymerization of the gel, the resolving 
gel was covered with 0.1% SDS w/v, isobutanol or water according to the acrylamide 
concentration (low, medium or high respectively), the gel was then placed for 5-15 minutes 
vertically at room temperature. The cover liquid was removed after the resolving gel 
polymerisation. Then the top of the gel was washed with water twice to remove the un-
polymerised acrylamide. The liquid was removed completely from the top of the resolving gel. 
Then the stacking gel was prepared, pipetted on the resolving gel, and the comb was inserted 
immediately in order to avoid any air bubbles. The comb was removed after polymerisation to 
reveal the samples’ wells. The prepared SDS gel had two separated layers: the upper stacking gel 


















Figure 3.1 SDS-PAGE system gel consists of two components. The stacking and resolving 
(running) gels, the stacking gel has lower micro-pores sizes, pH and ionic strengths. The resolving gel has higher 
micro-pores sizes, pH and ionic strengths. The protein samples travel through the gel from the cathode (-) to the 
anode (+) after applying electric power to the running buffer.  
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The cell culture media or the cell lysate samples were prepared by mixing 25 µL 5x loading 
buffer (Appendix A.26) and 5 µL of β-mercaptoethanol was added to 95 µL of sample lysate or 
the cell culture media. Later this mixture was heated for 5 minutes at 90oC. After processing the 
lysates with a loading buffer, samples were run through SDS-PAGE in order to separate proteins 
based on their molecular weight. The gel concentrations were selected to meet the size of the 
targeted proteins; 15 % v/v gels were used for small proteins with a molecular weight of up to 
12-25 kiloDalton (kD). 10-12 % v/v were for proteins with a molecular weight from 10 – 70 kD, 
and less than 10% for those larger than that. Running buffer (Appendix A.27) was added to the 
running tank and samples were loaded in the stacking gel wells after being filled with the 
running buffer. An electrical current was applied to the running tank, using 10 to 15 V and 30 
mA per cm of the gel. Visualisation of the targeted proteins was carried out by either the 
Coomassie Blue staining or blotting of the protein bands on a transfer membrane. 
3.2.7.3 Staining Polyacrylamide SDS-PAGE Gels with Coomassie Blue 
The SDS gel was washed with distilled water 3 times for 5 minutes each to remove the SDS 
because it interferes with the staining process. The water was removed and enough Coomassie 
Blue stain (Bio-safe™) was added to cover the gel. The gels were then gently shaken on a rocker 
for one hour. The proteins bands were usually visible within 20-30minutes. After the appearance 
of the bands, the gel was washed with distilled water for at least 30 minutes to reduce the 
background and the stained gels were stored in water at 4C.  
3.2.7.4 Transferring the protein from the gel to the transfer membrane  
The gel was removed from the running tank, the stacking gel and the no ladder corner of the 
separating gel were removed for orientation. The gel was transferred to transfer buffer (Appendix 
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A.28) for 20 minutes. The transfer membrane (0.45 μm pore size polyvinylidene difluoride 
(PVDF)) was submerged in methanol for 30 seconds and then washed in distilled water. Six 
filtered papers were submerged in the transfer buffer, three of them were put on the semi-dry 
transfer machine and all bubbles were removed. The transfer membrane was put on top of the 
filter papers. Then the gel was placed on the transfer membrane and the remaining three filter 
papers were put on top of the gel. An electrical current was applied for 1.5 hours to transfer 






Figure 3.2 Sandwich semidry system of protein transfer after SDS page electrophoresis. The system was setup to 
transfer proteins from the SDS page gel to a solid blotting membrane for further analysis. The system consisted of 2-
3 filter papers, the gel, the blotting membrane and finally 2-3 filter papers. The protein samples travel from the gel to 
the membrane (from the cathode (-) to the node (+)) after applying electric power. 
 
The transferred membrane was moved into the tray, blocked with 5% dry skimmed milk, 
dissolved in Tris-Buffered Saline Tween (TBST) (Appendix A.29), for one hour at room 
temperature with agitation. The membrane was washed three times with TBST for 10 minutes 
each also with agitation. The primary antibody was added to the membrane after an appropriate 
dilution usually 1:1000 in 5% w/v BSA or low-fat milk (dissolved in TBST) and incubated 
overnight at 4oC with agitation. The following day, the membrane was again washed in TBST 
three times, for 10 minutes each with agitation. A horseradish peroxidase (HRP) conjugated 
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secondary antibody, prepared and properly diluted (1:4000 in 1% w/v BSA or low-fat milk 
dissolved in TBST), was applied to the membrane for one hour at room temperature with 
agitation and finally the membrane was once again washed in TBST three times, 10 minutes each 
with agitation. 
3.2.7.5 Imaging and data analysis  
Amersham ECL Plus (substrate detection solution mix) was prepared and used to cover the 
membrane. Any protein bands were detected using Image Quant LAS 4000 mini - GE Healthcare 
machine. 
3.2.8 Magnetic Activated Cell Sorting (MACS) 
Magnetic activated cell sorting (MACS) is a common method used to isolate target cells. In 
MACS, magnetic microparticles are coated with antibodies to cell surface markers and cells 
expressing this marker then become associated with the beads. The cells are then transferred to a 
column and a magnetic field is then applied, then when the column is washed, unwanted cells are 
washed away, retaining the cells of interest. MACS was instrumental in our understanding 
behaviour of the isolated cells in vitro. 
3.2.8.1 Labelling antibody with para magnetic beads 
 Pierce N-hydroxysuccinimide (NHS)-Activated Magnetic Beads were used for the 
immunoprecipitation of the Thy-1 target cells. This required binding a specific antibody with the 
magnetic beads.  
The binding procedure was conducted using 300μL of magnetic beads (10mg/ml) in a 1.5ml 
microcentrifuge tube to bind 500μL of protein solution following the manufacture’s protocol. 
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The coupling and blocking procedure began by equilibrating the Thy-1 antibody solution and 
magnetic beads to room temperature and chilling the wash buffer (PBS) on ice. 
The magnetic beads were mixed by gentle tapping and repeated inversion until no clumps were 
seen. Each 300μL of the magnetic beads were prepared individually and were then placed into a 
1.5 microcentrifuge tube in a magnetic stand (Promega). The magnetic beads were attached to 
the side of the tube closest to magnet in a few seconds leaving a coluorless solution in the bottom 
of the tube, which was discarded while the tube was inside the magnetic stand. Then the tube 
was removed from the magnetic stand and the beads were washed with 1ml of ice-cold PBS and 
gently mixed by tapping for 15 seconds until the solution was homogeneous. The tube was 
returned into the magnetic stand, the beads again moved toward the side wall of the tube and 
quickly attached to the magnetic side, leaving a colourless solution which was discarded. The 
tube was taken out of the magnetic stand, the Thy-1 antibody solution (500μL containing 235μg 
of the Thy-1 antibody) was added immediately to the tube and mixed gently by tapping for 30 
seconds. 
It was then incubated overnight at 4°C on a rotator (the 1.5ml microcentrifuge tube was placed in 
a 20ml tube and put in a horizontal rotator). During the first 30 minutes of the incubation, the 
solution was mixed for 10 seconds every 5 minutes. Then the tube was mixed twice for 15 
seconds every 15 minutes. Then left on the horizontal rotator until incubation was complete.  
The bead-antibody complexes were collected with the magnetic stand and washed twice with 
PBS (1ml) each as previously described. One ml of ultrapure water was added and mixed for 15 
seconds. The tube was placed into a magnetic stand where the bead-antibody complexes were 
collected and the supernatant was discarded. Then the beads were quenched by mixing with 1ml 
of quenching buffer for 30 seconds. The quenching buffer was 300μl of 3M ethanolamine in 5ml 
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of 1M HCl, pH 8.5.  The pH was measured and drops of ethanolamine were added if it was 
acidic, but if it was alkaline HCl was added until the pH reached 8.5.  
 
Then the tube was incubated for 2 hours at room temperature on a rotator. The beads-antibody 
complex was collected using the magnetic stand and the supernatant was discarded. Then 1 ml of 
ultrapure water was added to the bead-antibody complexes and mixed for 15 seconds. The tube 
was placed onto the magnetic stand, the bead-antibody complexes were again collected and the 
supernatant discarded. Finally, 1 ml of storage buffer [Coupling Buffer (50mM sodium 
bicarbonate) with 0.05% sodium azide] was added to the bead-antibody complexes and mixed 
for 15 seconds. The tube was placed onto the magnetic stand, the bead-antibody complexes were 
collected again and the supernatant was discarded. This wash was repeated two additional times 
and then the beads were stored in 300μL of storage buffer at 4°C until ready for use. 
3.2.8.2 Binding the bead-antibody complexes to the target cells 
MACS was applied to the primary adrenal cells after one day of culture in order to isolate the 
cells expressing Thy-1 protein in their cell membrane. The cultured cells were counted using a 
haemocytometer, then pelleted at 600g for 5 minutes at 4°C to remove the culture medium. Then 
2 ml of sterile ice-cold PBS, containing 0.1% w/v bovine serum albumin (BSA) buffer, was used 
to re-suspend 2.5 million cells. 
 An appropriate volume (50µl) of Thy-1 antibody conjugated beads was prepared for each 
adrenal gland. Thy-1 antibody conjugated beads were pipetted into a 1.5 microcentrifuge tube. 
Then, 1 ml of PBS was added to the conjugated beads and mixed for 15 seconds. The tube was 
placed into a magnetic stand, the beads-antibody complexes were collected and the supernatant 
was discarded. This wash with PBS was repeated twice. The next step, pipetting, was conducted 
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slowly and gently to minimise harm to the cells. The cell suspension was added to the conjugated 
beads and incubated at 4°C on a rotator (Fisherbrand) with a slow rotation (20 RPM) for 30 
minutes to bind the conjugated beads to the target cells. Again, the tube was placed onto the 
magnetic stand and the negative cells were collected. Then the tube was moved out of the 
magnetic stand and 1 mL of ice-cold PBS, containing 0.1% BSA, was added and gently mixed to 
remove any negative cells. The tube was placed onto the magnetic stand; the conjugated bead-
cell complexes started to move toward the side wall of the tube and attached to the magnetic side 
in a few seconds leaving a clear solution, which was discarded. This wash step was repeated 
twice to remove negative cells.  
The conjugated bead-cell complexes in each tube were re-suspended in a pre-warmed DMEM 
culture at 37°C and moved to one well of a 12 well plate. The plate was incubated at 37°C in a 
5% CO2 humidified incubator for 10-14 days before changing the media.  
3.2.9 Cells tracking and wound healing assays 
The isolated cells were cultured in the DMEM media for over one year, cell tracking and wound 
healing assays were conducted to monitor cell proliferation and migration in vitro. Cells were 
prepared 1-7 days before the day of the assay, the cells seeded on a 12 and 24-well plate at 10-
30% confluence for cell tracking assay and 70-90% confluence for wound healing assay. Cells 
were seeded in triplicated. Confluent cells underwent wound healing assay and were scratched 
by a 200μl pipette tip along the diameter of each well. Cells were rinsed twice with culture media 
to remove any floating cell debris. The cells were refreshed with fresh media before positioning 






Immunocytofluorescence assays were conducted to examine the expression of the protein of 
interest in the Thy-1 positive cells. Dual Immunocytofluorescence staining assays were 
conducted using primary mouse antibodies and rabbit antibodies. The cells were washed twice 
with PBS to remove the culture medium and then they were fixed with 4% paraformaldehyde in 
PBS (w/v) for 5 minutes, washed three times (3x) with PBS and blocked with 10% v/v goat 
serum in PBS for 30-60 minutes. After this, the cells were incubated with the primary antibodies 
(1:200 dilution in 1% v/v goat serum in PBS for each) overnight at 4°C. They were washed with 
PBS (3x), incubated with fluorescent Alexa-Fluor conjugated secondary antibody (anti-mouse 
and anti-rabbit) at a 1:200 dilution for 30 minutes before washing three times with PBS. The 
coverslips were mounted with DAPI (VECTASHIELD). In the dual immunocytofluorescence 
both primary and secondary antibodies (mouse and rabbit) were mixed together in the primary 
and secondary incubation steps, respectively. The slides were tested using a Zeiss-Axio Imager. 
 
3.2.11 RNA isolation from cultured cells 
The RNA was isolated from the cultured cells using an RNeasy mini kit after trypsinising the 
cells using TrypLE reagent (Gibco). The cells were washed with PBS and centrifuged at 800 x g 
for 5 minutes. The supernatant was completely aspirated.  
The pelleted cells were loosened thoroughly by flicking the tube. They were then entered into the 
RNA isolation process. Several preparations were conducted before the use of the kit 
components following the provider’s recommendations. The loose pelleted cells were disrupted 
by adding the appropriate volume of Buffer RLT (350-600μl). 
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The mix was pipetted and homogenised by passing slowly through a pipette tip and the bottom of 
the tube at least 10 times. Based on the volume of the RLT buffer that was added initially, one 
volume of 70% ethanol was added to the homogeneous lysate and mixed well by pipetting. The 
mixed sample (no more than 700μl) including any precipitate that may have formed was 
transferred to an RNeasy spin column and placed in a 2 ml collection tube. The lid was gently 
closed and the sample was centrifuged for 15 seconds at 8000 x g (10,000 rpm). The flow-
through was discarded. If the sample volume exceeded 700 μl, it was divided and centrifuged in 
the same RNeasy spin column. The flow-through was discarded after each centrifugation. To 
eliminate genomic DNA contamination, an on-column DNase digestion was conducted. 
To wash the spin column membrane, 350μl of buffer RW1 were added to the RNeasy spin 
column. The lid was gently closed and the column centrifuged for 15 seconds at 8,000 x g 
(10,000 rpm). The flow-through was discarded, and the collection tube was reused. Ten μl of 
DNase I stock solution was mixed gently with 70μl of buffer RDD. The mix (80μl) was added 
directly to the RNeasy spin column membrane and placed on the bench-top (20–30°C) for 15 
minutes. The previous wash step was then repeated by adding 350μl of buffer RW1 to the spin 
column membrane. The lid was gently closed and the column centrifuged for 15 seconds at 8000 
x g (10,000 rpm). The flow-through was discarded, and the collection tube was used again.  
The spin column membrane was washed twice with buffer RPE to ensure that no ethanol was 
carried over during RNA elution because residual ethanol may interfere with downstream 
reactions. The first wash was conducted by adding 500μl of buffer RPE to the RNeasy spin 
column. The lid was closed carefully and the sample was centrifuged for 15 seconds at 8000 x g 
(10,000 rpm). The flow-through was discarded, and the collection tube was reused again. The 
second wash was conducted by adding 500μl of Buffer RPE to the RNeasy spin column. Again, 
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the lid was gently closed and the column centrifuged for 2 minutes at 8,000 x g (10,000 rpm). 
The flow-through was discarded. The RNeasy spin column was placed in a new 2 ml collection 
tube and the old collection tube was discarded with the flow-through. The lid was gently closed 
and the column centrifuged for 1 minute. The RNeasy spin column was placed in a new 1.5 ml 
collection tube and 30–50μl RNase-free water was added directly to the spin column membrane. 
The lid was gently closed and the column centrifuged for 1 minute to elute the RNA. The RNA 
concentration and purity were measured using a Nanodrop (2000).  
The isolated RNA from rat adrenal tissue was usually obtained using the TRIzol Reagent method 
(section 2.2.1.1) for the positive controls of the RT-PCR tests.  
 
3.2.12 cDNA synthesis for RT-PCR 






Table 3.1 List of primers (invitrogen) used in the RT-PCR, their accession number, position in the mRNA sequence 
and their product size. 





 Size(bp)  
Accession 
 number 
GAPDH  CAAGGTCATCCATGACAACTTTG (540-562) GTCCACCACCCTGTTGCTGTAG (1035-1014) 496  XM_017593963.1 
Klf5  CACAGCGCCAGAGGTGAACAATATC (507-531) ATGGATGCGTCGCTTCTCCAGATC (1020-997) 514  XM_006252403.3 
Thy-1  CCTCCAAGCCACGGACTTCATTTC (865-888)  AAGGCTCAGCAGCGCTCTCCTATC (1377-1354) 513  XM_017595476.1 
Tmem121  TTGGTAGGCGATGTGTGCTTCCTG (393-416) ATCATCTTCTGCGGTGCGATGTGC (901-878) 509 XM_006240674.3 
NR5a1  AGCCCGATAGCCACTGCCCTA (28-48) GCCCCGCATTCGATCAGCAC (414-395) 387 NM_001191099.1 
3BHSD GCAGACCATCCTAGATGTCAATCTG (434-458) CAAGTGGCACATAGCCCAGATCTC (1182-1159) 749 NM_001007719.3 
steroidogenic acute regulatory protein  
(STAR) 
GGAGAGTGGAACCCAAATGTCAAGG (549-573) TGGTTGATGATGGTCTTTGGCAGCC (889-865) 341 NM_031558.3 
CyP11B1 AAGAACACTTTGATTCCTGGGATA (761-784) GTGTCAACACTTCCAGCAATAAGT (950-927) 190 NM_012537.3 
Cyp21a1 ACTCACAGCTGTGTCCGGGACTTG (644-667) CAGCAGCGTGAAGGTCTGGAGCAG (1423-1400) 780 XM_006255907.2 
Aldo Synthase (Cyp11b2) AAGAACATTTTGATGCCTGGGATG (805-828) GTGTCAACGCTCCCAGCAGTGAGC (997-974) 193 XM_008765542.1 
Scc (Cyp11a1) GCACACAACTTGAAGGTACAGGAG (1018-1041) CAGCCAAAGCCCAAGTACCGGAAG (1361-1338) 344 NM_017286.2 
 NPR  ATGGCGTGTGCTGACCTTCTCATC (472-495) TTGACCGTCTTCACCTTGGTCCTG (980-957) 509 XM_017592662.1 
CD29 ACTGAAGAGCGGCTGAGACCCG (1-22) TGGCCGGAGCTTCTCTGCCAT (524-504) 524 XM_006255824.1 
Etv5 GAAGTGGCCGCTCAGGAGGATCT (46-68) GTGACAAAGGAGTGGCGGGC (565-546) 520 NM_001107082.1 
Shh ATCCAAAGCTCGCATCCACT (845-864) GGTTGATGAGAATGGTGCCG (1344-1325) 500 NM_017221.1 
Gli1 CCGACAGAGGTTGGGATGAAG (114-134) ATGGAGAGATGGCCGTAGGA (590-571) 477 XM_008765375.1 
Wt1 CCACACCAGGACTCATACAGG (1632-1652) ACAACCGCTCTAATCCCAGC (2123-2104) 492 XM_006234622.2 
Tert TTCCTTCCACCAGGTGTCAT (207-226) AGGCACGTTTGTACTGGTGA (726-707) 520 NM_053423.1 








3.2.13 Generating amplicons of target genes by PCR 
 PCR was used to detect the expression of the genes of interest. The preparation of the PCR 
reactions and the PCR conditions followed by agarose gel electrophoresis were described in 
section (2.2.3).  
3.2.14 Immunohistofluorescence  
 Adrenal cryosections were prepared and the Immunohistofluorescence assays were conducted as 
described in section (2.2.12).  
3.2.15 Microscopy  
The immunofluorescent imaging for immunocytofluorescent and Immunohistofluorescence 
experiments were examined using a Zeiss-Axio Imager A1 fluorescent microscope with four 
filters: Blue/cyan filter for (4',6-diamidino-2-phenylindole (DAPI)), Alexa Fluor (AF) 488 green 
AF 546 yellow and AF 660 red. The magnification powers of the objective lenses used in these 
experiments were 5x, 10x, 20x and 40x. The fluorescent microscope was fitted with a camera 
(Axio cam MRm) linked to a computer and controlled by AxioVison software (Rel.4.8). This 
software was used to adjust the coluors, and quality of the images.  
The cell numbers and viability were measured using an inverted transmitted-light microscope 
(Leitz LABOVERT) fitted with a camera (WILD MPS 12). The magnification power of the 10x 
objective lens was usually used in the primary cell experiments.  
Time-lapse images sequences were taken (every 10 or 15 min) for cell tracking and wound 
healing assays using a Nikon TiE Time Lapse System, which included a moveable stage and 
environmental chamber set at 37C with a continuous flow of CO2 through the plate. The assays 
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were run using a 10X Nikon lens. The quality of the images was adjusted using the microscope 
fine adjustment. 
3.2.16 Image analysis by Image J software 
The time lapse videos of cell tracking and wound healing assays were analysed using image J 
(Fiji) software. Single cell tracking was conducted to measure the time required for each cell 
division (doubling time) and the ratio of cells undergoing division per day was also calculated.  
The wound healing assays were carried out to measure and compare the differences of cell 
migration ability of Thy-1 positive cells. Image J (Fiji) software was used to measure the areas of 
the wounds after a certain amount of time.  
3.2.17 Statistical analysis  
 
The resulted data of ELISA after ACTH treatment to the adrenal primary cultured cells and cell 
migration assays for Thy-1 positive cells were analysed using "Dunnett's Multiple Comparison Test" 








 The assays and the analysis of the results of the previous chapter suggested that the Thy-1 
protein was a potential adrenocortical stem cell marker. The aims of this chapter were the 
isolation of Thy-1 positive cells and to study them in vitro. These aims required the primary 
culture of dispersed adrenal cortex cells and testing their viability and hormonal response in 
vitro.   
 3.3.1 Adrenal cell primary culture, ACTH treatment, and ELISA. 
Primary cultures of adrenal gland cells were prepared successfully from freshly isolated rat 
adrenal glands after mechanical and enzymatic digestion. The isolated cells were cultured in 
vitro under controlled condition. The viability of the adrenal primary cells was examined using 
Trypan blue exclusion and showed 87±5% viable cells.  
In addition to the viability test, a hormonal response induction test was conducted to evaluate the 
ability of these primary cells to release corticosterone hormone after treating them with ACTH. 
The cells were subjected to treatment with ACTH and the corticosterone released from the cells 
was measured using ELISA. Cells were incubated for 24 hours before exposure to serial doses of 
ACTH (1nM, 100pM, 10pM, 1pM and control). The medium was collected after 4 hours of 
exposure to ACTH and the corticosterone released by the cells was measured in the medium. The 
ELISA results showed that the rat adrenal gland primary cells had responded to the ACTH 
treatment by releasing corticosterone hormone in the culture medium. The cells response to 
ACTH treatment was dose dependent, with corticosterone concentration increasing from the 







































with (1-1000 picomole) of ACTH (figure 3.3). Generally, the results of ACTH treatment showed 
expected corticosterone releasing response of these primary cells. A statistical analysis of one-way 
ANOVA showed significant [** (P<0.01) and *** (P<0.001)] responses of ACTH treatments at the 









Figure 3.3 The effect of ACTH on corticosterone secretion from primary adrenal cultures. Cells were cultured at 
100,000 cells/ml of DMEM media. The corticosterone response was measured by ELISA after 4 hours of ACTH 
treatments with (1nM, 100pM, 10pM, 1pM and control. Values are mean± standard error of mean (SEM) based on 3 
independent cultures. summarized one-way ANOVA results revealed that significant [** (P<0.01) and *** 
(P<0.001)] responses of ACTH treatments at the two highest concentrations (100pM and1000pM respectively). 
 
 
3.3.2 Production of anti-Thy-1 monoclonal antibody from hybridoma cells 
 The production of anti-Thy-1 monoclonal antibody on a large scale was necessary to accomplish 
a number of experiments in this project. This involved growing OX-7 hybridoma cells in RPMI 
medium which was successfully achieved in large scale. Samples of cultured media (RPMI) from 
several flasks were tested for the presence of the Thy-1 antibody using SDS-PAGE Coomassie 
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blue staining (figure 3.4), before proceeding with further production steps. The antibody was 
detected in all tested samples showing the presence of both heavy chain (~50KD) and light 
chains (~25KDa). The OX-7 hybridoma cells were transferred to the SFM medium to induce the 
cells to increase Thy-1 antibody production. The medium was collected and the anti-Thy-1 
antibody was purified by utilising the binding affinity of the antibody to protein G (an 
immunoglobulin-binding protein). The Thy-1 antibody was subsequently recovered from the 
column. Acetonitrile was evaporated from the antibody solution (the evaporation of acetonitrile 
from the antibody solution reduced the volume of the anti-Thy-1 antibody solution from 10ml to 
6ml) and the concentration of the protein was determined to be 0.781mg/ml. Thy-1 antibody 
solution was diluted to 500µg/ml with PBS. Samples from the media before and after the 
purification of the Thy-1 antibody and from the purified antibody solution were subjected to 
Western blotting to show the presence of the antibody light and heavy chains (figure 3.5). The 
bands of the purified antibody product were larger than the bands of the antibody before purification, 
which confirmed the successful purification. However, there was residual antibody that remained in 
the media after purification (figure 3.5), which might due to the limited binding capacity of the 
column. The intensity of the antibody band from the SFM culture before purification (figure 3.5) was 
more intense than one from the SFM culture after purification, which indicated the efficiency of the 



























Figure 3.4 Three samples of the hybridoma culture media (RPMI) separated by SDS-page, showing the 
heavy chain (~50KDa) and light chains (~25KDa) of the reduced and SDS-denatured anti-Thy-1 antibody 
detected by Coomassie blue staining.  
 
Figure 3.5 Detection of Thy-1 antibody resolved on a 10% SDS gel before Western blotting. The heavy chain 
(~50KDa) and light chains (~25KDa) of the denatured anti-Thy-1 antibody were detected by Western blots using 
HRP-goat anti-mouse IgG. (A) The lane loaded with fresh SFM medium as the negative control. (B)The lane 
loaded with SFM from the culture before purification. (C) The lane loaded with SFM from the culture after 






3.3.4 MACS and the initial characterisation of the isolated cells 
The para magnetic beads were used for the immunoprecipitation of the Thy-1 target cells. The 
process required labelling the magnetic beads with anti-Thy-1 antibody. 
The labelling procedure was conducted usually by using 300μL of magnetic beads in a 1.5ml 
microcentrifuge tube to bind with anti-Thy-1 antibody from 500μL of anti-Thy-1 antibody 
solution. The final product was 300μL of Thy-1 conjugated beads. Fifty-microliter of Thy-1 
conjugated beads was prepared for each adrenal gland. Primary culture of the freshly isolated 
adrenal gland was carried out after removing the adrenal medulla and most of the zF by adrenal 
gland enucleation. MACS was applied to the primary adrenal cells after one day of culture in 
order to isolate the cells expressing Thy-1 protein in their cell membrane.  
The number of isolated cells was variable and was approximately 8-11x102 from each adrenal 
gland. The isolated cells were then successfully cultured in the culture media. However, the Thy-
1cells were slow growing cells and did not attach to the surface of the well until they spent 









3.3.5 Monitoring of Thy-1 cell proliferation and migration in vitro  
The isolated cells were monitored from the first day of isolation until they had been in in vitro 
culture for 12 months. The cells were seeded at 1,000-5,000 cells/cm2. Thy-1 positive cells spent 
8-10 days floating or semi-attached to the plastic surface in culture before they fully attached. 
After then the attachment was relatively strong and consequently, 20-25min incubation with 
TrypLE was required to detach the cells from the wells. They were replenished with fresh 
DMEM every 2-3 weeks and passaged when they reached confluence every 5-6 weeks. The 
attached cells showed fibroblast cell like characteristics with cellular projections extending at 
certain times in column like projections. From the first month until one year in culture, the cells 






Figure 3.6 Thy-1 positive cells isolated from rat adrenal gland using MACS. The cells 
showed fibroblast cell like colony formation after 2months in the culture. The growing 
pattern of the confluent cells developed the whirlpool-like shape in culture. Scale bar 100um. 
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The morphology characteristics of the cells in culture remained relatively identical for the first 8-
9 months but slight changes were recorded with time in culture, especially in the last two months 
in vitro (11-12 months). Cell size and body shape were the most changeable at that time and the 
vast majority of the cells became much smaller in comparison with cells of a younger age (figure 
3.7). These morphological changes in Thy-1 positive cells over time might be associated with 
changing in these cells behavior in vitro, which required more investigation regarding cell 
proliferation and cell migration. 
The cells division rates were calculated in terms of either the cell doubling time or number of 
days per cell cycle method. The cell division rates of the younger larger cells (2-7 months) in 
comparison with the older smaller cells (10-12months) were tracked in culture using time lapse. 
The division rate of the younger cells was slower than the older cells. In general, single cell 
tracking showed that cells in their 2nd month in culture, underwent division approximately every 
3 days while the old cells (10-12 months) underwent division every 36-48 hours (figure 3.7). In 
order to study the difference in cell doubling times between cells in their 2nd month in culture 
and cells in their 12th month in culture, the younger cells required trypsinisation using a long 
incubation time (25 minutes) with TrypLE™, while the older cells required trypsinisation using a 
short incubation time (10 minutes) with TrypLE™.  
 The existence of a few large cells was recorded during the second month of cultivation (figure 
3.7), these cells had the slowest proliferation and migration rate amongst the cells. Tracking 
these cells for over three days showed limited divisions amongst these cells at 2 months in 
culture and no divisions after 6 months of cultivation. However, at the age of 10 months, these 












Figure 3.7 Comparison of Thy-1 positive cell proliferation between young cells (2 months in the culture) and older 
cells (12 months in the culture) using cell tracking assay. Cells were cultured to 30-40% confluent before cell 
tracking. Time lapse acquisition every 15 minutes was conducted. Proliferation of young cells was significantly less 
than the proliferation of the old cells. The arrow referred to the co-existence of large and slow proliferative cells with 





The migration of the Thy-1 positive cells was tested using a wound-healing assay. A comparison 
between cells in their 2nd month in culture and cells in their 12th month in the culture were 
conducted after a long incubation time (25 minutes) with TrypLE™ for the younger cells and a 
short incubation time (10 minutes) with TrypLE™ for the older cells (figure 3.8). The old cells 
were found to migrate faster than the young cells. The wound of the old cells closed completely 
after 20 hours while only 53±7% of the wound closed after 20 hours for the young cells (figure 
3.8). A statistic analysis of these results revealed significant (P<0.01) differences in wound 
closer between 10 and 20 hours of both groups and the older cells (12 month group) was 












































Figure 3.8 Comparison of Thy-1 positive cell migration between young cells (2 months in the culture) and old cells 
(12months in the culture) using wound healing assay. Cells were cultured to full confluency before scratching the 
wounds. Time lapse acquisition every 15 minutes was conducted. Migration of young cells was significantly less than the 
migration of the old cells. Independent experiments performed in triplicate. Scale bars: 50µm. Summarized one-way 
ANOVA results revealed significant ** (P<0.01)  differences in wound closer between 10 and 20 hours of both groups 









3.3.6 Characterisation of Thy-1 positive cells after two-weeks in culture  
  
After two weeks, the putative Thy-1 positive cells were tested for Thy-1 expression using 
immunocytofluorescence (figure 3.9). Dual staining immunocytofluorescence assays were used 
to evaluate Thy-1 expression in the cells after two weeks in culture using anti-Thy-1 antibody 
and to test possible contamination with blood cells using anti-CD45 (blood cell marker). The 
results of the immunocytofluorescence showed that the vast majority of the cells were expressing 
Thy-1 but not CD45. This experiment therefore showed the isolated cells were not contaminated 
















Figure 3.9 Immunocytofluorescence on 2 week old cultures of Thy-1 positive cells isolated using MACS. Cells were 
fixed, stained with DAPI (A, D) and incubated with either anti-CD45 antibody (Abcam) (B) or anti-Thy-1 antibody (E) 
before detection with anti-mouse Alexa 546 antibody. Merged images of (A) and (B) are shown in (C) and of (D) and 





3.3.7 Characterisation of Thy-1 positive cells after eight weeks in culture  
To determine if the cells retained their Thy-1 positive phenotype, eight weeks after isolation the 
cells were split into three groups. One group of cells was tested by immunocytofluorescence for 
Thy-1, to compare the expression of Thy-1 to the expression after two weeks of culture. The 
results (Figure 3.10) showed that after eight weeks post-MACS the Thy-1 positive cells had 
increased in number and had higher Thy-1 expression (detected by increased fluorescence). 
Whilst Thy-1 positive cells represented 82±8% of the isolated cells two weeks after MACS, at 
eight weeks they now represented 96±3% of the cells. 
  
Figure 3.10 Immunocytofluorescence on 8 weeks old cultures of Thy-1 positive cells isolated using MACS. (B and 
E) Cells were incubated with either anti-CD45 antibody or with anti-Thy-1 antibody respectively before detection 
with anti-mouse Alexa 546 antibody. All samples were mounted and cell nuclei were stained with DAPI (A, D). 




After eight weeks post MACS, the expression of a number of different genes in the Thy-1 
positive cells was evaluated (figure 3.8). This would determine if the Thy-1 positive cells were 
mainly differentiated cells or not, and also what other stem/progenitor cell markers they were 
expressing. RT-PCR was performed on RNA extracted from the Thy-1 positive cells to detect 
steroidogenic genes (SCC, Cyp11b2, Cyp11b1, Cyp21, 3BHSD, STAR1) and also SF1, WT1, 
Shh, Gli1 and TERT. The results of RT-PCR showed the expression of WT1 in addition to Thy-1 
in the cDNA of the selected cells. No other steroidogenic genes or other markers in this 
experiment showed any product. 
 
 
Figure 3.11 RT-PCR on RNA isolated from a 12 week culture of Thy-1 positive cells to determine the gene 
expression of SCC, SF1, Cyp11b2, Cyp11b1, Cyp21, 3BHSD, STAR1, WT1, Shh, Gli1, TERT, NPR, Thy-1. (A) 






3.3.8 Detection of Etv5 and ID4 stem cell markers after eight weeks in culture 
Further investigations were conducted to identify the characteristics of these undifferentiated 
cells. The presence of Thy-1 on the cell membrane acts as a stem cell marker and as a cell 
surface antigen, which was a useful tool for the isolation of target cells and enabled culturing of 
them in vitro for further investigations. The expression of other stem cell markers was 
subsequently studied in the isolated cells. mRNA from both the stem cell markers Etv5 and ID4  












Figure 3.12 Agarose gel electrophoresis of RT-PCR products, which amplified approximatly 
500bp of the stem cell markers Etv5 and ID4 in the Thy-1 positive cells using specific primers. 
The PCR products showed the mRNA expression of these two genes. The primers were used 
against a water template as negative control. The primers were used against whole adrenal 
cDNA as positive control. 
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The detection of Etv5 and ID4 mRNA expression was confirmed by immunocytofluorescence to 
detect their protein expression. The results showed their expression in the nucleus (figure 3.13). 
The majority of the cells were expressing ID4 (84 ±7%). While the expression of Etv5 was 
relatively lower than ID4 expression (81±6.3%).  These findings were recorded when the cells 









Figure 3.13 Dual-immunocytofluorescence on 8 week old cultures of Thy-1 positive cells isolated using MACS. 
Cells were fixed with 4%PFA in PBS. Cells were incubated with mouse anti-CD45 antibody (Abcam) (B), mouse 
anti-Thy-1 antibody (F and J), control rabbit IgG (C), rabbit anti-Etv5 antibody (Abcam) (G) or with rabbit anti-ID4 
antibody (Abcam) (K) before detection with anti-mouse Alexa 488 and anti-rabbit Alexa647. All samples were 
mounted and cell nuclei were stained with DAPI in (A, E and I).  Merged images of (A), (B) and (C) are shown in 
(D) and of (E), (F) and (G) in (H), and (I), (J) and (K) in (L). The arrows in (G and J) refer to the location of Etv5 














3.3.9 Characterisation of Thy-1 positive cells after twelve weeks in culture  
Twelve weeks after isolation, immunocytofluorescence was used to confirm the expression of 
WT1 gene as it was shown in the RT-PCR results that were obtained from the Thy-1 positive 
cells after eight weeks in culture (figure 3.11). 
The expression of WT1 was suggested as a stem cell maintenance factor of the undifferentiated 
adrenal-gonadal primordium. WT1 is a marker related to the mesenchymal origin of the adrenal 
capsule, which in turn represents the layer where adrenocortical stem cell niche would be, while 
Sf1 is a nuclear receptor and key regulator for steroidogenic enzymes (Val et al., 2007). 
During development of adrenal gland, the WT1 positive cells give rise to cells which are WT1 
negative but Sf1 positive that are characterised as progenitor/differentiated cells (Bandiera et al., 
2013). Therefore, the co-expression of Thy-1 with the WT1 protein would potentially represent 
stem cells and the co-expression of Thy-1 with the Sf1 protein would potentially represent 
progenitor/differentiated cells. The differences of the co-expression ratios of each (Thy-1 with 
WT1 or Thy-1 with Sf1) would potentially suggest the ratio of stem cells (Thy-1 with WT1) 
against the ratio of progenitor/differentiated cells (Thy-1 with Sf1). These calculations would 
suggest Thy-1 positive cells were more likely to maintain the stemness state or they were more 
likely to be differentiating to progenitor/differentiated cells during cultivation in vitro. 
Characterisation of Thy-1 positive cells after twelve weeks in culture included dual stain 
immunocytofluorescence, which was conducted to examine WT1 and Thy-1 protein expression 
and dual stain immunocytofluorescence was also used to examine Sf1 and Thy-1 protein 
expression. The results showed increased Thy-1 expression with 97± 1 % (in comparison with 
82±8% during of the eight weeks immunocytofluorescence test) of the total cells now positive 
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for Thy-1, with Thy-1 mainly being observed in the cell membrane and in the endoplasmic 
reticulum (ER) (figure 3.14). The expression of WT1 was observed in 90± 2% of the Thy-1 
positive cells, with expression localised in the nucleus and/or in the cytoplasm since the nature of 
WT1 protein is to shuttle between the two, however, the intensity of expression did vary between 
cells (figure 3.14). While only 1 ± 1% of the cells were expressing Sf1, which was mainly 
detected in the nucleus (figure 3.14).   
 
 
Figure 3.14 Dual-staining immunocytofluorescence on three month old cultures of Thy-1 positive cells isolated 
using MACS. Cells were fixed with 4%PFA in PBS. (B) Cells were incubated with anti-CD45 antibody. (F and J) 
Cells were incubated with anti-Thy-1 antibody. (C, G or K) Cells were incubated with control rabbit IgG, anti-SF1 
antibody or with anti-WT1 antibody (Abcam) before detection with anti-mouse Alexa 647 in (B, F and J) and with 
anti-rabbit Alexa546 in (C, G and K). All samples were mounted and cell nuclei were stained with DAPI in (A, E 
and I). Merged images of (A), (B) and (C) are shown in (D) and of (E), (F) and (G) in (H), and (I), (J) and (K) in (L). 

























The high expression (90± 2%) of WT1 with Thy-1, led to an investigation of how the two 
proteins co-localised in the adrenal gland.  
Immunohistotofluorescence assays were conducted to reveal the co-expression of both WT1 and 
Sf1 with Thy-1 in the capsule and sub-capsular areas of the adrenal gland (figure 3.15). The 
images were analysed by Spearman's rank correlation value using the Image J (Fiji) software. 
The co-expression of WT1 with Thy-1 in the capsule and sub-capsular areas was high 




Figure 3.15 Dual-staining immunohistofluorescence on rat adrenal gland cryosections. Adrenal gland sections 
were fixed with ice-cold acetone. (B) Adrenal sections were incubated with mouse IgG. (F and J) Adrenal 
sections were incubated with anti-Thy-1 antibody. (C, G or K) Adrenal sections were incubated with control rabbit 
IgG, anti-SF1 antibody or with anti-WT1 antibody (Abcam) before detection with secondary anti-mouse Alexa 647 
in (B, F and J) and with anti-rabbit Alexa 546 in (C, G and K). All sections were mounted and cell nuclei were 
stained with DAPI in (A, E and I). Merged images of (A), (B) and (C)  are shown in (D) and of (E), (F) and (G) in 
























3.3.10 Immunocytofluorescence detection of Thy-1, WT1, Etv5 and ID4 after 10 months of 
culture. 
The Thy-1cells were tested by immunocytofluorescence during the early periods of culture (2 
weeks,8weeks and 12weeks) to investigate the expression patterns and specifically the changes 
in the expression of the proteins of interest because the cells were transferred to different 
microenvironment. These tests ran in parallel with RT-PCR experiment to continue monitoring 
the changes in the Thy-1 positive cells. The phenotype of the cells, proliferation rate and the 
expression pattern of the markers of interest was relatively unchanged from the early stages 
(after 8 weeks or 12 weeks of cultivation) as described earlier. Cell changes were noticed in the 
general cell shape and in the proliferation rate during their 9th month in culture. These changes 
imply alteration in the expression of the stem cell markers such as the proteins of interest Thy-1, 
WT1, Etv5 and ID4. 
 The immunocytofluorescence test of the cells in their 10th month in culture showed changes in 
the expression of the proteins of interest in comparison with young cells (2-3 months old in 
culture). Each dual staining included the test of Thy-1 expression co-localised with WT1, Etv5, 
ID4 or Sf1 protein expression. Random spots of different slides were used to calculate the ratios 
of the cells that expressed the protein of interest by counting the number of cells that expressed 
the protein of interest among the total number of cells, as calculated from the number of nuclei as 
visualised by DAPI stain. 
In general, the expression level of all genes of interest decreased in the old cells. However, the 
expression of Thy-1 had the largest decrease of the others. WT1 expression decreased from 
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90±2% in the young cells to 68±15% in the old cells (figure 3.16). The expression of Etv5 
underwent the smallest decrease amongst the other markers, with Etv5 expression being 71±16% 
in the young cells and was reduced to 62±18% (figure 3.17). ID4 protein expression decreased 
from 74 ±17 in the young cells to 46±23% in the old cells (figure 3.18). Sf1 expression was not 
















Figure 3.16 Dual-Immunocytofluorescence on 10 month old cultures of Thy-1 positive cells isolated using MACS. 
Cells were fixed with 4%PFA in PBS. Cells were incubated with mouse anti-Thy-1 antibody (B and F), or incubated 
Alexa 647. All samples were mounted and cell nuclei were stained with DAPI in (A and E). Merged images of (A), 
(B) and (C) are shown in (D) and of (E), (F) and (G) in (H). The upper row of photos are low magnification (A, B, C 
and D). The lower row of photos are high magnification (E, F, G and H). Arrows refer to the WT1 expression in the 










Figure 3.17 Dual-Immunocytofluorescence on 10 month old cultures of Thy-1 positive cells isolated using MACS. 
Cells were fixed with 4%PFA in PBS. Cells were incubated with mouse anti-Thy-1 antibody (B and F), or incubated 
with a rabbit anti-Etv5 antibody (Abcam) (C and G) before detection with anti-mouse Alexa 488 and anti-rabbit 
Alexa 647. All samples were mounted and cell nuclei were stained with DAPI in (A and E). Merged images of (A), 
(B) and (C) are shown in (D) and of (E), (F) and (G) in (H). The upper row of photos are low magnification (A, B, C 
and D). The lower row of photos are high magnification (E, F, G and H). Arrows refer to the Etv5 expression in the 













Figure 3.18 Dual-Immunocytofluorescence on 10 month old cultures of Thy-1 positive cells isolated using MACS. 
Cells were fixed with 4%PFA in PBS. Cells were incubated with mouse anti-Thy-1 antibody (B and F), or incubated 
with a rabbit anti-ID4 antibody (Abcam) (C and G) before detection with anti-mouse Alexa 488 and anti-rabbit 
Alexa 647. All samples were mounted and cell nuclei were stained with DAPI in (A and E). Merged images of (A), 
(B) and (C) are shown in (D) and of (E), (F) and (G) in (H). The upper row of photos are low magnification (A, B, C 
and D). The lower row of photos are high magnification (E, F, G and H). Arrows refer to the ID4 expression in the 









Figure 3.19 Dual-Immunocytofluorescence on 10 month old cultures of Thy-1 positive cells isolated using MACS. 
Cells were fixed with 4%PFA in PBS. Cells were incubated with mouse anti-Thy-1 antibody (B and F), or incubated 
with a rabbit anti-Sf1 antibody (Abcam) (C and G) before detection with anti-mouse Alexa 488 and anti-rabbit 
Alexa 647. All samples were mounted and cell nuclei were stained with DAPI in (A and E). Merged images of (A), 
(B) and (C) are shown in (D) and of (E), (F) and (G) in (H). The upper row of photos are low magnification (A, B, C 
and D). The lower row of photos are high magnification (E, F, G and H). The Sf1 expression was not detected in the 
cells. Scale bars: 20µm. 
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3.3.11 Characterisation of Thy-1 positive cells after one year in culture 
Immunocytofluorescent assays were conducted to reveal the expression pattern of Thy-1 protein 
in and around the cell colony of old cells (1-year old). The results showed the fibroblast-like 
cells in and around the centre of the colony were expressing Thy-1, while cells far from the 
colony centre were lacking Thy-1 expression (figure 3.20). 
The time lapse assays of the live cells showed that the smaller and far from the colony centre 
cells were propagating faster but they attached less to the plastic surface of the well. The 
reduction in cell attachment capacity in the old cells was associated with the reduction of Thy-1 
expression in the cells of that age (figure 3.20). The general reduction of Thy-1 expression in old 
cells in comparison with younger cells was confirmed using Western blotting.  Although Thy-1 
expression increased in the cultured cells with time, its expression clearly reduced after 11 
months in the culture (figure 3.21). These changes in Thy-1 expression over the time was 
statistically analysed and revealed that Thy-1 protein expression showed significant  (P<0.05) 
increase from one month to six months in vitro. However the reduction in Thy-1 expression after 






























  Figure 3.21.  Detection of  β actin and Thy-1 protein expression in Thy-1 positive cells using Western blotting after different 
periods of times in vitro. (A) Thy-1 negative cells collected directly after MACS. (B) Thy-1 positive cells collected after 1month 
in vitro. (C) Thy-1 positive cells collected after 6months in vitro. (D) Thy-1 positive cells collected after 11months in vitro. Cells 
were counted before lysis with RIPA buffer in the presence of Protease Inhibiter Cocktail (1:200). Proteins were resolved on a 
10% SDS gel before Western blotting with mouse anti-Thy-1 antibody (1:1000).  The graph shows the Western blotting analysis 
of Thy-1 expression levels normalised to the expression levels of the housekeeping protein (β Actin). Summarized one-way 
ANOVA results showed Thy-1 protein expression in Thy-1 positive cells was significant  (P<0.001)  in comparison with Thy-1 
negative cells and a significant  (P<0.05)  differences in Thy-1 protein expression between the one month old Thy-1 positive 
cells and 6months old ones in vitro. 
Figure 3.20 Immunocytofluorescence on 12 months old colony cultures of Thy-1 positive cells. Cells were fixed with 
4%PFA in PBS. Cells were incubated with anti-Thy-1 antibody (B) before detection with anti-mouse Alexa 546. Merged 
images of (A) and (B) are shown in (C) and of (D) and (E) in (F). The expression of the Thy-1 protein was mainly 
located in the cells in and around the colony centre. While the cells growing far from the colony centre lost Thy-1 
expression. The upper row of photos are low magnification (A, B and C). The lower row of photos are high 
magnification (D, E and F). All samples were mounted and cell nuclei were stained with DAPI (A). Merged images of 




The results of this chapter described the isolation of potential adrenocortical stem cells using a 
specific marker. The characteristics of these cells (Thy-1 positive cells) in the early months in 
culture after MACS (younger cells) were different from Thy-1 positive cells in the later months 





Table 3.2 Summary of the relative differences of the studied parameters in the young and old Thy-1 positive cells.  
Thy-1 expression was high in the young cells and it was increasing, but its expression deteriorated in the older cells. 
Young and old Thy-1 positive cells were negative to CD45 and steroidogenic genes. Stem cells markers such as 
WT1, Etv5 and ID4 were found to be expressed in the Thy-1 positive cells. However, their expressions were 
decreased in the old cells. Sf1 expression was already weak in the young cells and disappeared in the old cells. Cell 
proliferation and migration were slower in the young cells in comparison with the old cells. Senescent cells were 




Parameter  Young Thy-1 positive cells (2-3 months)  Old Thy-1 positive  cells (10-12 months) 
Thy-1 Highly expressed with increasing expression Highly expressed with decreasing expression 
CD45 No  No  
WT1 Yes  Yes, but decreased 
Etv5 Yes  Yes, but decreased 
ID4 Yes  Yes, but decreased 
Sf1 Weak 1% No  
Steroidogenic genes No No  
Cell division 
Doubling time 
Longer time for one division (3 days) Shorter time for one division (36-48 hours) 
 
Cell migration Slower Faster  
Senescent cells  Few cells present  No  
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3.3 Discussion  
The isolation and investigation of Thy-1 positive cells in vitro culture created an effective 
approach involving primary culture to investigate the cellular and molecular mechanisms 
controlling the cell behaviour, because it is difficult to explore specific cell behaviour in vivo. 
Adrenal gland primary culture was accomplished using mechanical and enzymatic digestion, this 
yielded viable primary cells. The hormonal response of the isolated cells to the ACTH treatment 
was another indicator of the cells interaction with their in vitro environment and it was generally 
in agreement with similar tests (Lefrancois-Martinez et al., 2011). Growing of the hybridoma 
cells, and inducing them to produce a monoclonal anti-Thy-1 antibody was also successful and 
confirmed using SDS-PAGE electrophoresis with Coomassie Blue staining (figure 3.4) and 
Western blotting (figure 3.5). The binding capacity and specificity of the anti-Thy-1 antibody 
was validated by immunocytofluorescence tests (figure 3.9), immunohistofluorescence tests 
(figure 3.15) and Western blotting (figure 3.21). The large-scale production of this antibody was 
important to produce the large quantities that were needed to conduct the later experiments. 
Further adrenal gland primary cultures were conducted after removing the medulla to eliminate 
the un-targeted part of adrenal gland because our findings suggested the isolation of the target 
cells after enucleating and discarding of the medulla and most of the zF, instead of using the 
whole adrenal would be more specific. This would eliminate most of the differentiated cells of 
the cortex as well as the medulla, which might contain their own stem cells. However, the zI was 
not the main target of this study since Thy-1 expression was confined only to the capsule and 
sub-capsular areas. 
The binding of the anti-Thy-1 antibody to magnetic beads was successful and the antibody- 
magnetic beads complex was successfully applied to the primary cells and achieved isolation of 
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the targeted cells. The isolated cells were seeded at low densities as recommended for seeding 
mesenchymal stem cells (Mareschi et al., 2012) which allowed successful maintenance of the 
culture for over a year.  
The phenotype of the isolated cells could be described as fibroblastic-like cells, which 
traditionally represent the capsular cells that are described as fibroblast-like capsular cells (Kim 
and Hammer, 2007a). The cells use to have long thin cytoplasmic extensions called telopods or 
projections, early histological studies proposed that these projections from the capsule cells 
might have a role in forming differentiated cells of the adrenal cortex (Baker, 1952). The cells 
attached to the plastic and they tended to form colonies and these general aspects are also what 
was originally used to characterise mesenchymal stem cells in vitro (Castro-Malaspina et al., 
1980, Colter et al., 2001). The confluent cells developed a whirlpool-like shape growing patern 
in culture, which is in agreement with what has been described in the placental MSCs (Pelekanos 
et al., 2016).  
During the long-term culture (up to one year), Thy-1 positive cells exhibited morphological and 
cellular behaviour changes. For example, the proliferation rate of the younger cells was slower 
than the older cells and the younger cells were more attached to the plastic surface and required 
trypsinisation for a long incubation time (25 minutes) with TrypLE™ to detach them in 
comparison with the older cells, which required a short incubation time (10 minutes) with 
TrypLE™ to be detached.  
These changes were noticed during routine monitoring work such as changing the media and 
splitting after reaching confluency. These changes required more investigation to study the 
changes in cell cycle, cell migration and the expression of proteins of interest.    
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In order to determine the differences of cell division rates between the younger cells and the 
older cells, cells divisions rates were tracked in culture using time lapse and calculated in term of 
cell doubling time. 
 The single cell tracking assay showed that cells in their 2nd month in culture underwent division 
approximately every 3 days (younger Thy-1 positive cells showed 10-12% cell division every 24 
hours). While the old cells (10-12 months) underwent division every 36-48 hours (older Thy-1 
positive cells showed 30-46% cell division every 24 hours). The literature referred to a 
proliferation rate of rat adrenal gland primary cell culture of 10% after 21 days of cultivation. 
Then it was reduced to 1% after 100 days of cultivation (Arola et al., 1993). These results 
suggested Thy-1 positive cells were more constant and can survive longer in vitro in comparison 
to the whole adrenal primary culture which tends to lose its survival ability after 100 days in 
vitro.  
Time lapse techinque was also used to test the cell migration changes of Thy-1 positive cells 
using a wound-healing assay (figure 3.8). The older cells (12th months old in the culture) were 
significantly (P<0.01) migrating faster than younger cells ( 2nd months old in culture). 
Although the co-existence of large fibroblast-like cells was recorded in the primary culture of the 
rat adrenal gland (Guo and Liu, 2005), the co-existence of a few large slow/non-proliferative 
fibroblast-like cells within Thy-1 positive cells after the second month of cultivation (figure 3.7) 
might represent senescent cells. These cells died after few months of cultivation potentially due 
to reaching the Hayflick limit (Hayflick and Moorhead, 1961). Although, others suggested the 
decline in the senescent cell divisions might be observed after 8 doublings times in culture, it 
also might have randomly occurred (Rubin, 2002). 
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Investigating these few cells within the cells of interest revealed their common traits, which were 
the same as what had been recorded for senescent MSCs. These characteristics included 
morphological changes and reduction in both proliferation and differentiation potential (Zhu et 
al., 2015). This phenomenon is usually related to the age of the organism at the time of isolation 
(Yegorov and Zelenin, 2003). Although the presence of the senescent cells within the stem cells 
reduced the potential value of the stem cells, senescent cells have been recorded to accompany 
even the most potent stem cells such as human embryonic cells (Munoz-Espin et al., 2013) and 
mouse embryonic cells (Storer et al., 2013). Senescence has also been found to have a role 
contributing to the embryonic development, growth and cell patterning (Storer et al., 2013). 
Thy-1 increased in expression after cultivation (figure 3.21), which increased in parallel with the 
ability of cells to attach to plastic and this ability decreased when Thy-1 expression decreased in 
the old cells, which was in agreement with the role of Thy-1 in cell adhesion (Rege and Hagood, 
2006). As previously mentioned, the Thy-1 positive cells maintained a regular proliferation rate 
for more than six months in culture (10-12 % every 24 hours). However, the proliferation rate of 
the old cells increased in the last four months of cultivation. This rate increased to 20% in the old 
cells that lost their Thy-1 expression which was in agreement with the suggestion from (Mayani 
and Lansdorp, 1994) that Thy-1 acts as a proliferation inhibitor of the primitive cord blood 
stem/progenitor cells.  
The survival capacity of the Thy-1cells in vitro for more than one year suggested a possible role 
of Thy-1 in self-renewal regulation that allows maintenance of these cells and other stem cells 
types for long periods in vitro in comparison with the differentiated cells (Ishigaki et al., 2009, 
Bernardo et al., 2007).  
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The expression of Thy-1 was confirmed by immunocytofluorescence using an anti-Thy-1 
antibody and anti-CD45 antibody as a control after 2 weeks of culture. The results of the 
immunocytofluorescence against CD45 were negative, which meant that there was no 
contamination with blood cells, as this CD45 marker is well documented as a progenitor/adult 
blood cell marker (Shim et al., 2015). This was important because the presence of such blood 
cells might interfere with isolation of the target cells since they express Thy-1 as well. After 
eight weeks post-MACS, the immunocytofluorescence against Thy-1 revealed that it was still 
being expressed (figure 3.10). The immunocytofluorescence against Thy-1 also showed that the 
ratio of the number of cells that expressed Thy-1 was higher in comparison to the results of the 
first (two weeks post-MACS) immunocytofluorescence test, and the intensity of Thy-1 
expression within the cells after eight weeks post-MACS was also higher than the first 
immunocytofluorescence test (two weeks post-MACS). This increase in the Thy-1 expression 
was confirmed by Western blotting (figure 3.21) and seemed to be maintained for a few months. 
This increase in Thy-1 expression after cultivation was in agreement with the results from RT-
qPCR in human mesenchymal stem cells (Dudakovic et al., 2014). 
The RT-PCR experiments showed the cells were mainly undifferentiated cells (figure 3.11), 
since none of the steroidogenic genes were detected. However the detection of a few cells 
expressing Sf1 that were conversely steroidogenically negative might represent the progenitors 
cells (Kim and Hammer, 2007b). However, These RT-PCR experiments showed the expression 
of other stem cell markers such as WT1, Etv5 and ID4 (figure 3.11 and figure 3.12). 
The finding of WT1 expression in the isolated cells using RT-PCR was confirmed by 
immunocytofluorescent assay. The expression of WT1 in the adrenocortical stem cells was 
expected because it was described as an important protein in the embryonic 
145 
 
development of adrenal glands because WT1 knock-out mice die at embryonic day E13.5 due to 
deadly defects in their urogenital system (Moore et al., 1999). It was also proposed as a factor 
maintaining the undifferentiated adrenal-gonadal primordium state in the adrenal gland and also 
as an inhibitor of the differentiation process (Bandiera et al., 2013). The same study tracked the 
descendants of WT1 positive cells and found they gave rise to cells which were WT1 negative 
but Sf1 positive and expressed steroidogenic genes. On the other hand Shh and Gli1 were not 
detected in the assayed cells but both have been described as progenitor cell markers in vivo 
(Kim et al., 2009), suggesting the Thy-1 positive cells were more likely to be stem cells rather 
than progenitors cells. 
As WT1 is a known stem cell marker with a specific role in the development of the adrenal 
cortex, this warranted further investigation into the native expression patterns of this protein in 
the capsule and sub-capsular areas of the adrenal gland. Furthermore, it was important to 
investigate the co-expression  ratios of WT1 or Sf1 with Thy-1 in the isolated cells in 
comparison with their co-expression in adrenal gland cryosections. The finding of WT1 
expression along the capsular line supports the hypothesis of the existence of capsular stem cells. 
The high co-expression ratio of WT1 with Thy-1 in the adrenal gland (0.59±0.052) and the low 
co-expression ratio of Sf1 with Thy-1 (0.23±0.11) supports the notion of Thy-1 as a stem cell 
marker. Furthermore, the co-expression of WT1 with Thy-1 increased to 90±2% in the isolated 
cells after 12 weeks of cultivation, which means these cells were maintaining a self-renewing 
capacity in culture and they can survive longer in comparison with the differentiated cells 
(Ishigaki et al., 2009). While the Thy-1 and Sf1 positive cells were the opposite of that. The co-
expression of Thy-1 with Sf1 in the adrenal gland was low 0.23±0.11 and decreased to 1±1% in 
the isolated cells. These results suggested that WT1 expression is important in the maintenance 
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or activation of stem cells, which is in agreement with recent observations of nephrogenesis, 
which suggested a mechanism by which WT1 regulates stem cells (Akpa et al., 2016). So the 
expression of Sf1 in the isolated cells might represent the presence of progenitor cells rather than 
differentiated cells, especially as these cells were lacking other steroidogenic genes (figure 3.11) 
and they represented a low ratio (1±1%) in culture.  
Detection of the stem cell markers Etv5 and ID4 in the isolated cells support the identity of these 
cells as stem cells. These transcriptional regulatory proteins are defined as stem cell markers 
because they contribute to stem cell properties such as self-renewal. Etv5 has been found to be a 
transcriptional regulator of the self-renewal process of the closest cell type to the adrenal cortex, 
which is the spermatogonial stem cell (Wu et al., 2011). The high level of expression of Etv5 in 
the isolated cells might have the same role in maintaining the self-renewal capacity of these cells 
since they survive for a long time in culture.  
ID4 was also reported as a protein maintaining the stemness state of the spermatogonial stem 
cells (Oatley et al., 2011) and is essential for spermatogenesis (Sun et al., 2015). Recent findings 
also show the expression levels of ID4 are indicators of the regenerative capacity of 
spermatogonial stem cells (Helsel et al., 2017).    
ID4 also called inhibitor of differentiation 4 (Patel et al., 2015), was identified as an inhibitor of 
other transcription factors known as basic helix-loop-helix (bHLH) transcription factors. These 
bHLH transcription factors have been described as the main controller of cellular differentiation 
of mesenchymal organs (Lu et al., 1998). So the expression of this protein in the cells of interest 
suggested that it maintained the undifferentiated state of the cells. The findings of two common 
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stem cell markers might reveal a developmental relationship between the two organs: the gonads 
and the adrenal cortex.    
The transformation in the characteristics of the Thy-1 positive cells in their last few months in 
vitro is more likely to be what has been described as the immortal transformation of primary 
cells to cancer like cells. This phenomenon is not only recorded in the primary culture of adult 
differentiated cells but also recorded in the MSCs (Urraca et al., 2015). However, this 
transformation may not necessarily be an oncogenic transformation (Gordon et al., 2014). This 
transformation includes changes in cell morphology, the cells ability to attach to plastic, cell 
cycle, cells migration and alteration in the expression of the proteins of interest, especially Thy-1 
that had reduced expression in older cells. However, the expression of Sf1 was already absent in 
these older cells (figure 3.19), which possibly suggests the cells remain undifferentiated. 
Thy-1 expression reduced dramatically in the old cells. The changes in the old cells morphology 
and behaviour in comparison with the younger cells (especially the high proliferation and 
migration rate in vitro) can described as similar to the behaviour of cancer cells in vitro. These   
changes might have resulted from the reduction of Thy-1 expression in the old cells, because the 
Thy-1 protein was shown to have an inhibitory effect on ovarian cancer cells (Zeng et al., 2009). 
In agreement with these findings, the progenitor cells of leukemia that are able to maintain blood 
cancer both in vivo and in vitro were lacking in Thy-1 expression in comparison with normal 
hematopoietic progenitor cells (Blair et al., 1997). These results suggest that Thy-1 might has an 
inhibitory role in malignancy.  
The old highly proliferative cells also showed a general decrease in the expression of the other 
markers of interest WT1, Etv5 and ID4.  
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WT1 expression declined in the old cells in comparison with its expression in the young cells. 
Although, WT1 expression is up-regulated in a number of cancer cells, it has an inhibitory effect 
in the developmentally close cancer cell types to the adrenal cortex such as breast cancer cells by 
targeting the beta-catenin signaling pathway (Zhang et al., 2003). WT1 transfection into ovarian 
cancer cells also reduces their proliferation rate (Huo et al., 2011). 
This transformation of the old cells slightly lowered the expression of the Etv5 protein in 
comparison with its expression in the young cells. This slight change in Etv5 expression might 
result from the role of Etv5 as regulator not only of stem cells but also in cancer cells especially 
in ovarian cancer cells (Llaurado et al., 2012a, Llaurado et al., 2012b, Zhao et al., 2011).  
On the contrary to Etv5, the old highly proliferative cells showed a clear decrease in ID4 
expression. The reduction of ID4 would be expected from differentiated cells (Patel et al., 2015) 
and the senescent cells (Zhu et al., 2015). However, the old cells were essentially 
undifferentiated and they were propagating in a similar manner to cancer cells. ID4 reduction 
might be imputed to cancer like old cells because a number of primary cancers reported with low 
or no expression of the ID4 protein (Umetani et al., 2005, Wen et al., 2012, Baker et al., 2016).  
In general, the results of monitoring these cells in the culture showed they exhibited 
characteristics of stem cells in vitro. In addition, the findings of a number of stem cell markers 
and the changes in the expression of these markers coupled with cell changes supported the stem 
cell state for most of the cells for at least eight months of cultivation. However, whether these 





In vitro differentiation of Thy-1 positive cells 
 
4.1 Introduction 
4.1.1 In vitro differentiation of stem cells 
Stem cells differentiation is a process by which stem cells change from unspecialised cells into 
specialised cells like muscle, skin or neurons. The embryonic cells normally undergo 
differentiation due to several molecular chemical and physical factors that are eventually 
produced within the embryo. For example, differentiation factors released from adjacent cells or 
due to direct embryonic cell to cell or cell-matrix contacts. In addition, the mechanical or 
physical effect of embryonic movements during development might activate signaling pathways 
that contribute to the stem cells differentiation. Scientists basically attempt to mimic these 
differentiation factors to induce differentiation of stem cells in vitro. Numerous factors were used 
to differentiate different cell types including stem cells.  
4.1.1.1 In vitro differentiation of ESCs and hiPSC 
The differentiation of the pluripotent ESCs and hiPSC has it is advantagous  because of their 
ability to generate a myriad of different cell types, it also has a disadvantage because it is 
difficult to direct their differentiation process to a specific cell type.  
 Scientists basically have developed several differentiation methods, such as using either 
extracellular matrix proteins or supportive stromal layers as a base to culture the ESCs on it or 
150 
 
promote the ESC to form embryoid bodies (three-dimensional suspension cultures of stem cell 
aggregates after treating the ESCs with Knockout re-placement media). However, each of these 
methods demonstrates broad spectrum of cell types after the differentiation of ESCs (Murry and 
Keller, 2008). More protocols were developed using approaches which improved the 
differentiation process to more specific cells types such as the differentiation of hESCs and 
hiPSCs into hepatocytes (Si-Tayeb et al., 2010, DeLaForest et al., 2011). 
  The differentiation of ESCs and hiPSC might be required to be directed into either ectoderm 
lineage, mesoderm lineage or endoderm lineage. The importance of differentiating ESCs into one 
of these lineages is based on the requirement of a specific cell type derived from one of these 
lineages.  
For example, the endoderm gives rise to the internal organs such as the pancreas, liver, thyroid, 
and gallbladder (Lu et al., 2001). The differentiation of ESCs into these types of cells is 
important for treating diseases such as diabetes (type1) and chronic hepatitis. Several methods 
have been described to differentiate ESCs isolated from human and mouse into β cells (insulin-
expressing cells). In the early attempts, scientists used a cell-trapping system to select cell clone 
that secreted insulin from the undifferentiated ESCs in culture (this system based on using 
transfection were the ESCs was transfected with a chimeric construct of antibiotic resistance and 
insulin so the survived cells after antibiotic treatment were also expressing insulin (Soria et al., 
2000). While others reported that nestin positive progenitor cells isolated from mouse ES can 
produce insulin after in vitro differentiation using inhibitors of phosphoinositide 3-kinase which 
is a crucial regulator of intracellular signalling (Hori et al., 2002). Recent studies suggested small 
molecules that assist the differentiation of human iPSCs/ESCs into pancreatic cells such as 
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sodium cromoglycate which found to improve the derivation of β cells from hiPSC/hESC lines 
(Kondo et al., 2017). 
The use of pancreatic progenitor cells derived from ESCs to cure patients with diabetes is 
undergoing clinical trials in countries like North America (Kieffer et al., 2017).  
The differentiation of ESCs into mesenchymal lineages has been studied and conducted using 
different approaches such as raclure method which is based on the induction of spontaneous 
differentiation of ESCs or iPSCs when placed in appropriate growth conditions (Olivier and 
Bouhassira, 2011). For example, the ESCs were differentiated into adipogenic mesenchymal 
stem cells when exposed to retinoic acid (Ninagawa et al., 2011). Other factors such as Leukemia 
inhibitory factor (LIF) can promote germ cell differentiation from ESCs (Fukunaga et al., 2010). 
 The differentiation of ESCs into ectodermal lineages such as neurons or skin cells have also 
been studied and it was shown that several factors are important to direct differentiation. For 
example, small nuclear RNA called 7SK (Rn7SK) is crucial in the acquisition of a neural fate 
(Bazi et al., 2017) and the differentiation of the mouse ESCs into mature neurons can be 
accelerated by the nicotinamide (Griffin et al., 2017).  
The differentiation of other stem cell types was studied using different approaches, such as the 
differentiation of the umbilical cord stem cells reported using 17β-estradiol and growth factors to 
differentiate these stem cells into the endometrial epithelial cell and endometrial stromal cell 
respectively (Shi et al., 2017). More details regarding the differentiation of the MSCs will be 
presented because they are well studied as they are present in almost all vascularised organs of 
the body (Crisan et al., 2008) in particular the adrenal cortex.  
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4.1.1.2 In vitro differentiation of MSCs 
Although MSCs represent only a few cells within organs they are not immortal, but they are 
capable of propagating many-fold in vitro (Chamberlain et al., 2007). The replicative and 
differentiation capacity of MSCs give them the potential to have important applications in 
regenerative medicine.  
The embryonic mesoderm gives rise to the kidneys, adrenal cortex, gonads and their genital 
ducts, the bone and its cartilage, muscles, connective tissue, heart, the vessels of the blood and 
lymph, the spleen and the serous membranes of the body cavity (Doss et al., 2012). These organs 
mostly contain MSCs that have the characteristics of their mesoderm origin and continuously 
replenish these organs. MSCs are defined as multipotent (Nuschke et al., 2016) and are capable 
of differentiating into several cell types such as adipocytes, osteoblasts and myoblasts (Augello 
and De Bari, 2010). The differentiation of several MSCs into their tissue of origin and other 
tissue types has been an area of intense study. For example, the murine MSC fibroblast cell line 
C3H10T 1/2 was differentiated into adipocytes (Chen et al., 2014) and also into chondrogenic 
and osteogenic cells (Ker et al., 2015). Bone marrow MSCs were also differentiated into 
hepatocyte-like cells (Khanjani et al., 2014). Although there are variously identified in vitro 
differentiation stimuli, they have their own limitations due to the different culture conditions and 
the source of MSCs. Furthermore, the phenotypic characteristics of cells can alter after their 
isolation and in vitro cultivation as the cells are exposed to a new environment, which can 
include eventual changes in the expression of certain markers (Jones et al., 2002). A number of 
pathways and molecules have been suggested as important regulators or factors in MSC 
differentiation such as the Wnt signaling pathway.  The secreted proteins of the Wnt family are 
involved in spontaneous cell differentiation by directly influencing MSCs (Liu et al., 2009). 
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Others include the transforming growth factor beta (TGF- β) superfamily which is known to have 
a role in the differentiation of bone marrow derivative MSCs (Crane and Cao, 2014) and an 
enhancement of chondrogenic MSCs differentiation after up-regulation of  TGF-β1(Kim et al., 
2014). Fibroblast growth factor 2 (FGF-2) was also found to upregulate the kinetics of MSCs 
chondrogenesis and improve their differentiation (Cheng et al., 2012). 
Recent studies targeted a number of microRNAs which might be related to pluripotency and 
induction of differentiation in pancreatic islet derived MSCs (Coskun et al., 2017). The use of 
inorganic matrices to enhance bone repair has been suggested to induce the ex vivo genesis of T-
cells from progenitor cells (Poznansky et al., 2000), which then developed into artificial thymic 
organoids used to induce differentiation in hematopoietic stem cells (Seet et al., 2017). Several 
other factors and chemicals have been widely used to differentiate different types of cells other 
than what had been used in this project. 
4.1.2 Cyclic AMP  
The use of cyclic AMP analogs in the differentiation induction has been documented in variety 
of cells. Release of cyclic AMP as a differentiation factor normally occurs after activation of a 
receptor, such as FSH binding to its receptor, which stimulates cyclic AMP production 
(Bhattacharya et al., 2012). It has been used in vitro to differentiate mouse neural crest cells into 
dopamine neurons (Tremblay et al., 2010) and in the differentiation of mastocytoma cells 
(Goulding and Ralph, 1989), Cyclic AMP was also employed to obtain differentiated optic 
nerve-derived cells (Cohen et al., 1999), Schwann cells (Bacallao and Monje, 2015) and human 
placental cells (Yoshie et al., 2010). However, it has an inhibitory effect on the differentiation 
process of the stalk cells of Dictyostelium discoideum (Berks and Kay, 1988) and the 
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differentiation of megakaryocytes  (Rubinstein et al., 2012). Others have also suggested that 
different cyclic AMP variants have different effects on the differentiation of human MSCs into 
osteocytes and adipocytes. For example, the expression of adipogenic genes in hMSCs were 
increased after treatment with 8-bromo-cAMP. While treatment with dibutyryl-cAMP induced 
the expression of the osteogenic marker (alkaline phosphatase) (Doorn et al., 2012). Both of 
these cAMP variants were also reported to induce the expression of STAR which is required for 
the differentiation of steroidogenic cells (Ruiz-Babot et al., 2018). 
 
4.1.3 Forskolin 
Similar to the cyclic AMP, forskolin analogs have also been used for the differentiation of a 
variety of cells. Different mechanisms have been suggested for the role of forskolin in 
stimulating differentiation. For instance, forskolin is used to stimulate cyclic AMP production, 
which in turn is used to differentiate spermatogonia (Bhattacharya et al., 2012). Forskolin has 
been used to differentiate placental cells (Wu et al., 2013), neurons (Cao et al., 2012), osteoblast 
(Li et al., 2014), spermatogonial (Bhattacharya et al., 2012) and many other cell types. Using 
forskolin to differentiate malignant cells such as gliomas gives the potential for a therapeutic 
method for cancer treatment (He et al., 2011).  The use of forskolin in the differentiation of stem 
cells has been suggested by several studies, where it has been used to differentiate the iPSCs into 
brown adipocytes (Takeda et al., 2017), adipose-derived MSCs into neural cells(Blecker et al., 
2017) and the differentiation of the embryonic stem cells and umbilical vein endothelial cells 
(Wang et al., 2017). 
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5.1.4 Steroidogenic factor one (Sf1) 
Sf1 or also called Adrenal 4 binding protein (Ad4BP) is encoded by the nuclear receptor 
subfamily 5, group a, member 1gene (NR5A1). Sf1 is a nuclear receptor with the key role of 
steroidogenesis and is mainly expressed in the adrenal cortex, placenta and the gonads. In 
common with other nuclear receptors, Sf1 has an activation function domain at the amino-
terminal 1 (AF-1), DNA-binding domain, hinge, ligand- binding domain and the second 
activation function domain at the carboxy-terminal (AF-2). Although the ligand- binding domain 
of Sf1 is highly conserved, there is no genuine identified ligand for Sf1 (Mlynarczuk et al., 2014, 
Desclozeaux et al., 2002) which make it an orphan receptor. This orphan receptor not only plays 
a regulatory role in the mature steroidogenic cells of adrenal cortex, placenta and gonad, it is also 
has a regulatory role in the development of steroidogenic cells (Wang et al., 2013). The 
importance of Sf1 expression in the gonads and adrenal cortex has been revealed by several 
studies. For example, adrenal tumours were induced after Sf1 overexpression (Doghman et al., 
2007), while adrenal glands and gonads failed to develop in Sf1 knockout mice (Luo et al., 
1994). In either case the irregular expression of Sf1 cause abnormal development of both gonads 
and adrenals (Shima et al., 2012). Although the placenta is considered as the key regulator and 
producer of steroids during pregnancy, Sf1 expression has been detected only slightly in the 
placenta (Ramayya et al., 1997). However, neither placental steroid production nor placental 
development was detected in Sf1 knockout mice (Sadovsky et al., 1995). These data suggested 
the importance of this nuclear receptor in the adrenal gland not only for the production of 
steroids but also it is essential for the development of the adrenal cortex. 
The Thy-1 positive cells were identified as undifferentiated cells because they didn't show the 
expression of any of the steroidogenic enzymes and they showed the characteristics of MSCs. So 
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they probably have a potential capacity to differentiate into steroidogenic cells. The aim of this 
chapter was to promote the differentiation process in Thy-1 positive cells using external and 
internal inducers. The external inducers included the synthetic ACTH that had been tested earlier 
in chapter 3 on the rat adrenal primary cells and the cells showed a detectable response that was 
identified by detecting the production of corticosterone. Two other external factors were also 
used: forskolin as another synthetic differentiation factor and the naturally produced POMC from 
AtT20 cell line that contains the most effective peptides acting on the adrenal cortex cells. 
The internal differentiation inducer was the Sf1. This experiment included transfecting Thy-1 
positive cells with Sf1 gene. The transfection might start the steroidogenesis because this nuclear 
receptor represents the key role of steroidogenesis. The differentiation attempts were evaluated 
using immunostaining assays. Then the effect of Sf1 transfection was tested by measuring the 
mRNA expression of a number of steroidogenic enzymes in addition to its effects on the mRNA 





4.2 Materials and methods 
All materials were sourced from Thermo-Fisher Scientific unless stated otherwise. 
4.2.1 Thy-1 positive cells differentiation 
Differentiation is a normal process that usually occurs during development. The new 
(differentiated) cells rising from nonspecialised (undifferentiated) cells become more specialised 
and different from one another. Although all cells of a single organism have identical genomic 
information, the differentiated cells have specific gene expression activity that giving them 
different phenotype from other differentiated cells within the same organism.  
The differentiation might be induced by activating different genes or pathways within the 
undifferentiated cell. The isolated Thy-1 positive cells were mainly undifferentiated. As a result, 
several treatments were carried out to achieve differentiation.  
4.2.1.1 Differentiation by hormonal treatment 
The isolated Thy-1 positive cells were treated with serial concentrations of steroidogenic 
differentiation factors to induce differentiation. The first treatment was with forskolin (Sigma) 
with 100nM, 1µM and 10µM, in 2ml of DMEM culture medium. The second was with ACTH 
10nm, 100nm and 1 µM, in 2ml of DMEM culture medium and the third was with the AtT20 cell 
line media treatment. The AtT-20 is a POMC releasing cell line. This line was cloned from 
mouse pituitary tumor cells cultures, which was established after alternate passage of tumors in 
cell culture and in animals. This mouse pituitary tumor cell line was cultivated and the DMEM 
media of growing cells were collected before passaging to be used as a normal source of ACTH 
and all other POMC peptides that might induce differentiation. The collected media was filtered 
then mixed with fresh DMEM media 1:1 v/v and applied to Thy-1 positive cells.  
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The treatment lasted for 7 days, the cells were collected and the RNA was isolated. Then qPCR 
was conducted to compare the gene expression changes in comparison with un-treated cells. 
4.2.1.2 Mammalian cells transfection  
The mammalian cells transfection was used to study the effect of introducing the gene of interest 
and to achieve changes to the studied cells. This required transfection of the Thy-1 positive cells 
with the Sf1 gene is an attempt to induce differentiation.   
4.2.1.2.1 Gene cloning 
Mammalian cells transfection requires an appropriate vector with a detectable reporter. The 
cloning of the gene of interest into the mammalian cells was conducted using pIRES2 EGFP. 
pIRES2-EGFP vector (Appendix B.2) contains internal ribosomal entry site (IRES 1, 2) of 
encephalomyocarditis virus (EMCV), which is a small non-enveloped single-strand RNA virus 
between the multicloning site (MCS) and the enhanced green fluorescent protein (EGFP) coding 
region. This alignment permits both the EGFP gene and the gene of interest, which were cloned 
into the MCS to be translated. pIRES2-EGFP is designed for the efficient selection by 
fluorescent microscopy, flowcytometry or any other fluorescent methods of transiently 
transfected mammalian cells expressing the protein of interest and EGFP. The pIRES2 EGFP 
vector can also be used to express EGFP alone or to obtain stably transfected cell lines. 
4.2.1.2.1.1 RNA isolation from rat adrenal tissue  
Firstly, to prepare the coding sequence of the Sf1 gene, total RNA was isolated from freshly 
isolated adrenal tissues from adult Wistar-rats using TRIzol reagent (Ambion) as previously 
described in (2.2.1.1). The total RNA was analysed by spectrophotometry using a Nanodrop 




4.2.1.2.1.2 cDNA synthesis  
An aliquot of 1-5μg of total RNA was used for the synthesis of total cDNA using a cDNA 
synthesis kit as previously described in (2.2.2). 
4.2.1.2.1.3 Electrophoresis  
The isolated RNA, PCR products and DNA digestion products were analysed by agarose gel 
electrophoresis as previously described in (2.2.1.2). 
4.2.1.2.1.4 Primers design for PCR  
The full-length coding sequence of the gene of interest was identified using the NCBI website 
(https://www.ncbi.nlm.nih.gov/nucleotide/300797823). Primers were designed to target the coding 
sequences of the gene of interest. Primers sequences for the rat Sf1 gene were:  
Forward primer 5' TCCTTCCGTTCAGCGGACGCC 3' and reverse primer 5' 
CAGTCCCCGCCCATCCTTGC 3'. The primers were used to amplify 1569bp of the target gene 
using PCR.  
 
4.2.1.2.1.5 First cloning PCR 
The PCR reaction volume was prepared in 25μl, by mixing 12.5μl pre-aliquot master mix 
(Promega) in 0.2 ml tubes, with 1μl of each primer (10μM), 2μl cDNA (20ng/µl) and 8.5μl of 
nuclease-free water.  
The components of the reaction were mixed before cycling as follows: 94°C for 1 minute for the 
initial denaturation and activation of the Taq polymerase, followed by 39 cycles of 94°C for 20 
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seconds for denaturation, 58°C for 20 seconds for primer annealing, finally the extension at 72°C 
for 2 minutes which was carried out to ensure the completion of a full-length DNA product.  
After cycling, PCR products were separated by electrophoresis on a 1.2% (w/v) agarose gel with 
1kb plus ladder (generuler). The targeted band of the gene of interest was excised and the DNA 
purified as described in (2.2.4). The resulting DNA represents the full-length coding sequence 
which was used as the DNA template for the next PCR.  
4.2.1.2.1.6 Second cloning PCR 
The primers for this PCR were new and had the same sequences in addition to restriction site 
sequence and CGC or GCG platform sequence at the 5' of the primers. The two restriction sites 
of the two primers were chosen carefully to set the gene of interest correctly in the vector and not 
cut through the gene sequence. The EcoR1 restriction sequence (GAATTC) was added upstream 
the Sf1 forward primer and The BamH1restriction sequence (GGATCC) was added upstream the 
Sf1 reverse primer The primer sequences for cloning the rat Sf1 gene into pIRES2 EGFP vector 
were:  
EcoR1-forward primer 5' GCGGAATTCTCCTTCCGTTCAGCGGACGCC 3'  
                                                             and 
 BamH1-reverse primer 5' CGCGGATCCAGTCCCCGCCCATCCTTGC 3'.  
The two restriction sites contained within the two primers were chosen by analysing the target 
sequence before adding them to the primers. The target sequence of Sf1 had to be tested against 
these restriction sequences using the website (http://nc2.neb.com/NEBcutter2/) and the result 
showed the sequence did not have any restriction sites for EcoR1 or BamH1 within that 
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sequence. This test was carried out before primer purchase for the cloning process to avoid 
digestion of the DNA segment in case it has the restriction sequence within them. 
The components of the PCR reaction were mixed as described previously in (2.2.3). The targeted 
band of the Sf1 gene was excised and the DNA purified as described (2.3.2.2). 
 
4.2.1.2.1.7 Digestion, ligation and transformation 
Both the plasmid and insert were digested with restriction enzymes as described in (2.2.9), the 
digested DNA was mixed with 6 x loading buffer then profiled by agarose gel electrophoresis. 
The targeted bands of the digested vector and the digested gene of interest were excised and the 
DNA purified as described in (2.2.4). Ligation reactions were carried out using T4 ligase 
(Promega) to ligate the gene of interest to the pIRES2-EGFP vector as described in (2.2.5). The 
transformation of E-coli was conducted as described in (2.2.8). Three to six targeted colonies 
were picked; each colony was re-cultured in LB broth for purification of the plasmid.  
4.2.1.2.1.8 Purification of plasmid 
Plasmid DNA was isolated and purified from the transformed bacteria using either the Qiagen 
Miniprep as previously described in (2.2.7.1) where the purified plasmid was used for 
confirming cloning and detecting the targeted inserts. Or Plasmid DNA was purified using the 
Midiprep purification kit. 
4.2.1.2.1.8.1 Midiprep 
A single colony was picked from a freshly streaked selective plate and inoculated into a starter 
culture of 2–5 ml LB medium containing the appropriate selective antibiotic (kanamycin). The 
culture was then incubated for 3-4 hours at 37°C with vigorous shaking at 250 rpm. The culture 
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was used as a starter and diluted to 1/500 with LB medium containing the selective antibiotic. 
One hundred ml was inoculated and grew at 37°C for 8-12 hours with vigorous shaking at 300 
rpm. The culture reached a cell density of approximately 3–4 x 109 cells per milliliter, which 
typically corresponds to a pellet wet weight of approximately 3g/liter. 
The bacterial cells were centrifuged at 4000 g for 20 minutes at 4°C. The bacterial pellet was re-
suspended in 6ml of Buffer P1 by vortexing. Then 6ml of Buffer P2 was added and mixed 
thoroughly by inverting the tube 6 times, and incubating at room temperature (15–25°C) for 5 
minutes. The lysate appeared viscous. During the incubation, the QIAfilter Cartridge was 
prepared: the white cap was screwed onto the outlet nozzle of the QIAfilter Cartridge then placed 
into a convenient rack. Then 6 ml of chilled (4°C) Buffer P3 (Appendix A.12) was added to the 
lysate and mixed immediately by inverting vigorously 6 times. The lysate was then poured into 
the barrel of the QIAfilter Cartridge and incubated at room temperature for 10 minutes in a 
steady state without the plunger inside.  After the 10 minute incubation, the HiSpeed Midi Tip 
was equilibrated by applying 4 ml of Buffer QBT (Appendix A.13) and the column was allowed 
to empty by gravity flow until it had drained completely.  
 After this, the cap was removed from the QIAfilter outlet nozzle. Then the plunger was gently 
inserted into the QIAfilter Cartridge and the cell lysate filtered into the previously equilibrated 
HiSpeed Tip. The filtration proceeded until approximately 15ml of the lysate had passed through 
the QIAfilter Cartridge, without applying extreme force. The cleared lysate passed in the resin by 
gravity flow. The HiSpeed Midi Tip was washed with 20 ml of Buffer QC (Appendix A.14). 
This was allowed to move through the HiSpeed Tip by gravity flow. The primary elution of the 
plasmid DNA was carried out with 5 ml of Buffer QF (Appendix A.15). The eluted DNA was 
collected in a 15 ml tube, mixed with 3.5 ml of room temperature isopropanol and then incubated 
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at room temperature for 5 minutes to precipitate the DNA. During the incubation, the plunger 
was removed from a 20 ml syringe and the QIAprecipitator attached to the outlet nozzle. The 
steps were carried out without excessive force and the QIAprecipitator was always removed 
from the syringe before pulling up the plunger. The QIAprecipitator was placed over a waste 
bottle, the eluate/isopropanol mixture was transferred into the 20 ml syringe, and the plunger 
inserted. The mixture was filtered through the QIAprecipitator using constant pressure. The 
QIAprecipitator was removed from the 20 ml syringe and the plunger pulled out. The 
QIAprecipitator was then re-attached and 2 ml of 70% ethanol was added to the syringe. The 
DNA was washed by inserting the plunger and pressing the ethanol through the QIAprecipitator 
using constant pressure.  
The QIAprecipitator was again removed from the 20 ml syringe and the plunger pulled out. The 
QIAprecipitator was re-attached and the membrane was dried by pressing air through the 
QIAprecipitator quickly and forcefully. This drying process was repeated with the addition of an 
absorbent paper to dry the outlet nozzle of the QIAprecipitator to prevent ethanol carryover. 
The QIAprecipitator was removed from the new 5ml syringe and the QIAprecipitator attached to 
the outlet nozzle. This was positioned over a 1.5ml collection tube, 1 ml of Buffer TE (Appendix 
A.16) was added to the 5 ml syringe. The plunger was inserted and the DNA was eluted into the 
collection tube using constant pressure.  
The purified plasmids were digested with appropriate restriction enzymes and the resulting DNA 
was checked by agarose gel electrophoresis to ensure the presence of the insert in the plasmid. 
4.2.1.2.1.9 Plasmids sequencing  
The plasmids in this project were sequenced to verify the targeted nucleotides sequences within 
the vector as previously described in (2.2.8).  
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4.2.1.2.2 Transfection of the mammalian cells with gene of interest  
The mammalian cells transfection with the target gene was carried out after the gene of interest 
was cloned into the pIRES2 EGFP vector. The vector was employed to carry the gene of interest 
to the target cells by binding it with a transfection reagent.  
Transfection was usually conducted in a 6-well plate with each well being used. Cells were 
seeded on coverslips at least one day before transfection. The control wells were transfected with 
the empty vector only and the cells were 70-90% confluent at the day of transfection. The 
transfection reagent (TurboFect) was prepared immediately before transfection and briefly 
vortexed. Three micrograms of plasmid DNA (containing the gene of interest) was diluted in 
300µL of serum-free DMEM. Three microliters of the transfection reagent was added to the 
diluted DNA and mixed by a brief vortex. This mix was incubated for about 20 minutes at room 
temperature; then 300µL of the mixture was dropped into each well of the six-well plate. It was 
then rocked gently to distribute the complexes. The plate was incubated at 37°C in a CO2 
incubator for 5-6 hours before changing the media.  
4.2.2 Examine the transfection 
After 1-2 days of transfection, the transfected cells along with the control cells (those transfected 
with native plasmid and non-transfected cells) were examined using an inverted fluorescent 
microscope (Inverted Epifluorescent Microscope AXIO) to evaluate the rate of the transfected 
cells found amongst all the cells.  
The transfected cells were tested by immunocytofluorescence to examine the expression of the 
genes of interest. After 2-3 days of transfection, dual staining assays were conducted using 
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primary mouse antibodies and rabbit antibodies as previously described in (3.2.10). The slides 
were examined using a Zeiss-Axio Imager. 
4.2.3. RNA isolation from cultured cells 
The RNA was isolated from the cultured cells before and after treatments using an RNeasy mini 
kit as previously described in (3.2.11). 
4.2.4 Two-step quantitative RT- PCR (RT-qPCR)  
The RT-qPCR was employed to investigate changes in the gene expression after a specific 
treatment. The two-step (RT-qPCR) started with the reverse transcription of the total RNA into 
the first-strand cDNA. Then the resulted cDNA was used as a template in real time PCR using 
specific primers. The concentrations of RNAs samples were measured and the concentration 
used in making each 40μl cDNA was 400ng as described in section (4.2.1.2.1.3) cDNA synthesis 
. The isolated RNAs from the biological replicates were mixed together before conducting the 
cDNA synthesis. The cDNAs were diluted 1:20 in RNase-DNase free water.  
qPCR reactions were set up to analyse the gene expression of a number of steroidogenic genes 
and stem cell markers as fold changes using the ΔΔCt method in comparative quantification. 
This technique compares results from experimental samples with both a calibrator (untreated 
cells) and a normalizer which was β-Actin as a housekeeping gene. The choice of (β-Actin as the 
housekeeping gene) was made after running a qPCR stability test on GAPDH and β-Actin within 
the different treatments in the experiments. The stability test was conducted to reveal which of 
housekeeping genes are more stable after different treatments. 
 The Ct values for the gene of interest in the untreated cells and treated cells are adjusted in 
relation to β-Actin Ct from the same untreated cells and treated cells. The resulted ΔΔCt value 





qPCR primers were designed to meet specific criteria of the target gene. All primers were 
designed using the NCBI website tool called Primer-Blast, after detection of the gene mRNA 
sequence, using the gene accession number which can be found online from the option 
Nucleotide in the NCBI website (https://www.ncbi.nlm.nih.gov/nucleotide) Each primer was 
designed to be 18-22bp in long, with melting temperature (Tm) around 60°C and to amplify a 
single DNA segment located within the coding sequence of the target gene. The amplicon length 
ranged between 80-250bp. Primer efficiencies were tested prior to the actual experiments on 
cDNA of RNA isolated from the whole adrenal gland to validate the amplicons signal curve (ct), 
the threshold cycle and their melting curve. The tested samples were run on agarose gel 
electrophoresis after adding the loading buffer to verify the size and singularity of the amplified 
segments. The details of qPCR primers are in (Table 4.1). 
 
All qPCR experiments were conducted in 96 well plates and the reaction of each well was set up 
as follows: 0.3µL primers mix (5μM) each, 7μl of 2x quantiTect SYBER Green PCR master mix 
(Qiagen) and 6.7 μl of the diluted cDNA.  
The qPCR program for initial denaturation at 95°C for 15 minutes was used and then 40 cycles 
of 95°C for 15 seconds followed by 59°C for 1 minute were carried out. The final step was to 
show the melting curve of the products by raising the temperature slowly to 95°C for 15 seconds. 
The qPCR was performed using an AB Applied Biosystem device connected to a computer with 




Table 4.1 List of primers (Invitrogen) used in the RT-qPCR, their accession number, position in the mRNA 




Forward primer 5`-3` (position) Reverse primer5`-3` (position) Fragment  
Size(bp)  
Accession number 
Sf1 TCCAGTGTGTGGTGACAAGG (183-202) TTTGCAGCTCTGACTCTCGG (312-293) 130 NM_001191099.1 
Gapdh CCCAGCAAGGATACTGAGAGC (1097-1117) TCCTGTTGTTATGGGGTCTGG (1218-1198) 122 NM_017008.4 
 Itgb2 AGAGCCTGCAGATTGTTCCG (2741-2760) GCCACCTTTACTGAGACCCC (2827-2808) 87 NM_001037780.2 
β-Actin CACCCGCGAGTACAACCTTC (15-34) CCCATACCCACCATCACACC (221-202) 207 NM_031144.3 
Cyp11a1 TCAGCGATGACCTATTCCGC (612-631) AGTCTGGAGGCATGTTGAGC (779-760) 168 NM_017286.3 
Thy-1 CAAAACGCGGGGAGAAATGG (680-699) ACTAATCAGAAGCAGCCCCG (831-812) 152 NM_012673.2 
3βHSD TGTCATGATACTTGCGGCCC (749-768) AGCCAGAATATGTGCCCAGG (860-641) 112 NM_001007719.3 
Cyp21 CAAGCAGGACAGCACTTTGC (542-561) TTGGACGGACCAGTGATTCC (623-604) 82 NM_057101.2 
Wt1 CCACACCAGGACTCATACAGG (1632-1652) CTGGTGCATGTTGTGATGGC (1740-1721) 109 XM_006234622.2 
Gli1 ATGAAGAGGCAGTTGGGACG (129-148) ACATGGTGTCTCAGCGAAGG (217-198) 89 XM_008765375.1 
Etv5 AAGTCACTTTTCAGTGCAAGAGG (55-77) GTCCTCTGACCGAGATTTCCC (214-194) 160 XM_008768798.1 
Tert TCCTTCCACCAGGTGTCATCC (208-228) TGGGCAAGTAGCTATGCACG (373-354) 166 NM_053423.1 
ID4 GCAGGTCCAGGATGTAGTCG (192-211) CCTGCAGTGCGATATGAACG (316-297) 125 NM_175582.1 
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 4.2.5 Microscopy  
Immunocytofluorescence assays were used to examine the expression of the gene of interest after 
the transfection using a Zeiss-Axio Imager A1 fluorescent microscope with four filters: 
Blue/cyan filter for (4',6-diamidino-2-phenylindole (DAPI)), Alexa Fluor (AF) 488 green, AF 
546 yellow, and AF 660 red as previously described in (2.2.13). 
4.2.6 Statistical analysis  
 
RT-qPCR data were analysed using ΔΔCt which normalised with the expression of housekeeping 
gene (β-Actin) before conversion to relative fold difference values. Results were examined using 





The differentiation experiments of Thy-1 positive cells were conducted using two 
approaches.First, experiments designed to use external differentiation factors (specific such as 
ACTH and generally such as forskolin), which supposed to induce differentiation in the cells 
after binding to their cell membrane receptors which in turn activating pathways that cause 
differentiation. 
Second, experiments designed to induce differentiation by imitating the development process of 
adrenal cortex using transfection with Sf1 gene to change the gene regulatory pathway of Thy-1 
positive cells that may start the differentiation. 
4.3.1 RT-qPCR assays to determine the appropriate housekeeping gene and the 
appropriate RNA concentration 
Before starting the qPCR assays to detect changes in the genes of interest after the differentiation 
attempts, there were two tests required: first, a stability test, which was conducted to select an 
appropriate normaliser between the two housekeeping genes (GAPDH and β actin) in the tested 
samples. 
The stability test revealed both of the housekeeping genes were stable in the control and treated 
cells (Figure 4.1). However, β actin was more stable against both hormonal treatments and Sf1 
transfection.  
Second, a relative standard curve was employed to determine the appropriate RNA concentration 
for this test. The RNA was isolated from the cells and then 400ng of RNA (as measured by 
Nanodrop) was used to make 40µl cDNA. Then series of 10 dilutions of cDNA were prepared 
based on the RNA concentration (1 - 00.2ng/µl of RNA into qPCR reaction mix) to create a 
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trendline between the Ct value and the RNA concentration for β actin as normaliser in the control 
and treated cells. The trendline results showed similar Ct values of β actin between control and 
treated cells (Figure 4.2) and the coefficient of determination values (R
2
) showed high 
correlation between the Ct value and the RNA concentration. Further trendlines for the genes of 
interest were also used such as Thy-1 and WT1, which showed similar correlation values. These 
data also showed that RNA concentration from 1 - 0.25ng/µl was appropriate for threshold of Ct 
values of β actin, which was approximately 20 cycles. 
 
Figure 4.1 Amplification plots of the stability test for two housekeeping genes GAPDH and β actin using RT-qPCR 
on RNA isolated from 3 month old Thy-1 positive cells in culture including (untreated cells, cells after 2 days of 
transfection with Sf1 and cells after 2 days of transfection with native-plasmid). The red curves represent GAPDH 
and the green curves represent β actin. The picture was acquired from this test using StepOne software connected to 













Figure 4.2 Trendline plots of β actin expression against serial dilutions of RNA in the cDNA solution 
used for RT-qPCR (1ng/µl – 0.002 ng/µl) in both treated and control Thy-1 positive cells after 2 days 
of transfection with Sf1.  
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4.3. 2 Thy-1 positive cells differentiation by hormonal treatment 
The use of hormones to induce differentiation was conducted to investigate the response in the 
Sf1 gene expression and the expression of steroidogenic main genes Cyp11A1 and 3βHSD 
because both are usually expressed in the beginning of the steroidogenesis in the zG and zF of 
the adrenal cortex. The relative quantification RQ values were used to represent the number of 
the fold changes in the expression of the genes of interest after the differentiation treatments. RQ 
value analyses the difference in the mRNA expression of the genes of interest in the treated 
sample relative to the reference sample (as represented by the untreated control cells). 
The isolated Thy-1 positive cells were treated with serial concentrations of the differentiation 
factors forskolin, ACTH and AtT20 cell line media to induce differentiation of Thy-1 positive 
cells during their 3
rd
 month of in vitro culture. The treatment lasted for 7 days then the cells were 
collected and the RNA was isolated using an RNeasy mini kit. Then RT-qPCR was conducted to 
measure the changes in the gene expression of Sf1, Cyp11A1 and 3βHSD in comparison with 
untreated cells. The Ct values were normalised to β actin. The relative fold differences of the genes of 
interest were determined using the ΔΔCt value and presented in logarithm 10 of relative quantitation as 
fold changes. The results of the RT-qPCR (Figure 4.3) were showed no significant (p ≥ 0.05) 




























Figure 4.3 RT-qPCR relative quantification represented in fold changes of the mRNA expression 
of  Sf1, CYP11A1, and 3βHSD in the Thy-1 positive cells after one week of treatment with ACTH, 
AT20 cell line media and forskolin. The cells were treated in their 3
rd
 month of in vitro cultivation. 
The mRNA expression of all three genes showed no significant (p ≥ 0.05) response to all of these 




4.3.3 The differentiation of Thy-1 positive cells by transfection with Sf1  
This differentiation of Thy-1 positive cells using Sf1 required designing a vector-Sf1 complex 
that can be used to induce temporary expression of Sf1 gene in the Thy-1 positive cells using 
mammalian cell transfection procedure. A number of experiments were conducted to prepare an 
appropriate vector-Sf1 complex before transfecting the cells.  
4.3.3.1 Gene cloning 
The transfection of Thy-1 positive cells with Sf1 gene was conducted to induce differentiation. 
This experiment required cloning the Sf1 coding sequence in an appropriate vector that has a 
reporter gene (pIRES2 EGFP vector). Therefore, appropriate primers were designed to target the 
coding sequence of Sf1 mRNA in the whole adrenal cDNA using RT-PCR which was 
successfully achieved (Figure 4.4).  
The Sf1 band was excised and the DNA was purified. This purified DNA was then used as a 
DNA template for the next PCR. The primers for this PCR had the same sequences in addition to 
restriction site sequences and CGC or GCG platform sequence at the 5` of the primers. The 
addition of each restriction sequence to each primer was designed to be similar in annealing 
temperature and to orient the gene of interest into pIRES2 EGFP vector. The second PCR 






















Figure 4.4 Agarose gel electrophoresis of Sf1 RT-PCR products. A&B are the bands of RT-PCR 
products using appropriate pair of primers against whole adrenal gland cDNA to amplify the full 
coding sequence of the rat SF1. (C) is the single band represents the product of second PCR after 
using the first product as template DNA with primers designed to add EcoR1 restriction sequences to 
the 5' of the SF1 sequence and to add BamH1 restriction sequences to the 3' end of the SF1 sequence.  
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The Sf1 band from the second PCR was excised and purified successfully in order to digest it 
with EcoR1 and BamH1 enzymes. The Sf1 DNA was successfully digested with the two 
restriction enzymes. The digested DNA was then separated using agarose gel electrophoresis 
(Figure 4.5).  
  
Figure 4.5 Agarose gel electrophoresis of the Sf1 DNA coding sequence after PCR and subsequent 
restriction digest. The targeted band was amplified using specific primers in a PCR reaction with 
primers containing EcoR1 and BamH1 restriction sites to amplify the full coding sequence of the 
rat SF1. The Sf1 DNA product was then flanked with restriction sites that were then digested with 
EcoR1 and BamH1 enzymes.  
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The digestion of the pIRES2 EGFP vector was successfully conducted with the same restriction 
enzymes (EcoR1 and BamH1) and the digested vector was also purified in order to undergo 
ligation with Sf1. The ligation mixture was used in the transformation of E coli in parallel with a 
native-plasmid as a control. The transformation was successfully achieved and several colonies 
of each (transformed with Sf1 and control) were picked and used to inoculate 5ml of LB broth, 
then the plasmids were successfully extracted from 3ml of the culture using mini-prep. The 
extracted plasmid with the potential Sf1 insert was analysed using PCR which showed the 
presence of single band representing Sf1 (Figure 4.6). Then the plasmid was digested with 
EcoR1 and BamH1 enzymes to confirm the presence of a vector with the Sf1 insert (Figure 4.7).   
     
Figure 4.6 Agarose gel electrophoresis of PCR 
products to amplify the full coding sequence of the 
rat SF1 using the extracted plasmid as the DNA 
template with appropriate pair of primers. The single 
DNA band represents the full coding sequence of the 
rat SF1 at approximately 1500bp.  
Figure 4.7 Agarose gel electrophoresis of the 
extracted plasmid after digestion with EcoR1 and 
BamH1, showing the presence of the Sf1 at 
approximately 1500bp and the pIRES2 EGFP 
vector at approximately 5000bp. 
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  The plasmids were extracted using Midi prep kit to gain the appropriate quantity and the 
concentration of the vector required for mammalian cells transfection. The process was 
successfully achieved and the concentration of the vector with insert was 360ng/µl and the native 
vector was 500ng/µl. An aliquot of the plasmid with Sf1 was sent for sequencing and data 
successfully matched the Sf1 sequence.  
 4.3.1.2 Transfection of the Thy-1 positive cells with Sf1 
Transfection of Sf1 into Thy-1 positive cells was conducted to study the gene product and 
function of this gene in the initiation steroidogenesis in Thy-1 positive cells. The cells were 
transfected with Sf1 at two-time points during cultivation: after 3 months and 8 months of 
culture. These experiments were conducted in triplicates, 1-2 days after of transfection, the 
transfection efficiency was examined by visualising the expressing of GFP under the 
fluorescence microscope. The cells showed a transfection rate of approximately 30-45% both 
with native-plasmid and Sf1 plasmid. The effect of Sf1 transfection was tested using RT-qPCR 
and immunocytofluorescence. Specifically, changes in the expression of the genes of interest 
were tracked using RT-qPCR after Sf1 transfection. The gene's expression in transfected cells 
was tested after 2, 4 and 7 days of transfection.    
4.3.1.3 mRNA isolation after transfection of the Thy-1 positive cells with Sf1 
mRNA isolation from Thy-1 positive cells transfected with Sf1 were conducted at different 
intervals 2, 4 and 7 days along with the control cells (those transfected with native-plasmid and 
non-transfected cells). Two-step reverse transcription-quantitative polymerase chain reaction 







4.3.1.4 Relative quantification of genes of interest after Sf1 transfection using qPCR 
After the Sf1 transfection as a differentiation experiment, qPCR assays were carried out to investigate 
changes in the mRNA expression of genes of interest and also to verify the Sf1 expression after 
transfecting Thy-1 positive cells with Sf1. The RT-qPCR assays were conducted after transfection of 
the Thy-1 positive cells with Sf1 in two main periods of the cells life in vitro (after 3months and 
after 8months in vitro). 
4.3.1.4.1 RT-qPCR of the Sf1 transfection into the Thy-1 positive cells after 3months 
The RT-qPCR results of the Sf1 transfection into the Thy-1 positive cells after 3months of 
culture were showed changes in the genes of interests.   
Sf1 mRNA expression showed a significant increase (P< 0.001) after Sf1 transfection in the all 
test periods after Sf1 transfection (2, 4 and 7days) in comparison with untreated cells and the 
cells that were transfected with native-plasmid (Figure 4.8).  
Thy-1 mRNA expression showed slight non significant (P ≥ 0.05) changes after Sf1 transfection 

















Changes in the key steroidogenic pathway genes were detected in response to Sf1 transfection 
(Figure 4.9, Figure 4.10). In comparison with untreated cells and the cells that transfected with 
native-plasmid, the expression of steroidogenic gene Cyp11A1 increased in response to the Sf1 
transfection and this increase was elevated with time after transfection, which reached a 
significant increase (P< 0.05) after 7 days of Sf1 transfection (Figure 4.9). This elevated increase 
of Cyp11A1 might indicate that Sf1 transfection triggers the differentiation of Thy-1 positive 
cells.  
 Figure 4.8 RT-qPCR relative quantification represented fold changes of mRNA expression of Sf1 
and Thy-1 in the Thy-1 positive cells after Sf1 transfection. The cells were transfected in their 3
rd
  
month of in vitro cultivation and the mRNA expression was then tested at three interval periods 2, 4 
and 7 days after transfection. Three biological replicates were used in this experiment. Summarized 
one-way ANOVA results showed significant ** (P<0.01)  increase in Sf1 expression.  
181 
 
 In comparison with untreated cells mean 3βHSD mRNA expression was also increased in 
response to the Sf1 transfection but this increase was not significant (P ≥ 0.05) at either 2,4 or 7 












 Figure 4.9 RT-qPCR relative quantification represented fold changes of mRNA 
expression of 3βHSD and CYP11A1 in the Thy-1 positive cells after Sf1 transfection. 
The cells were transfected in their 3rd month of in vitro cultivation and the mRNA 
expression was tested at three interval periods 2, 4 and 7 days after transfection. Three 
biological replicates were used in this experiment. Summarized one-way ANOVA 




Cyp21mRNA expression showed a minimal not significant (P ≥ 0.05) response to Sf1 
transfection (Figure 4.10) in all testing periods. In comparison with untreated cells and the cells 
that transfected with native-plasmid. Gli1 mRNA expression showed a gradual increase after Sf1 
transfection (Figure 4.10), and this response increased to reache a significant increase (P< 0.05) 
after 7 days of Sf1 transfection.  
  
Figure 4.10 RT-qPCR relative quantification represented fold changes of mRNA 
expression of Gli1 and Cyp21in the Thy-1 positive cells after Sf1 transfection. The 
cells were transfected in their 3
rd
 month of in vitro cultivation and the mRNA 
expression was tested at three interval periods 2, 4 and 7 days after transfection. Three 
biological replicates were used in this experiment. Summarized one-way ANOVA 





ID4 and Tert mRNA expression both decreased dramatically after Sf1 transfection in all the test 
periods (2, 4 and 7 days), in comparison with untreated cells. ID4 showed a significant decrease 
(P< 0.05) after 7 days of Sf1 transfection. This decline in ID4 expression confirm the 
differentiation effect of Sf1 transfection. However, ID4 expression also showed non-significant 
(P ≥ 0.05) decreased in the cells that were transfected with native-plasmid (Figure 4.11).  
Tert was decreased to 0.1 fold, 2 days after Sf1 transfection. This decrease continued to reach the 
4
th
 day after Sf1 transfection then the cells lost Tert mRNA expression after 7 days after Sf1 
transfection. However, Tert also decreased slightly in the cells that were transfected with native-










Figure 4.11 RT-qPCR relative quantification represented fold changes of mRNA 
expression of ID4 and Tert in the Thy-1 positive cells after Sf1 transfection. The cells 
were transfected in their 3
rd
 month of in vitro cultivation and the mRNA expression 
was tested at three interval periods 2, 4 and 7 days after transfection. Three biological 
replicates were used in this experiment. Summarized one-way ANOVA results showed 




4.3.1.4.2 RT-qPCR of the Sf1 transfection into the Thy-1 positive cells after 8months 
The RT-qPCR results of the Sf1 transfection into the Thy-1 positive cells after 8months of 
cultivation are demonstrated in (Figure 4.12 - Figure 4.16)   
Sf1 mRNA expression showed a high significant increase (P< 0.01) after Sf1 transfection in the 
all test periods after Sf1 transfection (2, 4 and 7 days) in comparison with the untreated cells and 
the cells that were transfected with native-plasmid (Figure 4.12).  
In comparison with untreated cells, Thy-1 mRNA expression slightly decreased in the all test 
periods (2, 4 and 7 days) after Sf1 transfection which showed non-significant (P ≥ 0.05) decrease 






Figure 4.12 RT-qPCR relative quantification represented fold changes of mRNA expression of 
Sf1 and Thy-1 in the Thy-1 positive cells after Sf1 transfection. The cells were transfected in 
their 8
th
 month of in vitro cultivation and the mRNA expression was tested at three interval 
periods 2, 4 and 7 days after transfection. Three biological replicates were used in this 





Changes in key steroidogenic pathway genes were detected in response to Sf1 transfection 
(Figure 4.12). The first steroidogenic gene Cyp11A1 has a slight increase in expression in 
response to the Sf1 transfection at 2 and 4 days after transfection. Furthermore, a significant 
increase (P< 0.05) in Cyp11A1mRNA expression was recorded after 7 days of Sf1 transfection, 
in comparison with untreated cells and the cells that were transfected with native-plasmid 
(Figure 4.13). In comparison with untreated cells and the cells that transfected with native-
plasmid, 3βHSD mRNA expression was also increased in response to the Sf1 transfection and 
this increase elevated with time after Sf1 transfection, which reached a significant increase (P< 




Figure 4.13 RT-qPCR relative quantification represented fold changes of mRNA expression of 
Cyp11A1 and 3βHSD in the Thy-1 positive cells after Sf1 transfection. The cells were 
transfected in their 8
th
 month of in vitro cultivation and the mRNA expression was tested at 
three interval periods 2, 4 and 7 days after transfection. Three biological replicates were used in 
this experiment. Summarized one-way ANOVA results showed significant * (P<0.05)  increase 
























































































































































































ID4 mRNA expression as in the previous experiment decreased after Sf1 transfection in all test 
periods (2, 4 and 7 days) in comparison with untreated cells. However, this reduction in ID4 
expression was not significant (P ≥ 0.05) in comparison with untreated cells and cells transfected 
with native-plasmid (Figure 4.14). While Gli1 mRNA expression recorded gradual non-
significant (P ≥ 0.05) increase after Sf1 transfection in comparison with untreated cells and cells 
that transfected with native-plasmid (Figure 4.14). 
  
 Figure 4.14 RT-qPCR relative quantification represented fold changes of mRNA 
expression of Gli1 and ID4 in the Thy-1 positive cells after Sf1 transfection. The cells 
were transfected in their 8
th
 month of in vitro cultivation and the mRNA expression was 
tested at three interval periods 2, 4 and 7 days after transfection. Three biological 





Tert expression showed a slight but not significant (P ≥ 0.05) decrease after Sf1 transfection in 
all test periods (2, 4 and 7  days after Sf1 transfection) in comparison with untreated cells and in 
the cells that were transfected with native-plasmid (Figure 4.15). While Cyp21mRNA expression 
showed a weak, non-significant (P ≥ 0.05) and irregular response to Sf1 transfection (Figure 
4.15) in all test periods (2, 4 and 7 days) in comparison with untreated cells and the cells that 
were transfected with native-plasmid. 
 
  
Figure 4.15 RT-qPCR relative quantification represented fold changes of mRNA 
expression of Cyp21 and Tert in the Thy-1 positive cells after Sf1 transfection. The 
cells were transfected in their 8
th
 month of in vitro cultivation and the mRNA 
expression was tested at three interval periods 2, 4 and 7 days after transfection. 




4.3.1.5 Immunocytofluorescence detection of Thy-1, GFP and Sf1 after transfection Thy-1 
positive cells with Sf1 
 The RT-qPCR results of the transfected Thy-1 positive cells of both periods (3
rd
 month and 8
th
 
month) showed a high significant (P< 0.01) increase in Sf1 mRNA expression which in turn 
influenced changes in the expression of the other genes of interest. This increase in Sf1 after 
transfection and its effects especially on the expression of Cyp11A1, Gli1, ID4 and 3βHSD 
might be relevant to the activity of Sf1 protein as a nuclear receptor and differentiation factor.  
 Therefore, in order to confirm the high significant increase (P< 0.01) in Sf1 expression, this 
experiment was conducted to detect the Sf1 protein expression and the co-expression of Sf1 with 
the GFP from the vector in Thy-1 positive cells. 
 Dual-staining immunocytofluorescent assays were conducted to investigate the Sf1 protein 
expression in the Thy-1 positive cells after Sf1 transfection. 
 The transfected cells were subjected to test using a dual-staining immunocytofluorescent assay 
two days after transfection. The results of the transfection experiments (Figure 4.16) in the Thy-1 
positive cells at three months showed the co-expression of SF1 protein expression in the nucleus 
(detected by anti-Sf1 antibody) with gene fluorescent protein (GFP) expression in the cytoplasm 
(from the GFP in the pIRES2 EGFP vector). The results of the transfection experiments in the 
Thy-1 positive cells at eight months also showed the co-expression of SF1 protein expression in 
the nucleus (detected by anti-Sf1 antibody) with GFP expression in the cytoplasm (from the GFP 
in the pIRES2 EGFP vector). Also, few cells with low Thy-1 expression showed the co-
expressionof Sf1 in the nucleus with GFP expression in the cytoplasm (Figure 4.17), which 












Figure 4.16 Dual-Immunocytofluorescence staining on 3 months old cultures of Thy-1 positive cells isolated using 
MACS and transfected with the rat Sf1 gene cloned into the pIRES2 EGFP vector. Cells were fixed 2 days after 
transfection and incubated with mouse anti-Thy-1 antibody (B), incubated with a rabbit anti-Sf1 antibody (Abcam) (C) 
before detection with anti-mouse Alexa 546 and anti-rabbit Alexa 647. The GFP expression from pIRES2 EGFP vector 
is shown in (D). All samples were mounted and cell nuclei were stained with DAPI in (A). Merged images of (A), (B), 
(C) and (D) are shown in (E). Arrow in (C) refers to the Sf1 expression in the nucleus of the cells. Circles in (D) refer 



































Figure 4.17 Dual-Immunocytofluorescence staining on 8 months old cultures of Thy-1 positive cells isolated using MACS 
and transfected with the rat Sf1 gene cloned into the pIRES2 EGFP vector. Cells were fixed 2 days after transfection and 
incubated with mouse anti-Thy-1 antibody (B), incubated with a rabbit anti-Sf1 antibody (Abcam) (C) before detection with 
anti-mouse Alexa 546 and anti-rabbit Alexa 647. The GFP expression of the pIRES2 EGFP vector is shown in (D). All 
samples were mounted and cell nuclei were stained with DAPI in (A). Merged images of (A), (B), (C) and (D) are shown in 
(E). Arrows in (C) refer to the Sf1 expression in the nucleus of the cells. Circles in (D) refer to the GFP expression from the 
























The results of this chapter described attempts conducted to promote the differentiation process in 
Thy-1 positive cells using external factors (ACTH, forskolin and the naturally produced POMC 
from AtT20 cell line), which all failed to induce differentiation. However, the transfection of 
Thy-1 positive cells with Sf1 gene up-regulated mRNA expression of a number of steroidogenic 
enzymes and Gli1 (progenitor cells marker) in addition to decrease expression of ID4 
(differentiation inhibition marker). All these findings support that Sf1 transfection initiates the 
differentiation process.  All these results of Sf1 transfection can be summarised in (table 4.2). 
 
 Table 4.2 Summary of the effects of Sf1 transfection to the Thy-1 positive cells on the expression of the genes of 






Parameter  Young Thy-1 positive cells (3 months)  Old Thy-1 positive  cells (8 months) 
Sf1  Highly increased   Highly increased   
Cyp11A1 Increased  Increased  
3βHSD Increased increased 
Cyp21 NO NO 
ID4 Decreased  Decreased  
Thy-1 No  Decreased  
Gli1 Increased  Increased  




Differentiation process normally occrues during development and proceeds to adulthood, in 
which cells divide to change from the non-specialised cell into the more specialised daughter 
cell.  Differentiation is important for the normal cell turnover that maintains organs and to repair 
damaged tissues after injuries. During the embryonic development and adult cell differentiation, 
the gene expression patterns of the primary cell determine its fate as differentiated cells with a 
specific phenotype. During the development and the formation of the adrenal cortex, the 
minority of  AGP cells that migrate dorsomedially and distant to form adrenal foetal zone start 
expressing higher levels of SF1 as the first characteristics of their differentiation (Xing et al., 
2015). Therefore, the in vitro differentiation attempts basically seek for imitate the differentiation 
process that accrues in vivo. 
Thy-1 positive cells previously isolated using MACS were generally undifferentiated cells and 
they have several characteristics of mesenchymal stem cells. One of the main aspects of stem 
cells is their potential capacity to differentiate into their original somatic cell types. So, 
investigations of the Thy-1 positive cells were carried out to test their differentiation capacity. 
The choice of differentiation factors in this study was initially based on the expected effect of 
these factors on the target cells.  
The first attempt to differentiate Thy-1 positive cells was conducted using different 
concentrations of the differentiation factors forskolin, ACTH and AT20 cell line media. forskolin 
induces differentiation by stimulating intracellular cyclic AMP production, which in turn induces 
differentiation (Bhattacharya et al., 2012, Gilissen et al., 2015). The release of cyclic AMP as a 
differentiation factor normally occurs after activation of a steroidogenic receptor, such as when 
ACTH or FSH bind to its receptor, which stimulates cyclic AMP production (Bhattacharya et al., 
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2012, Beall and Sayers, 1972). However, Thy-1 positive cells showed no significant (P ≥ 0.05) 
increase in the expression of steroidogenic genes (CYP11A1 and 3βHSD), and SF1 after 7 days 
of treatment with forskolin. 
 There are several reasons that might be behind the un-successful differentiation attempt using 
forskolin: several differentiation attempts carried out using forskolin to differentiate MScs into 
neurons suggested that cAMP pathway that induces differentiation by Forskolin was proposed to 
be involved in changing the morphology of the cells but not the expression of the growth 
associated protein that changed MSCs into neurons (Wislet-Gendebien et al., 2012). Other 
researcher concluded that cAMP could not complete the differentiation of bone marrow derived 
MSCs and most of differentiation effect result from modifying the culture conditions rather than 
the forskolin treatment (Rooney et al., 2009, Zhang et al., 2011).  
ACTH and AT20 cell line media (as a source of normal POMC peptides) also failed to induce 
differentiation in the Thy-1 positive cells. The differentiation effects of ACTH required the 
presence of its receptor in the cell membrane. Thy-1 positive cells lacked the expression of the 
melanocortin receptor type 2 (MC2R), which is specific for ACTH. In general, Thy-1 positive 
cells showed no significant (P ≥ 0.05) increase in the expression of steroidogenic genes 
(CYP11A1 and 3βHSD), and SF1 after 7 days of any of the three external treatments. 
The second attempt to differentiate Thy-1 positive cells was conducted by transfecting these cells 
with Sf1 gene. Sf1 has been used in several differentiation experiments on a variety of stem cell 
types, for example with the mesenchymal non-steroidogenic stem cells (Yazawa et al., 2015) and 
murine embryonic stem cells (Jadhav and Jameson, 2011). Three steroidogenic genes were 
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basically proven to be under the regulation of Sf1: Cyp11A1 that encodes Scc (Hu et al., 2001b), 
3βHSD (Leers-Sucheta et al., 1997) and Cyp 21 (Lee et al., 1996). 
In order to attempt to differentiate the Thy-1 positive cells, Sf1 gene expression was induced 
using gene cloning and mammalian cells transfection. The full coding sequence of the rat Sf1 
was amplified successfully using specific primers during a PCR experiment, this was followed 
by another PCR experiment using specific primers which have the same sequence as the first 
primers but with a restriction site added to the 5` of each primer using the previous PCR product 
as a template in order to flank the Sf1 amplicon with these two restriction sites (EcoR1 and 
BamHI). Flanking the amplicon with restriction sites was achieved successfully and was 
followed by successful digestion of the amplicon and the vector at both restriction sites (EcoR1 
and BamHI). The following steps of ligation the Sf1 amplicon into the vector and transformation 
of competent E.coli with the construct (Sf1-vector) was achieved successfully. Targeted colonies 
were picked and tested for possession of the vector and the Sf1 amplicon using PCR and 
sequencing, and the digestion showed the expected size of both Sf1 amplicon and the vector. 
Since all test were positive for the presence of the Sf1 insert, the construct was purified using 
midiprep kit in order to transfect Thy-1 positive cells because the transfection required relatively 
high volumes and quality above what the miniprep kit can provide. Plasmid transfection into 
Thy-1 positive cells was conducted at two-time points during their one year of in vitro 
cultivation: at three months and eight months after initial isolation. Three months after isolation 
the cells were tested and they were mainly found to be undifferentiated. While eight months after 
isolation the cells remained undifferentiated but they were transforming to immortal in vitro as 
previously discussed in chapter three. This cloning process of the Sf1 coding sequence into the 
pIRES2 EGFP vector followed by transfection into Thy-1 positive cells was conducted to induce 
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temporary expression of the Sf1 gene in the cells to attempt differentiation. The successful 
transfection was achieved after several optimisation experiments which were analysed one day 
after transfection with both plasmids (with the Sf1 gene and the native-plasmid). The changes in 
Sf1 gene expression and other genes of interest in the transfected cells were tracked using RT-
qPCR and immunocytofluorescence assays.  
The RQ analysis of RT-qPCR assays showed a significant (P< 0.01) increase in Sf1 expression 
which up-regulated Sf1 to over 4000 fold in the treated cells in comparison with untreated cells 
and the cells that were transfected with native-plasmid. This high Sf1 mRNA expression was 
expected because of the cytomegalovirus (CMV) promoter up-stream the Sf1 gene in the pIRES2 
EGFP vector. This significant expression of Sf1 mRNA was maintained for at least 7 days after 
transfection in both experiments which were conducted during the third month and the eight 
month after isolation which might be maintained because of the low proliferation rate of the Thy-
1 positive cells in their 3
rd
 month in vitro. However, the old Thy-1 positive cells in their 8th 
month in vitro showed also high significant increase (P< 0.01) in Sf1 expression that continued 
for 7 days after Sf1 transfection in spite of their high proliferation rate.  
Tert associated with telomere maintenance is one of the cellular reprogramming factors that are 
related to pluripotency of embryonic stem cells (Orkin and Hochedlinger, 2011) and is highly 
expressed in spermatogonial stem cells (Bai et al., 2016). However, in this study, the Ct values of 
this epigenetic factor were around 30 cycles in the untreated cells after three months and eight 
months of isolation which represents very low mRNA expression. However, the transfection 
with Sf1 lowered the Tert expression in both Sf1 treated groups and this reduction in Tert 
expression continued with time after transfection to reach its lowest expression 7 days after Sf1 
transfection for the 3 months group (Figure 4.11). The reduction in Tert expression due to Sf1 
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transfection in the 8 months group was also in similar pattern of the 3 months group (Figure 
4.15). Although the adult normal adrenal cortex cells do not have telomerase activity (Yang et 
al., 2001), long-term in vitro cultivation might induce a number of epigenetic key factors such as 
Tert due to distribution of in vitro environment (Gabory et al., 2011).   
ID4 mRNA expression was recorded to have a gradual decrease in both Sf1 transfection groups 
with continues reduction 2, 4 and 7 days after Sf1 transfection respectively. This reduction in 
ID4 mRNA expression after Sf1 transfection reached a significant (P< 0.05) decrease after Sf1 
transfection in the 3
rd
 month group. This reduction in ID4 mRNA expression was in agreement 
with the role of ID4 as an inhibitor of differentiation (Patel et al., 2015) which confirm the 
differentiation effect of Sf1 transfection.  
Gli1 mRNA expression showed a gradual non-significant (P ≥ 0.05) increase after 2 and 4 days 
of Sf1 transfection in both groups (3
rd
 month and 8
th
 moth groups). However, Gli1 mRNA 
expression reached a significant increase (P< 0.05) after 7 days of Sf1 expression in the 3
rd
 
month group. This up-regulation of Gli1 expression due to Sf1 transfection might be related to 
the proposed role of Gli1 in the progenitor transition between stem cell and differentiated cells 
(Kim et al., 2009).  
The main target of Sf1 transfection is to enhance the expression of the steroidogenic genes that 
represent in the differentiated adrenocortical cells (Cyp11A1, 3βHSD and Cyp21) because 
several studies refer to Sf1 as a regulator of steroidogenic genes (Val et al., 2003). Others 
suggested Sf1 initiates differentiation of MSCs to steroidogenic lineage (Mizutani et al., 
2015). Both Cyp11A1 and 3βHSD were significantly (P ≥ 0.05) up-regulated after Sf1 
transfection in the 8
th
 month group and Cyp11A1 showed significant (P ≥ 0.05) increase after 
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Sf1 transfection in the 3
rd
 month group, which suggested that Sf1 might start steroidogenesis in 
the Thy-1 undifferentiated cells which was in agreement with Mizutani et al., (2015). This up-
regulating effect of Sf1 to Cyp11A1 might due to the two binding sites that Sf1 has at −40 and 
−1,600 upstream the CYP11A1 gene which triggers CYP11A1 cAMP-dependent gene 
expression in vitro (Guo et al., 1994, Watanabe et al., 1994, Hu et al., 2001a). Sf1 also regulates 
the 3βHSD gene (Baba et al., 2014). However, Cyp21 did not show any significant (P ≥ 0.05) 
response to Sf1 transfection.  
Immunocytofluorescence assays were conducted to reveal the presence of Sf1 protein expression 
in the nucleus after transfection and if it co-expressed with GFP protein. The up-regulation of 
Sf1 mRNA expression after transfection might not result in the functional translation of Sf1 
protein which localised in the nuclei of the transfected cells. Therefore, immunocytofluorescence 
assays were required to confirm the protein expression of Sf1 in the nucleus, which was expected 
to initiate the differentiation by up-regulating the expression of Cyp11A1 and 3βHSD. The 
immunocytofluorescence results confirmed that and showed the Sf1 protein expression in the 
transfected cells in both groups. The green fluorescent protein in the cytoplasm co-expressed 
with the Sf1 protein expression in the nucleus, which indicated that the transfection of Thy-1 
positive cells with Sf1 gene successfully increased functional protein expression of Sf1.   
In general, the differentiation response of Thy-1 positive cells after force expression of Sf1 was 
in agreement with a number of attempts used Sf1 to differentiate stem cells. The capacity of Sf1 
protein to differentiate several stem cell types into steroidogenic lineage has been reported in 
mesenchymal stem cell types such as bone marrow stem cells (Gondo et al., 2004) and adipose 





General discussion and future work 
5.1 Detection of potential adrenocortical stem cell marker mRNAs and proteins 
The aims of this study were primarily to isolate and study the adrenocortical stem cell in vitro 
because it had been described before as a difficult goal “It has proven difficult to isolate and 
characterise adrenocortical stem cell populations” (Pihlajoki et al., 2015). 
This project started with bioinformatics analysis of a whole rat adrenal transcriptome 
microarray data set. The data showed the expression of potential stem or progenitor cell 
markers based on their high expression in the capsule, or capsule and zI, in comparison with 
zF, because most of the research referred to these two zones (capsule and zI) as potential 
stem cell niches. The potential stem cell markers expressed in the capsule or capsule and zI 
when compared with zF displayed a 50-800 fold increase in expression. Over 60 potential 
stem/progenitor cell markers of the rat whole transcriptome were observed. Criteria for 
selection of these 60 potential stem cell markers were constructed based on a combination of 
the bioinformatics analysis results of the array data and the information in the literature. The 
literature criteria implied potential roles in stem/progenitor cell characteristics, cell 
proliferation, and cell migration. In addition, we included the rarely studied proteins that 
showed high expression in the capsule of the adrenal cortex. Three potential markers were 
selected to be tested: Transmembrane protein121 (Tmem121), Thy-1 cell surface antigen 
(Thy-1) and Krüppel-like factor 5 (KLF5). 
 Several molecular experiments were conducted in order to examine the existence of these 
markers followed by cloning into the p-GEM®-T Easy vector. This was followed by in vitro 
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transcription to produce probes to detect the mRNA expression patterns of these markers in 
the rat adrenal cortex by FISH. Immunohistofluorescence experiments also followed to detect 
the localisation of the proteins of interest in adrenal sections.  
In situ hybridisation experiments faced a number of difficulties and took a long time to be 
successful. Several In situ methods were conducted to achieve in situ hybridisation, these 
included the whole mount in situ hybridisation procedure described by (Nieto et al., 1996), as 
well as wax and cryosection in situ hybridisation protocols. Although the best working 
protocol with the adrenal sections was found to be the one described by (Lomthaisong, 2001), 
several modifications were required to reduce RNA degradation and increase the stringency 
such as increasing the hybridisation temperature and only using RNase free material.  
The in situ hybridisation results confirmed the microarray data and showed mRNA 
expression of the genes of interest in the capsular and the sub-capsular areas of the adrenal 
cortex (Figure 2.9).  
Klf5 mRNA had a high narrow and intense expression in the capsule with weak and 
expanded expression in the zG and zF (Figure 2.9). The Klf5 protein expression pattern was 
in agreement with in situ hybridisation with a low-level expansion in the zG and Zf, meaning 
that not all the mRNA was transcribed to protein. Although the Klf5 protein is considered to 
be one of the pluripotency markers in certain embryonic stages (Hou et al., 2016), the 
expansion of Klf5 protein expression in the two main differentiated zones (zG and zF) might 
not be related to the pluripotent stem cells within the adult adrenal cortex. This result 
suggested that Klf5 is not a stem cell marker in the adrenal cortex.  
Tmem121 mRNA expression was high in the capsule, but it showed a minor expansion in the 
zG, this pattern of expression represents most of the capsular area and a small fraction of the 
zG. The Tmem121 protein expression agreed with the in situ hybridisation results. The long 
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expanded line of Tmem121 protein expression along with capsule and sub-capsular areas 
reduced the probability of considering the Tmem121 from being a stem cell marker. This 
possible exclusion of Tmem121 can be explained by the presence of stem cell populations 
within the adult tissue, which have a limited existence, as seen in adipose tissue  (Zaman et 
al., 2014), heart (Navarro-Betancourt and Hernandez, 2015) and bone-marrow (Guerin et al., 
2015), which represent less than 0.1% of the main cell populations.  However, this interesting 
expression pattern of Tmem121 might suggest a role for Tmem121 in adrenal cortex cell 
proliferation and migration, because the adrenal cortex undergoes centripetal migration that 
starts from the subcapsular area towards the adrenal cortex medulla border where the cell 
proliferation rate was high. The detection of Tmem121 protein expression co-expressing with 
the Ki67 proliferation marker (Figure 2.13), primarily revealed a high co-expression between 
the two proteins (0.74 according to Spearman's rank correlation value). This value may refer 
to the existence of Tmem121 protein during cell proliferation (based on the Ki67) and that it 
might participate or have a role in cell proliferation, but it might not be essential to this 
process since not all the proliferative cells were expressing it. The interesting finding 
regarding the Tmem121 protein that related to the proliferation activity of the adrenal cortex 
cells suggests more investigation of the role of Tmem121 in the induction of cell proliferation 
is needed.    
Thy-1 protein had the most potential as a marker amongst the nominated markers. Several 
characteristics nominated Thy-1 as a marker for isolating the potential stem cells from 
adrenal gland primary cells:  
Firstly, the expression pattern of Thy-1 in the capsule that was distributed in a pattern of 
small pockets typically signifies the distribution pattern of stem cells in the adult tissues. 
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Secondly, the molecular structure of the Thy-1 protein in the cells as a cell surface antigen 
facilitated the use of a specific antibody to isolate the target cells.  
Furthermore, Thy-1 has the lowest expression level in the zG and zF, these zones represent 
the most differentiated part of the adrenal cortex.  
The results of in situ hybridisation and immunohistofluorescence experiments aimed to 
establish expression in the capsule and sub-capsular area as the stem cells niche. In this study 
we excluded the adrenal cortex zI, in spite of Mitani et al.,(2003) suggestion, which refers to 
the zI as stem/progenitor cell niche. This suggestion might be down to strain differences in 
the rats used in the experiments as we used the Wistar-rats strain, while Mitani and co-
workers used Sprague-Dawley strain. It has also been suggested that the adrenal cortical stem 
cells are Sf1 negative but the progenitor cells are Sf1 positive as they start to express Sf1 
before differentiation and commencing steroidogenesis (Kim et al., 2009). In our study, the 
mRNA expression of Sf1 (Figure 2.9) and protein expression of SF1 (figure 3.15) was 
detected in most of the adrenal cortex including the area where zI expected to be. 
 Generally, our results showed that a few cells within the capsule express a high level of the 
Thy-1 protein, which represents a specific cell type within the capsule, that might be stem 
cells according to the most identified adrenal cortex stem cells hypothesis (Walczak and 
Hammer, 2015).  
5.2 Isolation and characterisation of Thy-1 positive cells  
Chapter 3 demonstrated the isolation of Thy-1 positive cells and the study of them in vitro 
because it is difficult to investigate cell behaviour in vivo. Isolation and investigation of Thy-
1 positive cells in vitro created an effective approach involving primary culture to investigate 
the cellular and molecular mechanisms controlling the cell behaviour. Once the FISH and 
immunostaining assays analysis suggested the Thy-1 protein as robust potential stem cell 
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marker, the isolation of Thy-1 positive cells from the primary culture of rat adrenal gland was 
determined. Before starting the isolation process using MACS, two main preparations were 
required:  
First, an adequate amount of monoclonal anti-Thy-1 antibody was required for the isolation 
process and later in vitro assays. This was accomplished in-house by maintaing of the OX-7 
hybridoma cells in specific media to produce an adequate amount of the monoclonal anti-
Thy-1 antibody. The production of monoclonal anti-Thy-1 antibody was successful and 
confirmed using SDS-PAGE electrophoresis with Coomassie Blue staining (figure 3.4) and 
Western blotting (figure 3.5). The binding capacity and specificity of the anti-Thy-1 antibody 
were validated by immunocytofluorescence tests (figure 3.9) and Western blotting (figure 
3.21). The large-scale production of this antibody was also important to conduct the later 
experiments. 
Second, primary culture of rat adrenal gland was accomplished using mechanical and 
enzymatic digestion, yielding viable primary cells from the whole adrenal gland. The isolated 
primary cells showed expected hormonal response towards ACTH treatment, which was 
another indicator of cell interaction with it's in vitro environment. Further adrenal gland 
primary cultures were conducted after removing the medulla and the un-targeted part of 
adrenal gland. Our findings suggested the isolation of the target cells after enucleating and 
discarding of the medulla and most of the zF, instead of using the whole adrenal would 
eliminate most of the differentiated cells of the cortex as well as the medulla. However, the zI 
was not the main target of this study since Thy-1 expression was confined to the capsule and 
sub-capsular areas.  
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MACS was carried out using the anti-Thy-1 antibody to enrich the Thy-1 positive cells of the 
adrenocortical primary cultures. MACS is a well-documented method used for isolating 
target cells such as stem cells (Amiri et al., 2015, Zhong et al., 2015).  
The primary diagnosis of Thy-1 positive cells using a light microscope under the 10x power 
showed fibroblastic-like cells. These cells traditionally represented the capsular cells that 
were described as fibroblast-like capsular cells (Kim and Hammer, 2007a). The cells use to 
have long thin cytoplasmic extensions called telopods or projections, which might have a role 
in forming differentiated cells of the adrenal cortex (Baker, 1952). The cells showed MSC 
characteristics in vitro such as attaching to plastic and they tended to form colonies (Castro-
Malaspina et al., 1980, Colter et al., 2001). The confluent cells also developed a whirlpool-
like shape growing pattern in culture, which is in agreement with what has been described in 
MSCs (Pelekanos et al., 2016).  
Thy-1 positive cells exhibited morphological and cellular behavioural changes during in vitro 
cultivation. For example, the division rate of the younger cells was slower than the older 
cells. The younger cells were more attached to the plastic surface and required trypsinisation 
for a long incubation time (25 minutes with TrypLE™) to detach them in comparison with 
the older cells, which required a shorter incubation time (10 minutes with TrypLE™) to be 
detached.  
These changes were noticed during routine monitoring work such as changing the media and 
passaging before reaching confluency. These observations required more investigation to 
study the changes in the cell cycle, cell migration and the expression of proteins of interest.  
Therefore, the cell division rates were tracked in culture using time lapse microscopy. The 
cell tracking assay showed that young cells (2-6 months) especially in their 2nd month in 
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culture, underwent division approximately every 3 days. The old cells (10-12 months) 
underwent division every 36-48 hours.  
While proliferation studies of rat adrenal gland primary cell culture showed the cells 
underwent division approximately every 2 days (after 21 days of cultivation). Then it was 
reduced to one division every 5 days (after 100 days of cultivation) (Arola et al., 1993), 
which was probably because these cells became senescent cells after 100 days of cultivation. 
Our results suggested Thy-1 positive cells were more stable and can survive longer in vitro in 
comparison to the whole adrenal primary culture which tends to lose its survival ability after 
100 days in vitro. Time lapse techinque was also used to test the cell migration changes of 
Thy-1 positive cells using a wound-healing assay (figure 3.8). The older cells (12th months 
old in the culture) were significantly (P<0.01) migrating faster than younger cells ( 2nd 
months old in culture). These fast migrating cells were most likely immortalised cells because 
it is one of the characteristics of cancer cells in vitro because the cancer cells deform and 
reduce the nucleus size to minimum because it the most hardest cellular component in order  
to be efficiently able to pass through narrow spaces (Paul et al., 2017). 
The co-existence of senescent cells among the Thy-1 positive cells (figure 3.7) was not 
abnormal phenomenon because it was observed in the primary culture of the rat adrenal gland 
(Guo and Liu, 2005). These senescent cells died after few months of cultivation potentially 
due to reaching the Hayflick limit (Hayflick and Moorhead, 1961). Investigating these few 
cells within the cells of interest revealed their common traits, which were the same as what 
had been recorded for senescent MSCs. These characteristics included morphological 
changes and reduction in both proliferation and differentiation potential (Zhu et al., 2015). 
This phenomenon is usually related to the age of the organism at the time of isolation 
(Yegorov and Zelenin, 2003). However, the senescent cells have been recorded to accompany 
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even the most potent stem cells such as human embryonic cells (Munoz-Espin et al., 2013) 
and mouse embryonic cells (Storer et al., 2013). Senescence has also been found to have a 
role contributing to embryonic development, growth and cell patterning (Storer et al., 2013). 
Investigating Thy-1 positive cells also showed an increase in Thy-1 expression after 
cultivation (figure 3.21). This increase was in parallel with the ability of the cells to attach to 
plastic and this ability decreased when Thy-1 expression decreased in the old Thy-1 positive 
cells, which was in agreement with the role of Thy-1 in cell adhesion (Rege and Hagood, 
2006). The cell division rate of the old cells increased in the last four months of cultivation. 
This increase in cell division rate in the old cells was synchronised with the decrease of    
Thy-1 expression. This synchronisation was in agreement with what was Thy-1 suggested 
mode action as a proliferation inhibitor of the primitive cord blood stem/progenitor cells 
(Mayani and Lansdorp, 1994).  
Thy-1 positive cells survived in vitro for more than one year, which suggested a possible role 
of Thy-1 in self-renewal regulation that allows maintenance of these cells and other stem 
cells types for long periods in vitro in comparison with the differentiated cells (Ishigaki et al., 
2009, Bernardo et al., 2007).  
The protein expression of Thy-1 in Thy-1 positive cells was confirmed by 
immunocytofluorescence using an anti-Thy-1 antibody and anti-CD45 antibody as a control 
after 2 weeks of culture.  
 After eight weeks post-MACS, the immunocytofluorescence against Thy-1 revealed that it 
was still being expressed (figure 3.10). The immunocytofluorescence against Thy-1 also 
showed that the ratio of the number of cells that expressed Thy-1 was higher in comparison to 
the results of the first (two weeks post-MACS) immunocytofluorescence test, and the 
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intensity of Thy-1 expression within the cells eight weeks post-MACS was also higher than 
the first immunocytofluorescence test (two weeks post-MACS). This increase in the Thy-1 
expression was confirmed by Western blotting (figure 3.21) and seemed to be maintained for 
a few months. This increase in Thy-1 expression after cultivation was in agreement with the 
results from RT-qPCR in human mesenchymal stem cells (Dudakovic et al., 2014). 
The adrenocortical differentiated cells usually express steroidogenic genes. Therefore, Thy-1 
positive cells were tested against the expression of steroidogenic genes to identify if Thy-1 
positive cells were differentiated or undifferentiated cells. The RT-PCR experiments showed 
the cells were mainly undifferentiated cells (figure 3.11). However, these RT-PCR 
experiments showed the expression of other stem cell markers such as WT1, Etv5 and ID4 
(figure 3.11 and figure 3.12). 
The finding of WT1 expression in the isolated cells using RT-PCR was confirmed by 
immunocytofluorescent assay. The expression of WT1 in the adrenocortical stem cells was 
expected because it was described as an important protein in the embryonic development of 
adrenal glands because WT1 knock-out mice die at embryonic day E13.5 due to deadly 
defects in their urogenital system (Moore et al., 1999). It was also proposed as a factor 
maintaining the undifferentiated adrenal-gonadal primordium state in the adrenal gland and 
also as an inhibitor of the differentiation process (Bandiera et al., 2013). The same study 
tracked the descendants of WT1 positive cells and found they gave rise to cells which were 
WT1 negative but Sf1 positive and expressed steroidogenic genes. On the other hand, Shh 
and Gli1 were not detected in the assayed cells but both have been described as progenitor 
cell markers in vivo (Kim et al., 2009), suggesting the Thy-1 positive cells were more likely 
to be stem cells rather than progenitor cells. 
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It was important to investigate the co-expression ratios of WT1 or Sf1 with Thy-1 in Thy-1 
positive cells in comparison with their co-expression in adrenal gland cryosections to reveal 
which factors increased after cultivation that might be related to maintaining Thy-1 positive 
cells for a long time in vitro. The observation of WT1 expression along the capsular line 
supports the hypothesis of the existence of capsular stem cells. The high co-localisation ratio 
of WT1 with Thy-1 in the adrenal gland (0.59±0.052) and the low co-expression ratio of Sf1 
with Thy-1 (0.23±0.11) supported the notion of Thy-1 as a stem cell marker. Furthermore, the 
co-localisation of WT1 with Thy-1 increased to 90±2% in the Thy-1 positive cells after 12 
weeks of cultivation. This suggested these cells were maintaining a self-renewal capacity (as 
one of the characteristics of stem cells) in culture and that they can survive longer in 
comparison with the differentiated cells (Ishigaki et al., 2009). While the Thy-1 and Sf1 
positive cells were the opposite of that. The co-expression of Thy-1 with Sf1 in the adrenal 
gland was low (0.23±0.11) and decreased to 1±1% in the isolated cells. These results 
suggested that WT1 expression is important in the maintenance or activation of stem cells, 
which is in agreement with recent observations of nephrogenesis, which suggested a 
mechanism by which WT1 regulates stem cells (Akpa et al., 2016). So, the expression of Sf1 
in the isolated cells might represent the presence of progenitor cells rather than differentiated 
cells, especially as these cells were lacking other steroidogenic genes (figure 3.11) and they 
represented a low ratio (1±1%) in culture.  
Thy-1 positive cells also expressed transcriptional regulatory proteins (Etv5 and ID4), which 
are defined as stem cell markers because they contribute to stem cell properties such as the 
self-renewal of the spermatogonial stem cells (Wu et al., 2011, Oatley et al., 2011, Helsel et 
al., 2017). The high level of expression of Etv5 in the isolated cells might have the same role 
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in maintaining the self-renewal capacity of these cells since they survive for a long time in 
culture.  
In addition to the role of ID4 in the self-renewal state of stem cells, it has also an important 
role as a differentiation inhibitor (Patel et al., 2015). Therefore, the expression of this protein 
in the cells of interest suggested that it maintained the undifferentiated state of the cells. The 
findings of two common spermatogonial stem cell markers (Etv5 and ID4) might be related 
to the developmental relationship between the gonads and the adrenal cortex.    
The immortal transformation of the Thy-1 positive cells in the last few months in vitro was 
not only recorded in the primary culture of adult differentiated cells but also recorded in  
MSCs (Urraca et al., 2015). However, this transformation may not necessarily be an 
oncogenic transformation (Gordon et al., 2014). This transformation includes changes in cell 
morphology, the ability of cells to attach to plastic, cell cycle, cell migration and alteration in 
the expression of the proteins of interest, especially Thy-1. However, these cells remain 
undifferentiated because they did not show the expression of the steroidogenic genes. 
One of the other aspects of the old Thy-1 positive cells was the reduction in the expression of 
Thy-1 protein. The changes in the morphology of old cells and their behaviour in comparison 
with the younger cells (especially the high division and migration rate in vitro) can be 
described as similar to the behaviour of cancer cells in vitro. These changes might have 
resulted from the reduction of Thy-1 expression in the old cells because the Thy-1 protein 
was shown to have an inhibitory effect on ovarian cancer cells (Zeng et al., 2009). In 
agreement with these findings, the progenitor cells of leukemia that are able to maintain 
blood cancer both in vivo and in vitro were lacking in Thy-1 expression in comparison with 
normal hematopoietic progenitor cells (Blair et al., 1997). These results suggest that Thy-1 
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might have an inhibitory role in tumourgenesis. The old Thy-1 positive cells also showed a 
general decrease in the expression of WT1, Etv5 and ID4.  
Although, WT1 expression declined in the (cancer-like) older Thy-1 cells in comparison with 
its expression in the younger cells, WT1 expression in cancer cells showed slight 
controversial results. For example, WT1 expression has been found to be up-regulated in a 
number of cancer cells. However, WT1 transfection into ovarian cancer cells caused a 
reduction in their proliferation rate (Huo et al., 2011).  
The expression of the Etv5 protein in the older Thy-1 positive cells slightly decreased in 
comparison with its expression in the younger cells. This slight change in Etv5 expression 
might result from the role of Etv5 as regulator not only of stem cells but also in cancer cells 
especially in ovarian cancer cells (Llaurado et al., 2012a, Llaurado et al., 2012b, Zhao et al., 
2011).  
The older Thy-1 positive cells showed a clear decrease in ID4 expression. The reduction of 
ID4 would be expected from differentiated cells (Patel et al., 2015) and the senescent cells 
(Zhu et al., 2015). However, the old cells were essentially undifferentiated and they were 
propagating in a similar manner to cancer cells. The ID4 reduction in the (cancer like) Thy-1 
cells might be imputed to the number of primary cancers that showed low or no expression of 
the ID4 protein (Umetani et al., 2005, Wen et al., 2012, Baker et al., 2016). Although the 
findings of this chapter did not completely confirm the Thy-1 positive cells as stem cells, the 
Thy-1 positive cells exhibited the characteristics of stem cells in vitro.  
   5.3 In vitro differentiation of Thy-1 positive cells 
Work in chapter four demonstrated the differentiation of Thy-1 positive cells. Since Thy-1 
positive cells were generally undifferentiated cells and they have several characteristics of 
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mesenchymal stem cells. One of the main aspects of the adult stem cells is that they are 
multipotent. 
The differentiation of different cell types including stem cells has been conducted by the 
scientists using several differentiation factors. During embryonic development and adult cell 
differentiation, the gene expression patterns of the primary cell change to determine its fate as 
differentiated cells with a specific phenotype. Scientists have used approaches and materials 
that were similar to these factors, which are normally involved inducing differentiation.  
The choice of differentiation factors in this study was initially based on the expected effect of 
these factors on the target cells. For example, external factors such as forskolin and ACTH 
were used successfully to induce differentiation in several types of cells such as placental 
cells (Wu et al., 2013), neurones (Cao et al., 2012) and osteoblast (Li et al., 2014). The other 
method which was expected to induce differentiation was originally based on the 
development and event in the formation of adrenal cortex. These events usually start when a 
few AGP cells migrate dorsomedially and are destined to form an adrenal foetal zone. At that 
time these cells start expressing high levels of SF1 as the first characteristic of their 
differentiation (Xing et al., 2015). Therefore, we tried to imitate that event by transfecting 
Thy-1 positive cells with the Sf1 gene. 
Attempts to differentiate Thy-1 positive cells were first conducted using different 
concentrations of forskolin, ACTH (as a synthetic form of ACTH) and AT20 cell line media 
(as a mouse cell product form of all POMC peptides). The differentiation pathway of both 
Forskolin and ACTH are quite similar, which usually starts by stimulating intracellular cyclic 
AMP production, which in turn induces differentiation (Bhattacharya et al., 2012, Gilissen et 
al., 2015). The release of cyclic AMP as a differentiation factor normally occurs after 
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activation of a steroidogenic receptor, such as FSH to its receptor, which stimulates cyclic 
AMP production (Bhattacharya et al., 2012).  
However, Thy-1 positive cells showed no significant (P ≥ 0.05) response in the expression of 
steroidogenic genes (CYP11A1 and 3BHSD) and SF1 after 7 days of treatment with 
forskolin. 
The literature might explain the un-successful differentiation attempt using Forskolin. For 
example, the differentiation attempts that were carried out using forskolin to differentiate 
MScs into neurons suggested that cAMP pathway that induced by forskolin involved in 
changing the morphology of the cells but not the expression of the growth associated proteins 
that differentiate MSCs into neurons (Wislet-Gendebien et al., 2012). Other researchers 
concluded that cAMP could not complete the differentiation of bone marrow derived MSCs 
and most of the differentiation effect resulted from modifying the culture conditions rather 
than the forskolin treatment (Rooney et al., 2009, Zhang et al., 2011). However, Thy-1 
positive cells might lack forskolin receptor or a factor of the cAMP regulatory pathway 
required for forskolin effect. 
ACTH and AT20 cell line media also failed to induce differentiation in the Thy-1 positive 
cells. The differentiation effects of ACTH required the presence of its receptor in the cell 
membrane. Thy-1 positive cells lacked the expression of the melanocortin receptor type 2 
(MC2R), which is specific for ACTH. In general, Thy-1 positive cells showed no significant 
(P ≥ 0.05) response in the expression of steroidogenic genes (CYP11A1 and 3βHSD), and 
SF1 after 7 days of any of the three treatments (forskolin, ACTH and AT20 cell line media). 
The transfection of Thy-1 positive cells with the Sf1 gene showed significant responses. Sf1 
has been used in several differentiation experiments on a variety of stem cell types. For 
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example, Sf1 has been used to differentiate the mesenchymal non-steroidogenic stem cells 
(Yazawa et al., 2015) and murine embryonic stem cells (Jadhav and Jameson, 2011). Even 
after this study a recent literature revealed the potentials of Sf1 as a differentiation factor 
toward steroidogenesis which used to transform a fully differentiated cells such as urine-
derived cells, fibroblasts and blood cells into human induced steroidogenic cells (Ruiz-Babot 
et al., 2018). 
Three steroidogenic genes were proven to be under the regulation of Sf1: Cyp11A1 that 
encodes Scc (Hu et al., 2001b), 3βHSD (Leers-Sucheta et al., 1997) and Cyp 21 (Lee et al., 
1996). 
Thy-1 positive cells were transfected with the pIRES2 EGFP vector, which contained Sf1 
coding sequence at two-time points during their one year of in vitro cultivation: at three 
months and at eight months after initial isolation. The cells at both of these ages were 
undifferentiated. However, Thy-1 positive cells in their eighth month in vitro were 
transforming into immortal cells as previously discussed. Sf1 transfection into Thy-1 positive 
cells was conducted to induce temporary expression of the Sf1 gene in the cells to attempt 
differentiation. The successful transfection was achieved after several optimisation 
experiments, which were analysed one day after transfection with both plasmids (with the Sf1 
gene and the native-plasmid). The changes in Sf1 gene expression and other genes of interest 
in the transfected cells were tracked using RT-qPCR and immunocytofluorescence assays.  
The RQ analysis of RT-qPCR assays showed a significant (P< 0.01) increase in Sf1 
expression, which up-regulated Sf1 to over 4000 fold in the treated cells in comparison with 
untreated cells and the cells that were transfected with native-plasmid. However, the old Thy-
1 positive cells in their 8th month in vitro showed also high significant increase (P< 0.01) in 
216 
 
Sf1 expression that continued for 7 days after Sf1 transfection, in spite of their high 
proliferation rate. The high relative increase in Sf1 expression came from the very weak to no 
expression of Sf1 in the Thy-1 cells in addition to the successful transfection. 
The expression changes of several genes in Thy-1 positive cells were studied after 
transfection with Sf1. 
The main target of Sf1 transfection is to enhance the expression of the steroidogenic genes 
that are represented in differentiated adrenocortical cells (Cyp11A1, 3βHSD and Cyp 21), 
because several studies refer to Sf1 as a regulator of steroidogenic genes (Val et al., 2003). 
Others have suggested Sf1 initiates differentiation of MSCs to steroidogenic lineage 
(Mizutani et al., 2015).  
Both Cyp11A1 and 3βHSD were successfully up-regulated significantly (P ≥ 0.05) after Sf1 
transfection in the 8th month group and Cyp11A1 showed significant (P ≥ 0.05) increase after 
Sf1 transfection in the 3rd month group, which suggested that Sf1 might start steroidogenesis 
in the Thy-1 undifferentiated cells, which is in agreement with Mizutani et al., (2015). This 
up-regulating effect of Sf1 to Cyp11A1 might due to the two binding sites that Sf1 has at −40 
and −1,600 upstream of the CYP11A1 gene, which triggers CYP11A1 cAMP-dependent 
gene expression in vitro (Guo et al., 1994, Watanabe et al., 1994, Hu et al., 2001a). Sf1 also 
regulates the 3BHSD gene (Baba et al., 2014). However, Cyp21 did not show a significant (P 
≥ 0.05) response to the Sf1 transfection, which might be due to the sequence of 
differentiation events that required more than 7 days to show a detectable response of Cyp21, 
or that it required the interference of other factors.  
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Sf1 transfection caused a reduction in ID4 mRNA expression in both groups with continued 
reduction 1, 4 and 7 days after Sf1 transfection respectively. Sf1 transfection significantly 
(P< 0.05) decrease ID4 mRNA expression in the 3rd month group 
This reduction in ID4 mRNA expression after Sf1 transfection was in agreement with the role 
of ID4 as an inhibitor of differentiation (Patel et al., 2015). Gli1 also showed a gradual but 
non-significant (P ≥ 0.05) increase after 2 and 4 days of Sf1 transfection in both groups (3rd 
month and 8th moth groups). However, Gli1 mRNA expression reached a significant increase 
(P< 0.05) after 7 days of Sf1 expression in the 3rd month group. These changes might be 
related to the proposed role of Gli1 in the progenitor transition between stem cells and 
differentiated cells (Kim et al., 2009). From these results, we can propose that the Sf1 
transfection caused the transition of Thy-1 positive cells into progenitor/differentiated cells. 
Immunocytofluorescence assays also confirmed Sf1 protein expression in the transfected 
cells in both groups. The green fluorescent protein in the cytoplasm co-expressed with the 
Sf1 protein expression in the nucleus, which indicated that the transfection of Thy-1 positive 
cells with Sf1 gene successfully increased protein expression of Sf1. Although the expression 
of the genes of interest was traced only till 7 days after transfection, the characteristics of 
Thy-1 positive cells after transfection with Sf1 were changed toward differentiation.  
The amount of time and the appropriate in vitro microenvironment required to reach a fully 
differentiated state still unknown. Therefore, we recommend further investigations to induce 
specific differentiation of Thy-1 positive cells, which may start with Sf1 transfection and 
incubation for longer than 7 days and involve other differentiation factors in vitro. Or re-
inoculate Thy-1 positive cells into rat adrenal glands and trace their changes in vivo. 
218 
 
Other possible future work regarding differentiation may include using the properties of the 
adrenal cortex extracellular matrix, which is have been described as quite complex (Ruiz-
Babot et al., 2015). The reasons after this complexity are related to the different extracellular 
matrix components (collagen IV, fibronectin, and laminin (Chamoux et al., 2001), and each 
of them influences adrenal cortex cells differently. For example, collagen IV or laminin were 
found to enhance proliferation of human fetal adrenal cells, but fibronectin was found as an 
inducer of cell apoptosis. Furthermore, fibronectin and laminin decreased cell sensitivity to 
ACTH, whereas collagen increased cell sensitivity to ACTH (Chamoux et al., 2002). These 
characteristics of the adrenal cortex extracellular matrix may be harness-able to the purposes 
of Thy-1 positive cells differentiation.     
In terms of steroid identification and quantification after differentiation attempts, the future 
study might include the use of the multicomponent mass spectrometric detection technique. 
This technique can be combined to the detection of mRNA expression of the steroidogenic 





The investigation of adrenocortical stem cells in this study presented suggestion, detection 
and evaluation of three potential stem cells markers Klf5, Thy-1 and Tmem121. These 
markers showed interesting expression patterns in the adrenal cortex. However, the most 
representative stem cell marker (Thy-1) was used to isolate Thy-1 positive cells. The isolated 
cells were cultured in vitro and monitored for over one year. These cells demonstrated 
characteristics similar to those of MSCs in vitro. Furthermore, other stem cell markers were 
detected in these cells (WT1, Etv5 and ID4). These cells were tested for their potential 
differentiation capacity using differentiation factors such as forskolin, ACTH, AT20 cell line 
media and transfection with the Sf1 gene. The differentiation responses were only observed 
after Sf1 transfection, which significantly (P<0.05) elevated the expression of Gli1, Cyp11A1 
and 3BHSD. This study provides seminal findings for more investigation of adrenocortical 














Appendix A:  Stock solutions 
A.1.  10x DNase I reaction buffer  
100 mM Tris-HCl (pH 7.5 ) 
 25 mM MgCl2 
 1 mM CaCl2  
A.2. cDNA synthesis 5X reaction buffer 
250 mM Tris HCl (pH 8.3) 
 250 mM KCl 
 20 mM MgCl2 
 50 mM DTT) 
A.3. Buffer QC (wash buffer) 
1.0M NaCl 
50 mM MOPS pH 7.0 
15% isopropanol 
A.4. Buffer PE 
10 mM Tris-HCl pH 7.5 
80% ethanol 
A.5. 10x ligation buffer 
 300mMTris-HCl (pH 7.8) 
 100mM MgCl2  
100mM DTT and 10mM ATP 
A.6.A.Luria-Bertani (LB) broth  
10 g  of Tryptone, 5g  yeast extract and 10 g NaCl dissolved in 1 Litre of sterile distilled 
water and autoclaved.  
 A.6.B. LB agar plate  
         For LB agar plate: as above togather with 15g of agar. Then autoclaved and allowed to 
cool to 55C before addition of 2ml of 50mg/ml ampicillin in sterile distilled water. The 






A.7. Inoue transformation buffer 
 Preparation of Inoue transformation buffer for Competent Cells 
Inoue transformation buffer was prepared (chilled on ice bath before use).  0.5 M PIPES (pH 
6.7) (piperazine-1,2-bis[2-ethanesulfonic acid]) was Prepared by dissolving 15.1 g of PIPES 
in 80 ml of pure H2O, the pH of the solution was adjusted to 6.7 with 5 M KOH, and then 
pure H2O was added to bring the final volume to 100 ml. The solution Sterilized by 
filtration and divided into aliquots and stored frozen at -20ºC.  Inoue transformation buffer 
was prepared by dissolving all of the solutes listed below in 800 ml of pure H2O and then 
20 ml of 0.5 M PIPES (pH 6.7) was added and the volume of the Inoue transformation 
buffer adjusted to 1 litter with pure H2O. 
 
Reagent Amount per litre Final concentration  
MnCl2.4H2O 10.88g 55mM 
CaCl2.2H2O 2.20g 15mM 
KCl 18.65g 250mM 
PIPES(0.5 M, pH 6.7) 20 ml 10mM 
H2O To 1 litre  
 
A.8.Buffer P1  
• 50 mM Tris-HCl pH 8.0  
• 10 mM EDTA  
• 100 μg/ml RNaseA  
A.9. Buffer P2  
• 200 mM NaOH  
• 1% SDS 
• 3.0 M potassium acetate pH 5.5  
A.10.Buffer N3  
• 4.2 M Gu-HCl  
• 0.9 M potassium acetate  





A.11.Buffer PE  
• 10 mM Tris-HCl pH 7.5  
• 80% ethanol  
A.12.Buffer P3 :   
3.0 M potassium acetate, pH 5.5 
A.13. Buffer QBT (equilibration buffer) 
▪ 750 mM NaCl 
▪ 50 mM MOPS pH 7.0 
▪ 15% isopropanol 
▪ 0.15% triton X-100 
A.14. Buffer QC (wash buffer) 
▪ 1.0M NaCl 
▪ 50 mM MOPS pH 7.0 
▪ 15% isopropanol 
A.15 Buffer QF (elution buffer) 
▪ 1.25M NaCl 
▪ 50 mM Tris-HCl pH 8.5 
▪ 15% isopropanol 
A.16 Buffer TE  
• 10 mM Tris·Cl, pH 8.0 
• 1 mM EDTA 
A.17.10X MULTI-CORE™ Buffer  
• 250mM Tris-acetate (pH 7.5 at 37°C) 
• 1000mM potassium acetate 
• 100mM magnesium acetate 
• 10mM DTT 
A.18.  5x Transcription buffer 
▪ 250 mM Tris-HCl (pH 8.3 at 25°C) 
▪ 375 mM KCl 





▪ 50 mM DTT 
A.19.  4%PFA in PBS 
For 1 L of 4% Formaldehyde, 800 mL of 1X PBS was added to a glass beaker on a stir plate 
in at 60 °C. 40 g of paraformaldehyde powder was added to the heated PBS solution. Once 
the paraformaldehyde is dissolved, the solution should be cooled and filtered. The pH, 
rechecked and adjusted to approximately 6.9. The volume of the solution was completed to 
1 L with 1X PBS. The solution aliquoted and frozen at -20°C for up to one month. 
 
A.20. Hybridisation buffer 
50 ml of  
50%Formamide 
SSC (5X) 
100ug/ml Fish sperm DNA (Sigma)   
 
A.21.  20x SSC (1 litre) stock solution 
1. NaCL 175.3g 
2. Tri-Sodium citrate 88.2g 
3.  Dissolve in water 800ml 
4. Adjust pH to 7.0 with 10N NaOH/HCL  
5.  DEPC 1ml 
Stand at RT overnight in fume hood. Sterilise by Autoclave. 5x,2x and 0.2x SSC dilute of 
20x in DEPC H2O. 
A.22. RNA wash buffer  
400mM NaCl 
10mM TrisHCl, pH 7,5 
5mM EDTA 
A.23. Post-fixation solution 
  Prepare a solution of 2% formaldehyde in PBS, containing 20 mg/mL bovine serum 
albumin.  This solution can be used immediately or stored at 4°C for up to six months.  
A.24 PBT (500ml) 
 Water 500ml 





 Shake properly and stand at RT overnight in fume hood, loose lid. Sterilise by Autoclave. 
Pre-warm the triton. Then add 500ul Triton X-100. 
  
A.25. TMB  
50mM sodium acetate anhydrous,3.6g citric acid, dissolve in 600ml water then add: 
 270mg TMB (from sigma) dissolved in 400ml methanol, store in dark at 4oC. 
Western Blotting Solution and Reagents 
A.26.Loading buffer (5X):  
5mL 0.3M Tris•HCl, pH6.8, 5% SDS, 50% glycerol, lane marker tracking dye 
A.27. 5X Tris –Glycin electrophoresis (Running Buffer) 
        
1 Litter: 
1. 15.1g Tris base 
2. 94g Glycine (in 900ml ddH2O) 
3. Then add 50ml of 10%SDS 
4. Complete to 1 litter by ddH2O 
1X Tris –Glycin electrophoresis (Running Buffer) 
1 Litter: 
1. 200ml  of 5X Tris –Glycin electrophoresis (Running Buffer) 
2.  Add 800ml of ddH2O 
Check the pH and adjust to pH 8.3    
A.28. Transfer Buffer 
1 Litter: 
1. 2.9g Glycine 
2. 2.8g Trise base 
3. 200ml Methanol 
4. Complete to 1 litter by ddH2O 
Check the pH and adjust to pH 8.3   if necessary 
A.29. 10X Tris Buffer Saline (TBS) 
 
1 Litter: 
1. 80g of NaCl 
2. 2g KCl 
3. 30g Tris base 





5. Adjust to the pH to 7.4 using concentrated HCl    
6. Complete to 1 litter by ddH2O 
 
1X Tris Buffer Saline Tween (TBST) 
 
1 Litter: 
1. 100ml of 10X TBS 
2. 900ml of ddH2O 
3. 1ml of Tween 20 
Check the pH and adjust to pH 8.3   if necessary  
 
Running Buffer 10X. 
  
35 mM SDS                (10.08 g) 
250 mM Tris               (30.3 g) 
1,92 M glycine             (144g) 
  





Appendix B: Vectors structure 
B.1 pGEM®-T Easy Vector  
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